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PREFACE
The Occupational Safety and Health Act of 1970 emphasizes the need 
for standards to protect the health and safety of workers exposed to an 
ever-increasing number of potential hazards at their workplace. The 
National Institute for Occupational Safety and Health has projected a 
formal system of research, with priorities determined on the basis of 
specified indices, to provide relevant data from which valid criteria for
effective standards can be derived. Recommended standards for occupational 
exposure, which are the result of this work, are based on the health 
effects of exposure. The Secretary of Labor will weigh these recommen­
dations along with other considerations such as feasibility and means of 
implementation in developing regulatory standards.
It is intended to present successive reports as research and epide­
miologic studies are completed and as sampling and analytical methods are 
developed. Criteria and standards will be reviewed periodically to ensure 
continuing protection of the worker.
I am pleased to acknowledge the contributions to this report on 
dioxane by members of my staff and the valuable, constructive comments by
the Review Consultants on dioxane, by the ad hoc committees of the American
Academy of Industrial Hygiene and the American Academy of Occupational
Medicine, and by Robert B. O'Connor, M.D., NIOSH consultant in 
occupational medicine. The NIOSH recommendations for standards are not
necessarily a consensus of all the consultants and professional societies 
that reviewed this criteria document on dioxane. Lists of the NIOSH Review 
Committee members and of the Review Consultants appear on the following 
pages.
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Director, National Institute for 
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Division, had NIOSH program responsibility and 
served as criteria manager. Tabershaw-Cooper 
Associates Inc. developed the basic information for 
consideration by NIOSH staff and consultants under 
contract HSM-99-73-39.
The Division Review of this document was provided by 
Keith H. Jacobson, Ph.D. (Chairman), Douglas L. 
Smith, Ph.D., Frank L. Mitchell, D.O., and Clara H. 
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I. RECOMMENDATIONS FOR A DIOXANE STANDARD
The National Institute for Occupational Safety and Health (NIOSH) 
recommends that worker exposure to dioxane (p-dioxane, 1,4-dioxane, 
diethylene dioxide, glycol ethylene ether) in the workplace be controlled 
by adherence to the following sections. The standard is designed to 
protect the health and provide for the safety of employees for up to a 10- 
hour workday, 40-hour workweek, during their working lifetime. Compliance 
with all sections of the standard should minimize adverse effects of 
exposure to dioxane on the health and safety of employees. The recommended 
environmental limit presented should be regarded as the upper limit of 
exposure, and every effort should be made to maintain exposure as low as is 
technically feasible. The standard is measurable by techniques that are 
valid and available to industry and government agencies. Sufficient 
technology exists to permit compliance with the recommended standard. The 
criteria and standard will be subject to review and revision as necessary.
Dioxane is a volatile liquid which can readily penetrate intact skin 
to cause systemic effects, which include adverse renal and hepatic changes. 
Exposure to dioxane may also cause cancer, a conclusion interpreted from 
experimental studies with animals, and much of the recommended standard is 
based on this conclusion. Because of the carcinogenic action of dioxane 
and its ability to penetrate the skin, occupational exposure to dioxane is 
defined as any work in workplaces where dioxane is handled, manufactured, 
or otherwise used, except where it is present as an unintentional 
contaminant in other chemical substances at less than 1% by weight or where 
it is only stored in leak-proof containers. The recommended exposure
limit, based on the belief that dioxane can be tumorigenic, is the lowest 
concentration reliably measureable by the sampling and analytical methods 
selected.
Section 1 - Environmental (Workplace Air)
(a) Concentration
Occupational exposure to dioxane shall be controlled so that
employees are not exposed at airborne concentrations greater than 1 ppm 
(3.6 mg/cu m) based on a 30-minute sampling period.
(b) Sampling and Analysis
Procedures for sampling and analysis of workroom air shall be as 
provided in Appendices I and II or by any method shown to be at least 
equivalent in sensitivity, accuracy, and precision.
Section 2 - Medical
Medical surveillance shall be made available as outlined below to all 
workers subject to occupational exposure to dioxane.
(a) Preplacement examinations shall include at least:
(1) Comprehensive medical and work histories with special
emphasis directed toward disorders of the upper respiratory system, and 
hepatic and renal functions.
(2) Physical examination giving particular attention to
nares, and the hepatic and renal systems.
(3) Specific clinical tests to include at least liver and
kidney function tests such as SGOT, SGPT, and a complete urinalysis.
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(4) A judgment of worker's ability to use positive pressure
respirators.
(b) Periodic examinations shall be made available at least
annually. These examinations shall include at least:
(1) An interim medical and work history.
(2) A physical examination as outlined in (a)(2) and (3)
above.
(c) Initial examinations shall be made available to all workers
occupationally exposed to dioxane within six months after the promulgation 
of a standard based on these recommendations.
(d) Pertinent medical records shall be maintained for all
employees exposed to dioxane in the workplace. Such records shall be kept
for at least 30 years after termination of employment. These records shall
be made available to the designated medical representatives of the
>■
Secretary of Health, Education, and Welfare, of the Secretary of Labor, of 
the employer, and of the employee or former employee.
Section 3 - Labeling and Posting
All labels and warning signs shall be printed both in English and in 
the predominant language of non-English-reading employees. Employees 
unable to read the language used on labels and posted signs shall be 
appropriately Informed of the location of hazardous areas and of the 
instructions on labels and signs.
(a) Labeling
The following warning label shall be affixed in a readily visible 
location on dioxane processing or other equipment and on dioxane storage 
tanks or containers:
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DIOXANE
warning:
CANCER-SUSPECT AGENT
BREATHING VAPOR MAY BE HAZARDOUS TO HEALTH 
HARMFUL IF ABSORBED THROUGH SKIN OR IF INHALED
Avoid breathing vapor.
Avoid contact with skin or eyes.
Use only with adequate ventilation. 
Keep containers closed when not in use. 
Wash thoroughly after using. 
Extremely flammable.
May explode.
Keep away from heat, sparks, 
open flame and oxidizing materials.
First aid: In case of skin or eye contact, immediately flush eyes or skin
with water for at least 15 minutes. Call a physician.
If swallowed, induce vomiting immediately if patient is conscious. Call a 
physician.
(b) Posting
Areas in which dioxane is present shall be posted with a sign 
reading:
DIOXANE
WARNING! CANCER-SUSPECT AGENT 
HARMFUL IF ABSORBED THROUGH SKIN OR IF INHALED 
Extremely flammable.
May explode.
Do not use near open flame or oxidizing materials.
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Section 4 - Personal Protective Equipment and Protective Clothing
(a) Respiratory Protection
(1) Engineering controls shall be used if needed to 
maintain dioxane concentrations at or below the prescribed limit.
Compliance with the permissible exposure limit may be achieved by the use
of respirators only:
(A) During the time period necessary to install or 
test the required engineering controls;
(B) For nonroutine operations such as brief exposure 
at concentrations in excess of the environmental limit or for nonroutine 
maintenance or repair activities;
(C) During emergencies when air concentrations of 
dioxane may exceed the permissible limit.
(2) When respirators are permitted by paragraph (a) (1) of
this section, they shall be selected and used pursuant to the following
requirements:
(A) The employer shall ensure that no employee is
being exposed to dioxane in excess of the environmental limit because of
improper respirator selection, fit, use, or maintenance.
(B) The employer shall establish and enforce a 
respiratory protection program meeting the requirements of 29 CFR 1910.134.
(C) The employer shall provide respirators in 
accordance with Table 1-1 and shall ensure that the employee uses the 
respirators in a proper manner when the concentration of airborne dioxane 
exceeds the recommended concentration limit.
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(D) Respiratory protective devices described in 
Table 1-1 shall be those approved by NIOSH or the Mining Enforcement and 
Safety Administration. The standard for approval is 30 CFR 11.
(E) The employer shall ensure that chemical 
cartridges and canisters are not used with dioxane except for evacuation or 
escape.
(F) The employer shall ensure that respirators are 
adequately cleaned, maintained, and stored, and that employees are 
instructed and drilled, at least annually, in the proper use and testing of 
respirators assigned to them.
(G) Respirators shall be easily accessible and 
employees shall be informed of their location.
TABLE 1-1
RESPIRATOR SELECTION GUIDE FOR PROTECTION
AGAINST DIOXANE
Concentrations of 
Dioxane
Respirator Type Approved under 
Provisions of 30 CFR 11
Greater than the 
recommended environmental 
limit (1 ppm) or 
entry
into area of un­
known concentra­
tion for emergency 
purposes
(1) Self-contained breathing apparatus 
with full facepiece operated in pres- 
sure-demand or other positive pressure 
mode
(2) Combination Type C supplied-air 
respirator with full facepiece operated 
in pressure-demand mode with auxiliary 
self-contained air supply
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(b) Protective Clothing
Protective clothing shall be worn in any operation in which the 
employee may come into direct contact with liquid dioxane. The clothing 
shall be impervious to penetration and resistant to degradation by dioxane. 
Neoprene-coated gloves, boots, overshoes, and bib-type aprons that cover 
boot tops shall be provided when necessary. Impervious supplied-air hoods 
or suits shall be worn when entering confined spaces, such as pits or 
tanks, unless known to be safe. In situations where heat stress is likely 
to occur, air-supplied suits, preferably cooled, are recommended. The 
employer shall ensure that all personal protective clothing is inspected 
regularly for defects and is maintained in a clean and satisfactory 
condition by the employee.
(c) Eye Protection
Eye protection shall be provided to, and worn by, each employee
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engaged in an operation in which dioxane, liquid or spray, may enter the 
eye. Chemical-type goggles, safety glasses with splash shields, or plastic 
face shields (8-inch minimum) made completely of dioxane-resistant material 
shall be used. Suitable eye protection shall be in accordance with 29 CFR 
1910.133 and ANSI Z87.1-1968.
Section 5 - Informing Employees of Hazards from Dioxane Exposure
(a) All new and present employees working where occupational
exposure to dioxane may occur shall be informed of the hazards, signs and 
symptoms of dioxane exposure, appropriate emergency procedures, and proper 
conditions and precautions concerning safe use and handling of dioxane.
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(b) All employees occupationally exposed to dioxane shall be 
informed that dioxane has induced cancer in experimental animals after 
repeated oral ingestion and that, because of this finding, it is concluded 
that dioxane is a potential human carcinogen.
(c) Employers shall institute a continuing education program to 
ensure that all employees have current knowledge of job hazards and 
procedures for maintenance, cleanup, emergency, and evacuation. This 
program should include at least the following:
Emergency procedures and drills.
Instruction in handling spills and leaks.
Decontamination procedures.
Firefighting equipment location and use.
First-aid procedures, equipment location, and use.
Rescue procedures.
Confined space entry procedures, if relevant.
Inadequacy of odor as a means of detection.
The training program shall include a description of the general 
nature of the environmental and medical surveillance procedures and why it 
is advantageous for the worker to participate in these procedures.
Records of such training should be kept for at least 5 years. This 
training program shall be held at least annually, or whenever there is a 
process change, for all employees with occupational exposure to dioxane.
(d) Workers shall be informed that cancer has been induced in 
animals treated with dioxane at concentrations considerably higher than 
work environment exposures.
(e) Information as required shall be recorded on US Department of 
Labor Form 0SHA-20, "Material Safety Data Sheet," or similar form approved 
by the Occupational Safety and Health Administration, US Department of 
Labor.
Section 6 - Work Practices
(a) Emergency Procedures
Procedures for emergencies, including fires, shall be established to 
meet foreseeable potential events. Necessary emergency equipment shall be 
kept in readily accessible locations. Where appropriate, respirators shall 
be available for use during evacuation.
(b) Control of Airborne Dioxane
(1) Suitable engineering controls designed to limit 
exposure to dioxane to that prescribed in Section 1(a) shall be used. The 
use of completely enclosed processes is the recommended method for control 
of dioxane. Local exhaust ventilation may also be effective, used alone or 
in combination with process enclosure. When a local exhaust ventilation 
system is used, it shall be designed to prevent the accumulation or 
recirculation of dioxane in the workroom, to maintain dioxane 
concentrations below the limit of the recommended standard, and to remove 
dioxane from the breathing zones of employees. Exhaust systems discharging 
into outside air must conform with applicable local, state, and federal air 
pollution regulations. Ventilation systems shall be subjected to regular 
preventive maintenance and cleaning to ensure effectiveness, which shall be 
verified by periodic airflow measurements at least every 3 months. 
Measurements of system efficiency shall also be made immediately by 
personnel properly attired in any needed protective equipment and clothing 
when any change in production, process, or control might result in 
increased concentrations of airborne dioxane. Tempered makeup air shall be 
provided to work areas in which exhaust ventilation is operating.
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(2) Forced-draft ventilation systems shall be equipped with
remote manual controls and shall be designed to turn off automatically in
the event of a fire in the work area.
(3) Exhaust vents to the outside shall be so located as to 
prevent the return of the exhausted air via air-intakes.
(4) Buildings in which dioxane is used and where it could
form an explosive air-mixture shall be explosion-proof. Explosion vents
are available and are effective on windows, roof and wall panels, and
skylights as a safeguard against destruction of buildings and equipment in
which flammable vapors may accumulate. Stair enclosures shall also be
fire-resistant and shall have self-closing fire doors.
(c) General Work Practices
(1) Safety showers and eyewash fountains shall be installed
in areas where dioxane is handled or used. The employer shall ensure that 
the equipment is in proper working order through regularly scheduled
inspections performed by qualified maintenance personnel.
(2) Transportation and use of dioxane shall comply with all
applicable local, state, and federal regulations.
(3) When dioxane containers are being moved, or when they
are not in use and are disconnected, valve protection covers shall be in 
place. Containers shall be moved only with the proper equipment and shall 
be secured to prevent dropping or loss of control while moving.
(4) Process valves and pumps shall be readily accessible
and shall not be located in pits or congested areas.
(5) Containers and systems shall be handled and opened with
care. Approved protective clothing as specified in Section 4 shall be worn
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while opening, connecting, and disconnecting dioxane containers and 
systems. Adequate ventilation shall be provided to prevent exposure to 
dioxane when opening containers and systems.
(6) Personnel shall work in teams when dioxane is first
admitted to systems, while repairing leaks, or when entering a confined or 
enclosed space.
(7) Containers of dioxane shall be bonded and grounded to
prevent ignition by static electrical discharge.
(8) Smoking shall not be permitted in work areas where
there is dioxane.
(d) Work Areas
(1) Dioxane Hazard Areas
A hazard area is any space with physical characteristics and 
sources of dioxane that could result in air concentrations in excess of the 
recommended limit. Exits shall be plainly marked and shall open outward. 
Emergency exit doors shall be conveniently located and shall open into 
areas which will remain free of contamination in an emergency. At least
two separate means of exit shall be provided from each room or building in
which dioxane is stored, handled, or used in quantities that could create a 
hazard.
(2) Confined or Enclosed Spaces
Entry into confined spaces, such as tanks, pits, process
vessels, tank cars, sewers, or tunnels where there may be limited egress,
shall be controlled by a permit system. Permits shall be signed by an 
authorized employer representative certifying that proper preventive and 
protective measures have been followed.
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Confined spaces which have contained dioxane shall be 
thoroughly ventilated to ensure an adequate supply of oxygen, tested for 
dioxane and other contaminants, and inspected for compliance with these 
requirements prior to each entry. Adequate ventilation shall be maintained 
while workers are in the confined space. Leakage of dioxane into the 
confined space while work is in progress shall be prevented by 
disconnecting and blanking the dioxane supply lines. Individuals entering 
confined spaces shall be furnished with appropriate personal protective 
equipment and clothing and connected by a lifeline harness tended by 
another worker outside the space, who shall also be equipped for entry with 
approved personal protective equipment and who has contact with a third 
party. Communication (visual, voice, signal line, telephone, radio, or 
other suitable means) shall be maintained by the standby person with the 
employee inside the confined or enclosed space.
(e) Storage
(1) Dioxane shall be stored in tightly closed containers in 
a well-ventilated area away from excessive heat and sunlight.
(2) Containers shall be stored in a safe manner to minimize 
the possibility of accidental breakage or spill.
(3) Storage containers shall be periodically inspected for
leakage.
(4) Ventilation switches and emergency respiratory 
equipment shall be located outside storage areas in readily accessible 
locations which will be free of dioxane in an emergency.
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(f) Cleanup of Spills and Waste Disposal
(1) If dioxane is spilled, the following steps shall be
taken:
(A) Evacuate all nonessential personnel from the
area.
(B) Adequately ventilate the area of the spill to
prevent accumulation of the vapor.
(C) If in liquid form, collect for reclamation or 
absorb in vermiculite, dry sand, earth, or similar nonreactive material.
(2) Personnel entering the spill area shall be furnished 
with appropriate personal protective equipment and clothing. All other 
personnel shall be prohibited from the area.
(3) All wastes and residues containing dioxane shall be 
collected in dioxane-resistant containers and disposed of in a manner not
hazardous to employees or to the general population. Dioxane wastes shall
be appropriately marked. In selecting the method of waste disposal,
applicable local, state, and federal regulations shall be followed.
Section 7 - Sanitation Practices
(a) Appropriate locker rooms shall be available for changing into 
required protective clothing in accordance with 29 CFR 1910.141(e), which 
requires separate storage for street clothes and protective clothing. 
Clothing contaminated with liquid dioxane shall be immediately removed and 
placed in a closed container in a well-ventilated area for later disposal 
or decontamination. Employers shall ensure that personnel who work with
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dioxane shower before leaving the workplace at the end of a workday.
(b) Employers shall provide for decontamination of contaminated 
clothing, for example, by proper laundering. Commercial laundries, if 
used, shall be advised of dioxane hazards and of proper procedures for 
protection of laundry employees.
(c) Employers shall ensure that employees who handle dioxane wash 
their hands thoroughly with soap and water before eating, smoking, or using 
toilet facilities.
(d) The storage, preparation, dispensing, and consumption of food 
or beverages or smoking shall be prohibited in dioxane work areas.
Section 8 - Monitoring and Recordkeeping Requirements
(a) Personal Monitoring
A program of breathing zone or personal monitoring shall be 
instituted to identify and measure the exposure of all employees 
occupationally exposed to dioxane. This sampling and analysis shall be 
conducted at least every 3 months on at least 50% of the workers so that 
each worker’s exposure is measured at least twice a year; this frequency 
and fraction of employees sampled may be different if so directed by a 
professional industrial hygienist. Sufficient numbers of samples shall be 
collected and analyzed to permit construction of valid estimates of the 
exposures of employees during each workshift; the number of samples and 
concentration determinations shall be based on such factors as mobility and 
job functions of workers in that operation. If monitoring of any employee 
shows exposure in excess of the recommended environmental limit, additional 
monitoring shall be promptly initiated. If confirmed, control procedures
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shall be instituted as soon as possible; these may precede and obviate 
confirmatory monitoring if the employer desires. Affected employees shall 
be advised that exposures have been excessive and be notified of the 
control procedures being implemented. Monitoring of these employees’ 
exposures shall be conducted at least as often as every 30 days and shall 
continue until two successive samplings at least a week apart confirm that 
exposure no longer exceeds the permissible limit. Normal monitoring may 
then be resumed.
(b) Recordkeeping
Environmental monitoring records shall be maintained for at least 30 
years. These records shall include methods of sampling and analysis used, 
types of respiratory protection used, and concentrations found. Each 
employee shall be able to obtain information on his own environmental 
exposures. Environmental records shall be made available to designated 
representatives of the Secretary of Labor and of the Secretary of Health, 
Education, and Welfare.
Pertinent medical records shall be retained for 30 years after the 
last occupational exposure to dioxane. Records of environmental exposures 
applicable to an employee should be included in that employee's medical 
records. These medical records shall be made available to the designated 
medical representatives of the Secretary of Labor, of the Secretary of 
Health, Education, and Welfare, of the employer, and of the employee or 
former employee.
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II. INTRODUCTION
This report presents the criteria and the recommended standard based 
thereon which were prepared to meet the need for preventing occupational 
diseases arising from exposure to dioxane. The criteria document fulfills 
the responsibility of the Secretary of Health, Education, and Welfare under 
Section 20(a)(3) of the Occupational Safety and Health Act of 1970 to 
"...develop criteria dealing with toxic materials and harmful physical 
agents and substances which will describe...exposure levels at which no 
employee will suffer impaired health or functional capacities or diminished 
life expectancy as a result of his work experience."
The National Institute for Occupational Safety and Health, after a 
review of data and consultations with others, formalized a system for the 
development of criteria upon which standards can be established to protect 
the health and to provide for the safety of employees from exposure to 
hazardous chemical and physical agents. The criteria and recommended 
standard should enable management and labor to develop better engineering 
controls and more healthful work practices and simply complying with the 
recommended standard should not be the final goal.
These criteria for a standard for dioxane are part of a continuing 
series of criteria developed by NIOSH. The proposed standard applies only 
to the processing, manufacture, and use of dioxane as applicable under the 
Occupational Safety and Health Act of 1970. The standard was not designed 
for the population-at-large, and any extrapolation beyond occupational 
exposures is not warranted. It is intended to (1) protect workers against 
development of systemic effects and against local effects on the skin and
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eyes, (2) be measurable by techniques that are valid, reproducible, and 
available to industry and governmental agencies, and (3) be attainable with 
existing technology.
Experimental toxicologic studies in mice, rats, and guinea pigs have 
indicated that dioxane can cause malignant tumors. These studies involved 
administration of the compound in drinking water. There is also equivocal 
evidence of carcinogenesis from dioxiane when applied dermally, but this 
evidence has not been judged persuasive. While experimental inhalation 
studies and limited epidemiologic studies have not supported the 
implications that dioxane is carcinogenic, these studies have not been 
considered to be sufficient to negate the implications of the studies of 
dioxane administered at higher doses in the drinking water. Since a safe 
limit for this chemical substance, judged to be carcinogenic, is not known, 
a limit based on the sensitivity of the analytical and sampling methods has 
been recommended.
Concern for the carcinogenic and other toxic properties of dioxane by 
manufacturers may stimulate action to replace dioxane, for example, as a 
stabilizer for trichloroethane, by chemicals presumed or known to be much 
less toxic. Such manufacturers are urged to ensure that the substitutes 
are known, rather than presumed, to pose more acceptable toxicity 
properties.
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III. BIOLOGIC EFFECTS OF EXPOSURE
Extent of Exposure
Dioxane (C4H8 02), also known as p-dioxane, is a colorless combust­
ible liquid with a faint pleasant ethereal odor similar to that of absolute 
ethyl alcohol. Other names commonly used for dioxane are 1,4-dioxane, 
diethylene dioxide, diethylene ether, and glycol ethylene ether. The more 
significant physical and chemical properties are listed in Table XII-1 [1- 
3].
Dioxane was first prepared by Lourenco [4] in 1863 by heating 
ethylene glycol with ethylene dibromide in sealed tubes for several days at 
160 C. At about the same time, Wurtz [5] prepared dioxane by treating 
dioxane dibromide with hydrogen sulfide or mercury at room temperature. 
The dibromide of dioxane resulted from the reaction of one mole of bromine 
with two moles of ethylene oxide at low temperatures [6],
Dioxane is produced commercially by dehydrogenation of ethylene 
glycol [7], It can also be produced by catalytic dimerization of ethylene 
oxide in the vapor phase or by reaction of bis(2-chloroethyl) ether or 2- 
chloroethyl-2'-hydroxyethyl ether with strong aqueous sodium hydroxide [8].
Dioxane became available in commercial quantities around 1929 and 
has been used industrially as a solvent for fats, waxes, greases, paint and 
varnish strippers, resins, polyvinyl polymers, dyes, lacquers, varnishes, 
paints, mineral oil, celluloid, and similar products where nitrocellulose, 
cellulose acetate, or other cellulose esters or ethers are used. It has 
had a minor use as a wetting agent and dispersing agent in dye baths, 
textile processing, and stain and printing compositions [1,7,9,10], It has
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been used in cleaning and detergent preparations, adhesives, cosmetics, 
emulsions, polishing compositions, and as a stabilizer for chlorinated 
solvents. Dioxane has also been used as a preservative, fumigant, 
deodorant, and as the nonaqueous solvent with lead-ion selective electrodes
[11]. It was formerly used in the preparation of tissue sections for 
histology [12,13],
Dioxane has also been used as a solvent in the purification of 
organic compounds and in molecular weight determinations [14]. In 1974, 
Ziegler and Wilke [15] described a method for radioimmunoassay of glucagon 
after extraction of blood with dioxane.
There are two large and two small dioxane-manufacturing plants in the 
United States [16], The two larger plants produce annually about 10 and 5 
million pounds of dioxane, respectively, and one of the smaller plants 
produces about 1 million pounds. Most of the dioxane produced is used as a 
solvent as previously discussed [1,7,9,10] and as a stabilizer in 
chlorinated solvents [written communication, R Daniels, March 1977]. NIOSH 
estimates that 100,000 US workers are exposed to 1,1,1-trichloroethane 
[17], and many of these are also exposed to dioxane. NIOSH further 
estimates that an additional 2,500 people in the United States are exposed 
to dioxane in their work environment.
A summary of some operations where dioxane exposure may occur is 
presented in Table XII-2 [18].
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Historical Reports
Dioxane was prepared as early as 1863 [4,5] but it was not used 
commercially until 1929 [9].
The earliest studies of the biologic effects of dioxane on guinea 
pigs and humans were reported in 1930 by Yant et al [19], The first report 
of adverse effects from industrial use of dioxane appeared in 1934 in which 
five fatalities occurred when a change was instituted in a process where 
dioxane was used as a solvent [20].
A 1934 report by Fairley et al [21] on human exposures to dioxane at 
1,000 and 2,000 ppm for 3-5 minutes concluded that, beyond an unpleasant 
sensation of warmth in the throat and chest, there were no subjective 
responses to warn workers of dioxane exposure. In a series of 15-minute 
exposures to dioxane at 200 and 300 ppm, Silverman and coworkers [22] 
reported in 1946 that, although the odor was not objectionable, the 
majority of subjects complained of irritation of the eyes, nose, and throat 
at dioxane concentrations above 200 ppm. The dioxane occupational 
literature was reviewed by Estler in 1935 [23], Gross in 1943 [24], Smyth 
in 1952 [25], Rowe in 1963 [2], and Browning in 1965 [1],
Effects on Humans
(a) Experimental Studies
Experimental studies to determine the effects of dioxane on humans 
have been limited to identifying sensory responses during exposures lasting 
15 minutes or less [19,21,22,26-28]. Yant et al [19], in 1930, described 
the effects on five volunteers after they inhaled air containing 5,500 ppm 
dioxane for 1 minute. Signs and symptoms of exposure included eye
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irritation, a burning sensation in the nose and throat, and, in three
subjects, a slight vertigo that disappeared "quickly" after they left the
exposure chamber. When the same five subjects were exposed to air 
containing 1,600 ppm dioxane for 10 minutes, they experienced an immediate 
slight burning of the eyes with lacrimation and a slight irritation of the 
nose and throat. The alcohol-like odor of dioxane, easily noticeable at 
first, decreased in intensity with continued exposure. Lacrimation and 
nasal irritation persisted throughout the test. No vertigo was noticed, 
but one subject complained of an upset stomach after the exposure had been 
completed. The specifications of the exposure chamber, the purity of 
dioxane, and the methods of generating and measuring the dioxane
atmospheres were not reported.
A 99.8% dioxane-0.2% water preparation, completely free of aldehydes 
and other impurities, was used in studies reported in 1936 by Wirth and 
Klimmer [26], Several subjects were simultaneously exposed in a 10-cu m 
glass and stoneware exposure chamber at dioxane concentrations of 0.7, 1.4, 
2.8, 5.6, 8.4, 280, 1,400, and 2,800 ppm. The lower concentrations (8.4
ppm and less) were generated by evaporating the calculated amount of 
dioxane from a filter paper with the aid of a fan. The higher
concentrations were attained by dispersing dioxane using a compressed-air 
sprayer. The duration of the exposures was not reported. The detection 
threshold, the concentration at which dioxane was perceived as an 
unidentified odor, was 2.8 ppm. At a concentration of 5.6 ppm, the odor, 
which was described as fruity and not unpleasant, was identified as that of 
dioxane. As the concentration was increased, the odor was eventually 
described as that of methylated spirits. Slight mucous membrane irritation
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occurred at 280 ppm, while at 1,400 ppm the irritation was quite distinct 
with slight stinging in the nose and scratchiness and dryness in the 
throat. At 2,800 ppm, irritation was initially very strong and complaints 
of slight pressure in the chest were expressed. The subjects became 
accustomed to the irritation and odor after a few minutes, but continued to 
experience an unpleasant, metallic, bitter taste. The application of 0.05 
ml of either pure or technical grade dioxane three times daily to the 
underside of the forearm dried the skin but caused no other signs of 
irritation. When liquid dioxane was dropped on the mucous membrane of the 
mouth, a temporary, slight burning sensation was experienced [26].
In experiments reported in 1946, Silverman and coworkers [22] found, 
in 15-minute exposures to dioxane, that a concentration greater than 200 
ppm was required to cause eye, nose, or throat irritation in the majority 
of subjects. The subjects were exposed at either 200 or 300 ppm technical 
grade dioxane in a 1,200-cu ft chamber. Air-vapor concentrations were 
produced in a dynamic exposure chamber by continuously adding a known 
quantity of air saturated with dioxane to the measured flow of air being 
continually forced into the chamber. Motion pictures were shown during the 
exposure to occupy the subjects' attention. The exact number of subjects 
was not given, but an average of 12 men and women were used for each of a 
number of exposures to different concentrations of dioxane. The majority 
experienced eye, nose, and throat irritation at a dioxane concentration of 
300 ppm, although they did not find the odor objectionable. No further 
details or experimental results were reported.
A dioxane odor threshold of 170 ppm was reported by May [27] in 1966, 
with a pronounced odor being noticed at 270 ppm. In this experiment, a
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panel of eight men and eight women between the ages of 31 and 63 sniffed 
graded dilutions of dioxane from wide-mouth flasks. This 170-ppm odor 
threshold was considerably higher than either the 2.8-ppm threshold for 
detection or the 5.6-ppm threshold for recognition reported by Wirth and 
Klimmer [26], or the 100% odor recognition threshold of 5.7 ppm reported by 
Heilman and Small [28], An odor fountain, used by the latter investigators 
[28], was placed about 14 inches below the vent pipe which carried the 
odorous stream out of the exposure chamber. With the exception of valves 
and couplings made of stainless steel, the system was constructed of glass 
and Teflon to minimize absorption of the odorant. The concentration of the 
odorant at the odor fountain could be changed within 1 minute. The 
detection threshold was 1.8 ppm and the recognition threshold was 5.7 ppm 
[28].
Studies of dioxane exposure of four healthy male volunteers were 
conducted at a concentration of 50 ppm (48-52 ppm) for 6 hours and reported 
by Young et al [29] in 1976. An extensive physical examination including a 
chest X-ray, an electrocardiogram, respiratory function tests, conventional 
blood chemistry determinations, and urinalysis were conducted on the 
volunteers prior to the study. Following the exposure, all the tests 
except the chest X-rays were repeated at 24 hours and at 2 weeks. Samples 
of blood and urine collected during and after the exposure were analyzed 
for dioxane and its metabolite, beta-hydroxyethoxyacetic acid (HEAA), by 
gas chromatography and mass spectrometry.
A dynamic chamber, 2.49 x 2.64 x 4.06 m (26.7 cu m ) , was used for the 
exposure studies, and the airflow was maintained at 3.68-4.16 cu m/minute 
throughout the exposure. A circulating fan was used inside the chamber to
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provide uniform distribution. The concentration of dioxane in the chamber 
was determined and monitored throughout the exposure analytically by an 
infrared analyzer.
The half-life for elimination of dioxane was found to be 59 + 7 
minutes; 99.3% of the dioxane was eliminated in the urine as HEAA and 0.7% 
as dioxane. Dioxane and HEAA were detectable in the urine until 6 and 18 
hours, respectively, after the end of exposure. The total absorbed dose of 
dioxane during the 6-hour period was 5.4 + 1.1 mg/kg.
The investigators [29] constructed a one-compartment open system 
model to characterize the kinetics of dioxane and HEAA in humans; they used 
this model for simulating daily repeated 8-hour exposures at 50 ppm [30]. 
Using this pharmacologic profile in humans, they concluded that, at 
concentrations of 50 ppm or lower, dioxane is rapidly metabolized to HEAA 
and will not accumulate in the body even after continuous or repeated 
exposures. Mild eye irritation which persisted throughout the exposure was 
noted in all the volunteers, according to Chenoweth ('written communication, 
December 1976); however, no itching of the eyes or lacrimation, or any 
other sensory responses were noted.
(b) Occupational Case Histories
In 1959, Johnstone [31] described an occupationally related fatality 
in which a man had been exposed to dioxane for just 1 week. The 21-year- 
old man, who had a history of heavy beer consumption, had used dioxane to 
clean a workbench and to keep his hands free of resin-type glue. He kept 
an uncovered bucket of dioxane between his knees for these purposes. 
Neither a respirator nor an exhaust ventilation system was employed. After 
1 week of dioxane exposure, he was hospitalized with severe epigastric pain
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and rising blood pressure which reached 220/120 about 3 hours after 
admission. Within a few hours, he developed severe convulsions followed by 
unconsciousness and anuria. The anuria lasted 5 days during which time his 
blood nonprotein nitrogen rose to 181 mg/100 ml compared to a normal value 
of 15-40 mg/100 ml. His condition continued to deteriorate even after he 
regained kidney function, and he died on the 6th day of hospitalization. 
Autopsy findings included centrilobular liver necrosis and necrosis of the 
renal cortex with extensive interstitial hemorrhage and occasional 
hyalinization of glomeruli. There were microscopic findings in the brain 
that were considered to be secondary to anoxia and cerebral edema [31].
The exact dioxane concentrations to which the deceased worker was 
exposed were not known, but they ranged from 208 to 650 ppm and averaged 
470 ppm in the 75 X 50 X 25 ft workroom. When and where the samples were 
taken, the number of samples, and the method of collection and analysis 
were not mentioned. The worker may have been subjected to absorption of 
dioxane through the skin in addition to possible inhalation exposure at 
higher vapor concentrations because of the close proximity of his breathing 
zone to the open bucket of dioxane. The plant foreman was reported to have 
been exposed to dioxane for many months without evidence of ill effects 
[31].
A 47-year-old woman who had worked in the dioxane distillation 
department of a chemical concern for several weeks developed inflammatory 
skin abnormalities. The case was reported by Sonneck [32] in 1964.
Concentrations of dioxane to which the woman was exposed were not reported 
nor was it mentioned whether liquid dioxane came into direct contact with 
her skin. Her right arm was most affected but her face and left hand were
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also involved. Low-grade, vaguely defined, reddened areas with isolated 
pinhead-size, reddish papules were found on her face. The dorsal surface
of her left hand was almost all reddened with pinhead-size papules on the
sides of the fingers. Six to eight months previously, the woman's right
arm had suffered first and second degree burns from isoprene when an 
explosion occurred in a distillation process. Sonneck [32] considered the 
healed area to be especially sensitive and the reason why most of the right 
arm was affected. Skin sensitivity tests demonstrated the patient's 
pronounced hypersensitivity to dioxane as compared to skin sensitivity 
tests in two controls which were negative. The author's [32] diagnosis
from the skin tests and microscopic studies was contact eczema due to 
dioxane.
Epidemiologic Studies
The deaths of five men who were exposed to dioxane in an artificial 
silk plant in England were the subject of a report by Barber [20] in 1934. 
The deceased workers were 29-38 years of age and were stated to have been 
apparently healthy. The work conditions in the factory were partly 
described by Barber [20] and further described by Henry [33], The 
exposures occurred in an experimental plant where two similar machines were 
used to treat cellulose acetate yarn with dioxane during the manufacture of 
artificial silk. The process had been in operation since July 1932. Early 
in October 1933, the process in one of two machines was altered. In the 
Annual Report, the Chief Inspector of Factories [33] stated that, on one 
machine, the vessel containing dioxane solution was enclosed between the 
14th and 18th of September 1933, without exhaust ventilation. Dioxane
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vapor was thereby concentrated in the air above the liquid dioxane and, 
when the enclosure was opened for manipulation of the yarn, the men were 
exposed at this higher vapor concentration [33]. The time of exposure to 
the vapor was also increased at the end of October 1933, with some of the
men working approximately 12 hours on Saturdays and Sundays [20], These
work conditions continued during the period in which the fatal exposures 
occurred (November 5-19, 1933). Dioxane concentrations before, during, or 
after the change in process were not reported.
Prior to the change in process, evidence of liver or kidney damage 
was not noted although a few men had stayed away from work occasionally
because of anorexia, nausea, and vomiting. For example, one of the men, 
who had an exceptionally high exposure in April 1933, stayed home with 
"stomach trouble" for several days. He was the first of the five men to 
die after the October 1933 process change.
According to Barber [20], 16 men were definitely exposed to dioxane, 
and 8 or 9 of these had worked on the machine where the process was
altered. Seven of these sixteen men became ill between the 5th and 19th of 
November, and five men died between the 11th and 25th of November. The 
first two men died at home after being attended by different physicians, 
and the other three were admitted to a hospital. A general examination of 
the latter cases revealed that they had enlarged livers and suffered from a 
hemorrhagic condition of the kidneys. In the histories of their illnesses, 
signs and symptoms of poisoning such as nausea and vomiting were followed 
by oliguria and anuria. Clinical blood findings included 21,000-38,000 
leukocytes/cu cm (sic) with 80-94% neutrophils compared to normal values of 
5,000-10,000 leukocytes/cu cm (sic) and 60-70% neutrophils. Necropsy
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findings included enlarged pale livers, swollen hemorrhagic kidneys, and 
edematous lungs and brains. Microscopic examinations revealed 
centrilobular liver necrosis, almost symmetrical necrosis of the outer part 
of the renal cortex, and hemorrhages around the glomeruli.
Eighty men who worked in the factory were studied by Barber [20] 7-14 
days after work with dioxane was stopped. These 80 men were all those who 
had any potential for exposure to dioxane during the time it was used in 
the factory. The kinds of jobs these men had and the extent of their 
exposures were not well described. It was reported that other processes 
were going on in the room that housed the dioxane machines [33], The 
number of men working on the other processes and the nature of the 
processes were not stated.
Of the 80 men, 11 were classified as "much exposed," with 3 or 4 of 
them having had exposures similar to those of the men who died. It could 
be interpreted that two of these three or four men worked on the same 
machine as those who died. One interpretation could be that one or two men 
had worked on the same machine as those who died and that the other seven 
or eight worked on the machine that was not altered. Another 
interpretation could be that some of the 11 men worked on other processes 
in the vicinity of the dioxane machine. Of the remaining 69 workers, 13 
were classified as "old exposures" since they had not had any potential for 
exposure to dioxane for at least 2 months. It was not indicated in the 
report whether any of these 13 men had worked on the dioxane machines. Of 
the other men, all may have worked in the room where the dioxane machines 
were housed, or they may have included managerial, maintenance, and other 
personnel with potential for exposures to dioxane. These 80 men may be
considered as representing four exposure groups: those 3 or 4 with near 
lethal exposure, those 7 or 8 with less exposure, those 56 with occasional 
or incidental exposure, and those 13 with past exposure. The 80 workers 
were queried for symptoms of poisoning and were examined for enlarged 
livers. Blood studies included urea nitrogen, the indirect van den Bergh 
test which was apparently used to check for liver changes, and blood cell 
counts; the urine was tested for albumin and RBC. The most significant 
findings in this study were in 1 of the 11 men classifed as "much exposed." 
It was not stated whether or not this man worked on the same machine as 
those who died. He complained of being unwell, had a positive indirect van 
den Bergh reaction, a trace of albumin and a few RBC in the urine, and a 
leukocytosis of 13,600/cu cm(sic). His was the only palpable liver among 
the 80 workers. Two other men, who had worked on the machine with those 
who died and who had been away from work because of illness for a day or 
two during the critical exposure period, did not have palpable livers at 
the time of the examination. These two men did have a trace of albumin in 
their urine and leukocyte counts of more than 10,000/cu cm(sic). Among the 
11 most exposed workers, one had RBC in the urine, four had a trace of 
albumin in the urine, and all but one had blood leukocyte counts in excess 
of 10,000/cu cm(sic). By comparison, RBC were not found in the urine of 
any of the other 69 exposed workers, and a trace of albumin was found in
nine of them. Barber [20] considered the leukocytosis in the 11 most
exposed workers to be due to their exposure. In the 13 men with past 
exposure, a tendency toward eosinophilia was noted.
Thiess et al [34] conducted an epidemiologic study of 74 workers who
had been exposed to dioxane in a dioxane-manufacturing plant in Germany.
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As a group, these workers had a cumulative potential exposure of 1,840 man- 
years and an average potential exposure of 24.9 years. A series of 
measurements of dioxane concentrations was taken in 1974 at various 
locations in the production plant. Sampling and analytical methods were 
not described. The results of these measurements are presented in Table 
III-l, During a cleaning operation in one of the stills, an attempt was 
made to simulate earlier working conditions by evaporating dioxane until 
its odor was considered similar to that of past years. At the simulated 
level, the odor was described as being highly offensive and the
concentration of dioxane was found to be 3.5 ppm (odor threshold, 2.8 ppm
and recognition threshold, 5.6 ppm [26]).
The 74 employees included 24 workers who were then working at the
dioxane plant, 23 former employees who were then working elsewhere, 15 who
had retired but still alive, and 12 who had died.
The current workers had been exposed to dioxane for 5-41 years and 
their ages varied between 32 and 62 years. Six of them had a history of 
exposure to ethylene chlorhydrin and dichloroethane by inhalation or from 
burns of the skin and mucous membranes due to contact with butanol or 
acetic acid. Two of the workers had suffered slight facial burns as a 
result of contact with dioxane-containing sodium hydroxide, All 24 
employees were given clinical examinations during 1974 and 1975 that 
included a chest X-ray. Clinical data from these 24 current workers in the 
dioxane plant and from the 23 who had previously worked with dioxane are 
presented in Table III-2.
30
TABLE III-l
CONCENTRATIONS OF DIOXANE IN THE WORKPLACE 
OF A PRODUCTION PLANT IN GERMANY
Dioxane Work Area Dioxane 
mg/cu m
Concentration
ppm
Synthesis cauldron R301 normal operation 0.8 0.22
t l  11  I t  I t  f t 1.0 0.28
Synthesis cauldron installation shut off 0.2 0.06
Stirring cauldron R302 normal operation 1.8 0.50
f t  f t  1 1  f t  I t 1.5 0.42
Sample taken from cauldron R302 
during normal operation 2.0 0.60
Old building 1.5 0.42
f t 12.6 3.50
t l 0.1 0.03
t t 3.7 1.03
New building separated by firewall 
near dioxane installation 0.02 0.01
With dioxane apparatus shut off 0.07 0.02
Dioxane distillation point 1.4 0.39
2.3 0.64
0.1 0.03
0.2 0.06
During cleaning operation (simulation 
of working conditions of previous years) 12.6 3.50
Measurement station 5.4 1.50
i r  t t 2.3 0.64
Measurement at 30 cm distance from 
end of production line 47.8 13.28
Small leak in pump 13.7 3.81
Small leak in pump (normal operation) 0.06 0.02
W  t t  t t  I f  I f  f t 0.2 0.06
t t  t t  f t  f t  t t  f t 1.0 0.28
Small leak (installation shut off) 0.02 0.01
Drumfilling room using exhaust 24.0 6.67
Adapted from reference 34
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TABLE III-2
CLINICAL MEASUREMENTS IN 24 CURRENT DIOXANE WORKERS AND IN 
23 PREVIOUS DIOXANE WORKERS
Clinical Author's Currently Previously
Measurement Normal Exposed Exposed
Range Subjects Subjects
Number Number
Range Abnormally Range Abnormally
High High
SGOT mU* 5-17 7.0-25.0 2 7.0-53 4
SGPT mU* 5-23 6.0-54.0 6 8.0-63 4
Alkaline
Phosphatase** 40-190 71-178.5 0 69-163 0
Gamma glutamyl 
transferase*** 
mU* 6-28 6-128 6 7.0-54 7
Creatinine** 0.8-1.2 0.8-1.6 5 00.9-1.4 1
Urea** 20-50 19-60 2 19-45 0
Thymol turbidity 
test 0-3.0 0.3-5.0 1 0.2-3.75 2
*Milliunits
**Unit8 not described
***The authors classified this as a test of liver function but did not
otherwise describe the test.
Adapted from reference 34
Two employees had reduced hemoglobin (Hb) and RBC counts, another had 
a slightly elevated leukocyte count, and still another had reduced Hb and 
RBC counts as well as a slightly elevated leukocyte count. The thrombocyte 
counts were slightly reduced in four employees. No hemorrhagic tendency 
was noticed in any of the 24 employees nor was enlargement of the liver or
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jaundice noted. Serum glutamic-pyruvic transaminase (SGPT) levels were 
elevated in six men and in two of these six men serum glutamic-oxalacetic 
transaminase (SGOT) levels were appreciably elevated. An abnormal thymol 
turbidity level was noted in one employee. All six who had elevated 
transaminase levels were known to have consumed daily for several years 
about 80 g of alcohol, either in the form of beer or wine. No liver 
complaints were noted among the six employees. When five of these men 
reduced their alcohol consumption, their transaminase levels returned to 
normal. Serum creatinine was slightly higher than normal in four employees 
and two others showed a slight increase in serum urea content. A follow-up 
examination of these workers, 6 months later, showed normal values for 
these two serum tests. Proteinuria, with no abnormal components, was found 
in one employee who had just recovered from an influenza infection.
Chromosome analyses were performed on six employees then working at 
the dioxane production plant as well as on six control persons. The sex of 
the subjects was not given. Lymphocyte cultures were prepared for both 
groups, incubated at 37 C for 70-72 hours with phytohemagglutinin, and 
subsequently processed. Thirty to fifty metaphases were investigated for 
each person. A total of 230 metaphases evaluated in the exposed group had 
a gap rate (cells with achromatic lesions) of 5.65% and other aberrations 
(fragments, deletions, dicentric chromosomes, and fractures) amounting to 
1.74%. In comparison, 306 metaphases evaluated in the control group had a 
gap rate of 5.24% and other aberrations amounting to 2.62%. No statistical 
evaluation was made.
The 23 workers working elsewhere and thus no longer exposed to 
dioxane had been exposed to dioxane for 3-38 years. Both SGOT and SGPT
33
levels were elevated In five employees and serum creatinine was higher than 
normal by 0.1-0.2 mg in two other employees. The daily consumption of 
alcohol by each of these seven employees was in excess of 80 g.
The 15 retirees, still alive in 1975, exhibited no evidence of liver 
or kidney disease. Retirement occurred when employees reached the normal
retirement age or because of medical reasons such as emphysematous
bronchitis, articular arthrosis, degenerative spinal diseases, or cardiac 
and circulatory problems. No liver or kidney diseases or any cases of 
carcinoma were detected in the 15 retirees who were still alive. No
details regarding alcohol consumption or results of laboratory
investigations of these retirees were reported.
Twelve deaths occurred during 1964-74 among the seventy-four exposed 
workers. The causes of death and other pertinent information are presented 
in Table III-3.
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TABLE III-3
CAUSES OF DEATH OF EMPLOYEES EXPOSED TO DIOXANE 
IN A DIOXANE PRODUCTION PLANT IN GERMANY*
Age at 
Death
Duration 
of Exposure 
at dioxane 
plant 
(mo)
Reported Cause of Death and 
Post-Mortem Analysis
51 188 Acute heart attack
54 204 Heart and circulatory failure
58 420 Cirrhosis of liver, bleeding of esophageal 
varices
60 264 Right heart failure due to pyloric stenosis, 
duodenal ulcer (histology, negative)
66 496 Liver and kidney insufficiency
67 264 Acute 'heart infarct
67 502 Heart infarct with lung edema
67 511 Pneumonia and sepsis, right heart failure, 
chronic interstitial nephritis
69 408 Pericardial flux, uremia, bronchopneumonia
69 414 Heart infarct
73 111 Suspicion of cerebral injury
73 372 Heart and circulatory failure
*As shown in official death certificates and other sources 
Adapted from reference 34
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For the 74 workers, 14.5 deaths were expected using German Federal 
Republic mortality statistics for 1970-73 as compared to the 12 deaths 
observed. Cancers found in 2 of the 12 employees, who died between 51 and 
73 years of age, were a lamellar epithelial carcinoma of the left lumbar 
region, and a myelofibrotic leukemia. According to the authors [34], 
these deaths were not statistically different from the number of expected 
cancer deaths.
A study of 165 employees who worked in a dioxane-manufacturing plant 
in Texas was undertaken by Buffler et al [35] in 1975. This included 100 
employees of the dioxane-production unit and 65 of the dioxane-processing 
subunit (closed system) within the vinyl chloride division. These men were 
all those who had worked in dioxane manufacture for more than 1 month 
between April 1, 1954 and June 15, 1959.
During the dioxane-manufacturing process, control operators, loading 
operators, and maintenance personnel were potentially exposed. The control
operators monitored the operations of the plant from an enclosed control
room. This included periodic monitoring of the control dials, and 
conducting sampling and analysis of the product twice each shift. Exposure
to dioxane vapor could have occurred during sampling as well as during
chemical analysis. The loading operators were responsible for loading 
three tank cars with dioxane weekly, the time required being approximately 
30 minutes/car. Escape of dioxane vapor occurred when loading lines were 
being connected or disconnected to the dioxane tank cars.
To repair or replace worn or damaged equipment, the appropriate 
dioxane line had to be drained by maintenance personnel and exposure to 
dioxane was likely to occur during these operations. Specialized
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laboratory personnel, engineers, foremen, and supervisors were also 
potentially exposed to dioxane [35].
In the dioxane-processing area, loading operators and laboratory 
personnel were potentially exposed to dioxane. The samples were drawn by 
the loading operators at various stages and analyzed by the laboratory 
personnel. The employees not included in the cohort were the maintenance 
personnel and those who barreled the finished product, chlorothene, which 
contained about 3.5% dioxane.
In the dioxane-production plant, area monitoring was conducted in 
1968, and both personal and area monitoring were conducted in 1973 and 
1974. The concentrations found in these studies were considered by the 
authors [35] to be representative of dioxane exposures since 1959 because 
no changes had been made in the dioxane-manufacturing plant after 
production began.
The area monitoring in 1968 was accomplished by sampling in 
impermeable plastic bags outside the control room and around storage tanks 
located approximately 50 feet from the dioxane control room. In 1973, area 
monitoring was conducted for 48 hours at 6 feet above ground level in the 
dioxane-production area, the loading area, and the storage area. In 1973 
and early 1974, the loading operators and various control operators were 
monitored with personal samplers as were the control operators and 
unloaders in 1974 and 1975. The data from these samplings are presented in 
Table III-4.
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TABLE III-4
DIOXANE CONCENTRATIONS (ppm) IN VARIOUS WORK 
LOCATIONS (1968-1975) IN A DIOXANE-MANUFACTURING PLANT
Location 1968
Grab
Range
Year and Type of Sample 
1973 1973-74 1974 
Area Personal Personal 
Avg Max Range Average
1975
Personal
Range
Outside control room <0.6-2.0
Around storage tanks 100 and 800 0.2 11
Production area 0.3 16
Loading area 0.5 22
Loading operator and 
control operators 0.1-1.5 0.8-32
Control operator 8.3
Unloading tank cars* 
Worker 1 
Worker 2 
Worker 3 
Worker 4 
Worker 5
Three measurements, one worker**
2.9
16.8
2.3
1.4 
<0.1
1.5-5.0
★Sampling time 5-26 minutes 
**Sampling time 3-6 minutes
Adapted from data supplied by Buff1er et al [35]
Of the 100 employees in the production plant, 68 were still employed 
in the plant, 21 were employed elsewhere, 2 had retired by choice, 1 had 
disability retirement, 1 was known to be alive but his employment status 
was not known, and 7 had died.
The case summaries of the seven employees from the production plant 
who died are presented in Table III-5. The exposure histories showed that 
they had been exposed to other chemicals of possible significance for 
longer periods than their exposure to dioxane. They had been employed at 
the plant for longer than 15 years with an average duration of exposure to 
all chemicals of 18.5 years, including an average of 4.2 years exposure to 
dioxane compared to an average of 4.4 years of dioxane exposure for the 
total group of 100 workers. Diseases of the stomach, liver, heart, and 
lungs were listed as causes of death. Two of the deaths were due to 
cancer, a carcinoma of the stomachy and an alveolar cell carcinoma. These 
cancers were different from those reported by Thiess et al [34]. The 
employees who died of cancer had been exposed to dioxane for less than 4 
years; one of them had also been exposed to hydrogen chloride, carbon 
tetrachloride, perchloroethylene, and trichloroethylene, and the other to 
vinyl chloride and methylene chloride. No statistically significant 
differences (P<0.05) were seen between the two observed deaths from cancer 
and an expected number of 0.9 as calculated for the study group from Texas 
vital statistics for the years 1960-69, based on a Poisson distribution 
(P=0.22).
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TABLE III-5
CASE SUMMARIES OF DECEASED EMPLOYEES EXPOSED TO 
DIOXANE IN A DIOXANE-PRODUCTION PLANT IN TEXAS*
Age at 
Death
Exposure to
Dioxane Other 
(mo) Chemicals 
(mo)
Death Certificate 
Statement of Cause 
of Death
39 59 Perchloroethylene (60) 
Trichloroethylene (49) 
Methylene chloride (19)
Stomach hemorrhage (no 
indication of malignancy)
45 77 Perchloroethylene (70) 
Trichloroethylene (79)
Cardiovascular (natural 
cause-heart attack)
49 28 Hydrogen chloride (3) 
Carbon tetrachloride (4) 
Perchloroethylene (131) 
Trichloroethylene (71)
Carcinoma of stomach
50 40 Iron oxide fumes (212) 
Sodium hydroxide (7)
Chronic hepatitis 
(pneumonitis due to chronic 
hepatitis, cirrhosis, and 
liver failure)
51 23 Hexachlorobenzene (3) 
Carbon tetrachloride (17) 
Mineral seal oils (83) 
Sodium hydroxide (42) 
Perchloroethylene (41)
Cardiovascular 
(myocardial infarction)
52 38 Vinyl chloride (131) 
Methylene chloride (18)
Lung cancer
(alveolar cell carcinoma)
64 89 Hydrogen chloride (20) 
Perchloroethylene (157)
Cardiovascular 
(natural cause- 
heart failure)
*As of June 30, 1975
Adapted from reference 35
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In the dioxane-processing subunit, 5 of 65 employees died. Table
III-6 presents the case summaries of the deceased employees. All these
employees were exposed to vinyl chloride simultaneously with their exposure 
to dioxane. Three of the deaths were attributed to accidents, the fourth
to myocardial infarction, and the fifth to cancer (malignant mediastinal
tumor). No statistically significant difference (P<0.05) was seen between 
the one cancer death and the 0.8 expected.
TABLE III-6
CASE SUMMARIES OF DECEASED EMPLOYEES IN 
THE DIOXANE-PROCESSING SUBUNIT*
Age at 
Death
Exposure
(mo)
Cause of Death Autopsy
Done
21 12 Malignant mediastinal tumor, 
unclassified with generalized 
metastasis
Yes
22 6 Tubular necrosis in both kidneys 
due to extensive third degree 
burns (automobile accident)
Yes
39 66 Accidental drowning No
43 13 Cardiac arrest due to electric 
shock
No
52 28 Myocardial infarction No
*As of June 30, 1975 
Adapted from reference 35
In another study of the same plant [36], the urine of five workers 
was collected daily for 10 days and analyzed for dioxane and its potential
41
metabolite, HEAA. Both dioxane and HEAA were found in the urine of the 
five workers. The average concentrations of dioxane and HEAA in the urine, 
as well as the exposure concentrations of dioxane, are presented in Table 
III-7. The average concentrations of dioxane and HEAA in samples of urine 
collected at the end of each workday were 3.5 and 414 ¿umol/liter,
respectively. This indicated that the biotransformation of dioxane in
humans was apparently to the same product (HEAA) as found previously by the 
same investigators [37] in rats. The authors [36] stated that the high
ratio of HEAA to dioxane, 118 to 1 in human urine, suggested that at low 
exposure concentrations dioxane was rapidly metabolized to HEAA. The
previous study conducted on rats demonstrated that the toxicity of dioxane 
was observed only when the metabolism of dioxane to HEAA was saturated 
[30]; hence, the high ratio of HEAA to dioxane in human urine indicated 
that the metabolic pathway was not saturated. This and animal findings
[30,37] led the investigators [36] to believe that exposure to dioxane 
vapor at low concentrations posed a negligible health hazard.
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TABLE III-7
DIOXANE AND HEAA CONCENTRATIONS IN URINE OF FIVE EMPLOYEES AND 
IN WORKROOM AIR IN A DIOXANE-MANUFACTURING PLANT IN THE USA*
Employee 
Body Weight 
(kg)
Urine
Dioxane
(^mol/liter)
HEAA*
(jumol/liter)
Air
Dioxane
(ppm)
74.8 4.3 60 1.0
110.7 3.3 + 2.0 230 + 8.5 1.6 + 0.5
74.4 3.6 + 0.4 622 + 154 2.0 + 1.0
79.4 3.7 + 1.4 470 + 229 1.8 + 0.4
78.5 3.0 + 0.7 445 + 144 1.1 + 0.6
Overall mean 3.5 + 1.2 414 + 216 1.6 + 0.7
*Values are the means +SD 
Adapted from reference 36
Two representatives of another manufacturing concern separately
«
provided information on exposure to dioxane among employees in their 
dioxane manufacturing plant (written communications, CU Dernehl, April 
1976, RE Peele, January 1977).
Area monitoring was conducted in 1974 and 1975 in both production 
and drumfilling facilities. Samples were taken by carbon tube as well as 
by grab sampling. Grab sampling was accomplished using 50-ml glass 
syringes and the sample was directly injected into the gas chromatograph. 
The areas that were sampled were divided into three categories: The
breathing zone, the general workroom, and point sources (leaks, vents, 
sewers, etc). Grab sampling in the breathing zone showed an average 
dioxane concentration of 11.36 ppm (range, 0.05-51 ppm) for 30 samples and 
an average of 4.28 ppm (range, 0.05-36.7 ppm) for 44 samples in the general
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drumming-type operations, an average of 9.0 ppm was obtained for 46 
samples, the range of dioxane concentration being 0.05-51 ppm. Only three 
samplings each were done using carbon tube in the breathing zone and 
general workroom atmosphere. Carbon tubes were primarily used for 
detection of dioxane concentrations in point sources and these did not 
necessarily result in occupational exposure. Five samples, ranging from
12.1-108,9 ppm, gave an average of 45.52 ppm at point sources.
During the 42 years of dioxane production in the plant, about 80 
workers were thought to have been potentially exposed to dioxane. In 1976, 
42 persons, who were identified as having worked in the dioxane unit at 
some time or other, were given complete physical examinations, chest X- 
rays, electrocardiograms, and a series of liver profile tests. It was 
reported that abnormalities were not found in any of the 42 employees. 
The company had begun cancer surveillance of all of its employees about 20 
years ago. A total of 67 reported deaths from malignancy was reported 
among the company employees. Four of these deceased employees were known 
to have been potentially exposed to dioxane; one died with cancer of the 
colon, one with lymphosarcoma, one with lung carcinoma, and one with 
glioblastoma.
Animal Toxicity
(a) Acute and Subacute Studies
(1) Parenteral Injection
A dose-response relationship was noted by two investigators
[21,38] when dioxane was injected iv into rabbits. Target organs were the 
kidneys and liver, in which the damage, characterized by cellular
44
degeneration, became progressively more severe with increasing doses. 
Similar findings were observed when mice, rabbits, and guinea pigs were 
injected sc with dioxane [24,39,40]. Mice and rats were also injected ip 
to study the narcotic effects, incidence of tumors and LD50 of dioxane [41— 
44] .
Effects of dioxane administered iv to rabbits were reported by 
Fairley et al [21] in 1934. Four rabbits received a single dose of 1, 2,
3, or 5 ml of 80% dioxane diluted with saline to a total volume of 10 ml.
Three other rabbits each were given two 5-ml injections of dioxane mixed 
with 5 ml of saline with an interval of 48 hours between injections. One 
rabbit, used as a control, received 10 ml of saline. The immediate effect 
of dioxane injection in all the rabbits was violent struggling, which began 
as soon as the first few drops were injected. With doses of 4 or 5 ml of 
dioxane, the struggling was followed by convulsions and collapse; then the 
rabbits rapidly returned to normal. The four rabbits given the single 
doses of 80% dioxane were killed 1 month later. Degeneration of the renal 
cortices with hemorrhages was observed by microscopic examination. In the 
rabbit administered the 3-ml dioxane dose, the degenerative changes 
extended into the medulla, and the liver showed extensive and gross
cellular degeneration starting at the periphery of the lobules. No
abnormality was found in other organs. The livers of the rabbits given the 
1- and 5-ml doses showed no microscopic abnormalities, and areas of cloudy 
swelling were seen in the liver of the rabbit given 2 ml of dioxane.
One of three rabbits given two 5-ml doses of 80% dioxane was killed 
for necropsy when it seemed acutely ill, 5 days after the second injection. 
The two remaining rabbits appeared to be ill on the 7th day when one died
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and the other was killed. Macroscopically, the kidneys of the three 
rabbits were enlarged and the three livers appeared either normal, mottled, 
or pale, respectively. In all three animals, microscopic examination 
revealed almost total destruction of the renal cortex with only a few 
glomeruli remaining in a meshwork of connective tissue. Many of the 
medullary tubules were blocked with blood casts and hyaline material, but 
degenerative changes were not observed. Hemorrhages were seen in both the 
cortex and medulla. There were extensive degenerative changes in the 
hepatic cells of the livers of all three rabbits, apparently starting from 
the edges of the lobules [21],
Two more rabbits were given a single 4-ml dose of pure dioxane mixed 
with an equal volume of saline. The pure dioxane was prepared by the 
investigators [21] from redistilled dehydrated ether. The red cell counts 
and hemoglobin measurements were slightly lower, viz, 2,490,000 and 
3,170,000, and 65 and 70%, respectively, and the white cell counts were 
high, viz, 34,100 in one rabbit 24 hours after the iv injections. Forty- 
eight hours after the injections, the RBC and WBC counts had returned 
toward normal but the hemoglobin count remained low. Both rabbits 
developed hind-limb paralysis that continued until the 7th day after 
dioxane administration at which time they were killed. The average blood 
urea concentrations in the two rabbits, when measured at 24 hours (38 and 
40 mg/100 ml) and 6 days (37 and 36 mg/100 ml), were not significantly
different from the pre-injection values (35 mg/100 ml). Microscopically, 
both rabbits showed advanced cellular degeneration with hemorrhages in the 
renal cortex. The medullary tubules were blocked with casts. Well-marked 
cellular degeneration in the liver was found in one rabbit but no definite 
changes were found in the other.
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Dioxane was administered iv to rabbits by De Navasquez [38] in doses 
of 0.2 ml/kg in 10 ml of water or in doses of 1.0 or 1.5 ml/kg in 5 ml of 
water. A single dose of 0.2 ml/kg induced no visible effects in an 
unspecified number of rabbits. A few minutes after an unstipulated number 
of rabbits had been injected with 1.0 ml/kg of dioxane, they became flaccid 
in stature and appeared dazed. They moved slowly, exhibited poor 
coordination, and had weak reflexes. When they leaned against a structure 
such as a wall for support, they slowly collapsed to the bottom of the 
cage. A gradual improvement usually occurred within 4 hours. The author 
[38] stated that cats were similarly affected although the details of the 
cat experiments were not given.
Five rabbits were administered a single dioxane dose of 1.5 ml/kg
[38], Signs, similar to those described for the rabbits given the 1.0
ml/kg dose, disappeared within a few hours. However, in contrast to the
*
1.0 ml dose, a polyuric condition developed within 24-48 hours, with a 
corresponding decrease in the specific gravity of the urine. The rabbits 
then developed anuria, usually within 96 hours after the beginning of the 
experiment, with concomitant increase in blood urea that reached 300 mg/100 
ml or higher within 4-5 days of the dioxane injection. The animals lost 
weight, became lethargic, and eventually died after 3-4 days of complete 
anuria. Microscopic findings were acute hydropic degeneration of the 
convoluted tubules and vacuolization of liver cells, apparently because of 
glycogen accumulation.
A tolerance to acutely toxic doses of dioxane was observed in rabbits 
first given repeated sublethal doses of dioxane in an experiment conducted 
by De Navasquez [38], For example, in one animal initially given eight
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doses of 0.5 ml/kg of dioxane at weekly intervals, the only visible effect 
was temporary polyuria when the rabbit was subsequently given five doses of
1.5 ml/kg. Both the kidneys and liver were reported to be normal at 
autopsy; the method of examination was not reported. This phenomenon of 
developing tolerance was observed in other rabbits, although the author 
[38] did not specify the mode of administering the dioxane.
A single 1.5 ml/kg dose of dioxane in a 25% solution of unspecified 
solvent was administered to each of two rabbits in an experiment reported 
by Kesten et al [45] in 1939. One rabbit died 2 days after the injection. 
The other was killed for examination on the 4th day. The kidneys of both 
rabbits had hydropic degeneration of the convoluted tubular epithelium. 
The liver of the rabbit that died appeared normal; that of the other rabbit 
had hydropic cellular degeneration around the efferent hepatic veins and 
diffused glycogen deposits in some of the liver cells. There was no fat 
present in the vacuoles or vacuolated liver cells although small amounts of 
finely divided fat were occasionally found in both the epithelial and 
Kupffer cells. The nonprotein nitrogen of this rabbit had risen to 242 
mg/100 ml before it was killed.
Von Oettingen and Jirouch [39] injected 5 ml/kg dioxane 
subcutaneously (sc) into two white mice, and 7.5 and 10 ml/kg, 
respectively, into two additional mice in an experiment reported in 1931. 
One of the two mice given the 5 ml/kg dose died whereas the other three 
were alive after 24 hours. No additional information was provided.
In 1943, Gross [24] reported that rabbits tolerated 1 or 2 ml/kg sc 
injections of dioxane with temporary albuminuria being the only deleterious 
sign. In a cat, a 2-ml/kg dose, dissolved in 50% oil (unspecified),
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produced signs of illness including a loss of appetite and weakness.
Microscopic examination revealed hydropic degeneration of the tubular
epithelium of the kidneys, hydropic distension of the liver cells with
glycogen deposits. Five rabbits and six guinea pigs were administered
dioxane at 2, 4, or 6 ml/kg. All those animals given dioxane doses of 6
ml/kg died as did most of those given 4 ml/kg; one guinea pig given 2 ml/kg
died after several days. Microscopic findings were similar to those
reported for the cat. No further details were given.
An experiment was reported in 1942 by Cortese [40] in which two
groups of eight guinea pigs were administered sc injections of dioxane
diluted with equal parts of distilled water. Animals in one group received 
1 ml of the dioxane~water mixture/guinea pig for 10 successive days. Each
animal in the other group received the 1:1 mixture in amounts ranging from
0.20 to 0.75 ml each day for 35 days. Although the body weights of the 
guinea pigs were not given in this report [40], in two other reports 
[46,47], it was stated that the body weights of guinea pigs that were used 
ranged from 152 to 192 g. Evaluation of these three reports [40,46,47] 
indicates that the same guinea pigs may have been the subject of more than 
one report.
Three of eight guinea pigs given the 1-ml dose died between the 7th 
and 9th days of the experiment and the other five were killed for 
examination on the 10th day. One guinea pig from the 2nd group died on the 
30th day of the experiment, and the remainder of the animals were killed at 
the end of the experiment on the 35th day.
Microscopic findings in the guinea pigs from the 10-day study were 
pronounced. The glomeruli appeared congested, with extravasations in
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Bowman's capsules. The most marked changes were seen in the tubules where, 
in some cases, the nuclei were discolored and, in others, cells were found 
in the tubular lumen. Besides the cellular alterations, the tubular lumen 
also revealed a reticular formation, probably due to the presence of 
albumin. The lobular structure of the liver was barely recognizable; the 
cytoplasm showed many vacuoles, predominantly in the periphery of the 
lobules. Hemorrhages were present in the spleen, the pulp of which was 
congested with hematic pigments; the splenocytes were quite numerous, and 
some were filled with hemosiderin. The pancreatic tissue showed a 
regressive phenomenon, characterized by the disappearance of the protoplasm 
and barely visible nuclei; there were no hemorrhages and no microscopic 
changes evident in the islets of Langerhans. The lungs revealed a 
congested diffuse phenomenon with marked hemosiderin in the parenchyma. 
The adrenal cortices showed extensive cellular vacuolization and, in some 
cases, the nuclei also seemed to be in a phase of degeneration or had 
disappeared. Numerous hemorrhages were found in the adrenal medullas but 
cellular regression, though present, was less marked than in the cortices.
The myocardial fibers of the heart were separated because of edema 
and had lost their transverse structure. The nuclei were well preserved in 
some places while in others they were pyknotic or swollen or somewhat 
discolored. Edema was more pronounced around the coronary vessels, but no 
significant microscopic findings were seen in the vessels themselves.
The microscopic findings were similar in both the 10-day and 35-day 
studies of the guinea pigs; the major difference was that the adrenals were 
more severely affected in the 35-day study. There was an Increase In WBC 
count in the 10-day study group and a decrease in the 35-day study group.
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An increase in RBC showing excessive variation in size was observed in both 
groups of guinea pigs but no hematologic values were given [40].
The narcotic effects of dioxane administered intraperitoneally (ip) 
to rats were studied and reported by Knoefel [41] in 1935. On 
administering dioxane at 1.76 ml/kg to three rats, he noted that sleep was 
not induced. With a dose of 2.64 ml/kg, one rat slept for 8 minutes, 
another for 10 minutes, and the third was wide awake. When a dioxane dose 
of 4.40 ml/kg was administered to three other rats, all of them died. 
Microscopic findings were not reported.
The LD50 of dioxane, determined from studies on 60 female albino mice 
weighing between 18 and 27 g, was reported by Karel et al [42] in 1947. 
Pure dioxane injected ip was used in order to avoid any possible toxic 
interaction of dioxane with a diluting medium. The LD50 for dioxane was 
found to be 0.76 ml/kg based on deaths occurring within 7 days after 
dioxane administration. Moderate renal tubular degeneration was observed 
in animals that died from the 1st day through the 4th day of the 
experiment.
In a determination of the LD50 of dioxane in Sprague-Dawley rats, 
Argus and associates [43] administered dioxane in saline, ip, at 
concentrations ranging from 5.30 ml/kg to 5.80 ml/kg. In six other groups, 
each rat received ip 10 mg of methylcholanthrene (MC), a microsomal enzyme- 
inducing agent, 23 hours before the injection of dioxane at 4.90 ml/kg to 
5.30 ml/kg. The LD50 values were calculated based on deaths that occurred 
48 hours after dioxane administration. Though a statistically significant 
increase (P<0.001) in dioxane toxicity was observed when rats were 
pretreated with MC, as indicated by a reduction in the LD50 value from 5.60
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+ 0.06 ml/kg to 5.18 + 0.06 ml/kg, this increase in toxicity does not seem 
to be great. No results by the use of MC alone were reported.
For microscopic examination of dioxane-induced tissue and organ 
damage, 15 additional Sprague-Dawley rats were used. Five animals were 
each injected ip with doses of 10 mg MC, 5.18 ml/kg dioxane, or 5.18 ml/kg 
dioxane, 23 hours after having received the MC treatment. No changes were 
detected in the kidneys of the rats given MC alone but vacuolization of the 
tubular epithelium of the kidney was seen in two rats that were 
administered dioxane. All five rats given both dioxane and MC showed such 
vacuolization of the extensive tubular epithelium that the investigators 
[43] attributed the deaths to the combined action of dioxane and MC.
Weil et al [44], in a 1968 report, studied the production of tumors 
in dioxane-treated A/J mice, a strain with a normally high incidence of 
spontaneous pulmonary tumors. A preliminary study was undertaken to 
determine the maximum dose that could be used without causing excessive 
mortality. Dioxane doses (ip) of 1.25, 2.5, or 5.0 ml/kg, after a maximum 
of 6, 5, and 3 doses, respectively, killed all three mice in each of the 
three groups. Tricaprylin, a triglyceride, was used as the vehicle. Two 
of three animals died when administered a maximum of nine injections of 
dioxane at 0.625 ml/kg in tricaprylin solution, whereas none of three mice 
died when administered a maximum of five injections of 0.3125 ml/kg in 
tricaprylin solution. On the basis of these preliminary studies, doses of 
0.3125 and 0.156 ml/kg of dioxane in a 1:7 dilution with tricaprylin were 
selected for the tumor experiments. Groups of 40 male A/J mice, at a 
median age of 69 days at the first injection, were administered three 
injections of dioxane/week for 4 weeks. The mice received 0.06 or 0.03 ml
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of the dioxane-tricaprylin solution/injection. One mouse in the higher 
dose group died whereas all mice in the lower dose group survived.
Surviving mice were killed 38 weeks after the 1st injection. A control
group of 40 mice received 12 injections of tricaprylin (0.1 
ml/mouse/injection) but controls without tricaprylin were not used.
Twenty-four of thirty-nine and 21 of 40 mice that received 0.156 or
0.3125 ml/kg/injection of dioxane, respectively, had neoplasms compared to
18 of 36 tricaprylin-injected controls. When expressed as percentages of 
mice with gross neoplasms, these were 61.5, 52.5, and 50.0%, the higher 
dose level of dioxane and control groups being almost equal. Similarly,
the number of growths/tumor-bearing mouse was 1.5, 1.3, and 1.4,
respectively, for the same three groups. The authors [44] concluded that 
the incidence of pulmonary tumors, predominantly adenomas, was not 
increased by repeated ip injections of dioxane, and no gross tumors were 
observed in other organs.
(2) Oral
Narcotic effects, toxic effects on the liver and kidneys, and
LD50's were studied by a variety of investigators by the oral route, ie,
intragastric intubation (ig), or in drinking water [38,41,45,48-54]. Mice, 
rats, guinea pigs, rabbits, and dogs were used for these oral 
administrations.
Effects of dioxane, administered intragastrically at doses of 
0.88, 1.76, 4.51, 6.62 or 8.82 ml/kg to groups of one to three rabbits in 
an experiment to determine the narcotic potency, were described by Knoefel 
[41] in 1935. Two rabbits that received either a dose of 0.88 or 1.76 
ml/kg and two of three rabbits given 4.51 ml/kg appeared to be normal and
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remained erect in posture. The third rabbit administered 4.51 ml/kg 
remained semierect and in a staggering position. Two of three rabbits 
administered dioxane at 6.62 ml/kg died but the third one remained in a
staggering position. The rabbit administered 8.81 ml/kg of dioxane died.
Microscopic findings were not reported.
Effects of nonlethal and lethal doses of dioxane administered ig to 
an unspecified number of rabbits were reported by De Navasquez [38] in 
1935. Dioxane doses of 0.2 ml/kg in 10 ml water, 1.0 ml/kg in 5 ml water, 
or 2 ml/kg in 20 ml water were administered as single doses to an
unspecified number of rats. Doses of 0.2 ml/kg, repeated at weekly 
intervals for an unspecified number of weeks, did not appear to affect the 
rabbits at all; one rabbit received as many as 15 weekly doses of 0.2 ml/kg 
without effect. A state described as drunkenness was seen with 1-ml doses, 
but single doses of 2 ml/kg administered to five nonfasting rabbits killed 
them. The minimal lethal ig dose of dioxane was found to be 2.0 ml/kg in 
20 ml water. Microscopic changes observed in the kidneys and liver were 
similar to those seen in rabbits given iv injections of dioxane; they were 
hydropic degeneration of the convoluted tubules of the kidneys and
vacuolization of liver cells.
The effects of repeated doses of dioxane on renal function of one 
rabbit were described in greater detail by the investigator [38] . This 
rabbit received 1 ml/kg on days 1, 3, 5, 7, 10, 12, 16, and 18, and 2, 2.5, 
3, 4, and 5 ml/kg on days 20, 27, 38, 42, and 47, respectively. Blood urea 
and the volume of urine excreted were checked each day. The rabbit was 
found to be anuric on day 8, polyuric on days 20, 40, and 42, and oliguric 
on days 7, 10, 11, 27, 38, 39, and 48. The blood urea rose to 81 mg/100 ml
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after the administration of 4 ml dioxane on day 42 and increased to 175 
mg/100 ml after a 5-ml dose was administered on day 47, which produced a 
terminal uremia.
The ig administration to a dog of 25 ml of commercial dioxane in 75
ml water followed 50 minutes later by 100 ml of a 50% solution was reported
in 1936 by Schrenk and Yant [48] . The investigators attributed the
immediate effect as excitation of the "sexual centers" but presented no
evidence to that effect. Twenty minutes after the second administration,
the dog appeared unsteady and vomited; its hindquarters were stiff after
2.5 hours. A half-hour later, it lay down and was unable to rise; its
respiration was characterized by prolonged expiration. After 10 hours, the
dog began to improve and, by 15 hours, the only apparent sign was rigidity
during walking. The dog ate well and appeared in good condition for 3
days, then its condition began to deteriorate. The dog died 6 days after
>•
having received the 2nd dose of dioxane. No microscopic examination was 
conducted.
Laug and coworkers [49], in 1939, reported the ig LD50 of dioxane in 
male and female mice, rats, and guinea pigs. The animals died between 24 
hours and 5 days after the administration, with the highest average 
mortality occurring at about 36 hours. Limpness and distinct signs of 
intoxication with muscular incoordination were observed immediately upon 
administration of the lower dioxane doses followed by an apparent recovery; 
some animals died several days later. Animals given the larger doses 
showed similar signs of intoxication followed by coma and death within 24 
hours. The ig LD50 of dioxane was found to be 5.7 ml/kg for mice, 5.2 
ml/kg for rats, and 3.9 ml/kg for guinea pigs. Gross post-mortem
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observations included hemorrhagic areas near the pyloric end of the 
stomach, distension of the bladder, and somewhat enlarged kidneys. 
Microscopic changes in the livers and kidneys of some of the animals were 
slight, while extensive damage was noted in others. The other organs, not 
specified, appeared to be normal.
Nelson [50], in 1951, reported experiments in which he administered 
ig doses of dioxane in a total volume of 10 ml to rats and rabbits. Deaths 
were recorded 2 weeks after administration. Eight rats and two rabbits 
were used as controls. Doses of 0.2, 1.0, 3.16, 5.63, or 10 ml/kg were 
administered to 2-8 rats and 0.1, 1.0, 3.16, or 10 ml/kg to 2-3 rabbits. 
No details regarding the strain, sex, age, or weight of the animals were 
given. There was an increased anesthetic effect ranging from unsteadiness 
to narcosis with very weak or absent corneal reflexes in both rabbits ar.d 
rats with increasing doses; similarly, with increasing doses, the survival 
rate decreased, death occurring within 24 hours in animals administered 10 
ml/kg of dioxane. The approximate LD50 for rats was stated to be 6 ml/kg 
and 2 ml/kg for rabbits.
Preliminary studies on the toxicity of dioxane were reported by Smyth 
et al [51] in 1941. Dioxane was administered in aqueous solution by
stomach tube to albino male Wistar strain rats weighing 90-120 g and guinea 
pigs of both sexes, weighing 250-300 g. Different concentrations of
dioxane were used, the highest concentration being 50%. Details of the
actual amounts given to the rats wete rot stated. In most cases, 10
animals were used to determine the toxicity of each dose, and the range of 
doses included those that produced 0 and 10G*, roi.ality. All deaths that 
occurred within 14 days after administration of dioxane were used for
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calculations of LD50 unless the signs of poisoning were inconsistent with 
those of similarly treated animals, or if infection was found on autopsy. 
Microscopic studies of the tissues were not made. All the doses caused 
some degree of irritation of the digestive tract. The primary action was
upon the kidneys but did not proceed beyond bloody urine. The liver was
less affected. Narcosis was observed only at the LD50 or at higher doses. 
The LD50 of dioxane for rats was found to be 7.1 ml/kg and 3,15 ml/kg for 
guinea pigs.
Smyth et al [52,53] attempted to study the joint toxic action of
several industrial chemicals by intubation in rats in all possible pairs 
using equitoxic and equivolume mixtures. An equitoxic mixture was defined 
as a mixture of two chemicals in volumes directly proportional to their 
respective rat oral LD50 values, so that each component contributed the
same degree of toxicity to the mixture.
For this purpose, pairs of industrial chemicals were administered to 
an unspecified number of albino female rats in two separate experiments. 
In the first experiment, 350 pairs of 27 chemicals, mixed in equal volumes, 
were administered. In the second experiment, 53 pairs of 26 chemicals
mixed in volumes proportional to their LD50 values were administered. The 
chemical pairs were given to groups of five rats in doses differing by a 
geometric factor of 2. Chemical pairs that were not soluble were
administered separately with a minimum time delay between the two doses. 
The adjusted ratios of predicted to observed LD50 values of the four
chemicals that did not act additively with dioxane when mixed in both equal
volumes and equal toxicity are presented in Table III-8.
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TABLE III-8
RATIOS OF PREDICTED TO OBSERVED LD50 VALUES OF CHEMICALS MIXED WITH 
DIOXANE (LD50 =7.07 ml/kg) IN EQUAL VOLUMES, AND IN VOLUMES PROPORTIONAL
TO EQUAL TOXICITY
Component LD50 
of Com­
ponent
Unadjusted 
Ratio of 
Predicted to 
Observed LD50
Adjusted Ratio 
of Predicted to 
Observed LD50
Equal Equal 
Volume Toxicity
Acetonitrile 8.27 3.15 2.15 1.49
Propylene glycol 42.90 0.51 -0.96 -0.42
Tetrachloroethylene 8.00 2.83 1.83 0.41
Ucon fluid
50-HB-260 5.00 0.40 -1.52 i o •
Adapted from references 52,53
A positive adjusted ratio showed a greater than additive effect as 
compared to the predicted combined toxicities of the two chemicals, whereas 
a negative adjusted ratio showed a less than additive effect. From Table 
III-8, it can be seen that acetonitrile and tetrachloroethylene, in 
combination with dioxane, had a greater than additive effect in both equal 
volume and equal toxicity experiments, whereas propylene glycol and Ucon 
fluid with dioxane had a less than additive effect. The investigators [53] 
concluded that the greater the difference between adjusted ratios for 
equivolume and equitoxic mixtures the less likely it was that the pairs 
would act additively.
Fairley et al [21] reported in 1934 studies in which they gave six 
rats and six mice each a 5% solution of dioxane in water in place of their 
regular drinking water. The animals either died or were killed by the 67th 
day of the experiment.
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All six rats and three of six mice showed severe lesions in the renal 
cortex, of the patchy type of degeneration. Cellular degeneration was very 
advanced and showed large necrotic areas in many cases. Degeneration was 
slight or absent in the renal medulla, but many tubules were blocked with 
casts. Hemorrhages and vascular congestion were seen throughout the 
kidneys. In the remaining three mice, vascular congestion was quite marked 
with hemorrhages in both cortex and medulla, but cortical degeneration was 
not evident.
The liver also showed cellular degeneration in five rats and three 
mice; it was extreme in two rats, well-marked in one, and in an early stage 
in the other two rats and three mice. Vascular congestion was noted in all 
rats and mice. However, the animals that were killed on days 60 and 67 
showed cellular degeneration in the kidneys and vascular congestion in the 
livers. This may indicate that tolerance was achieved in these animals, 
more so in mice than in rats, or that liver cell regeneration may have 
commenced in these animals. No other organs showed any injurious effect 
with the exception that the spleens of two mice were slightly affected 
though no gross changes were observed. The rats seemed to be more severely 
affected than the mice and two rats died with an acute gastroenteritis. No 
details regarding control animals were given.
Drinking water containing 5% commercial dioxane was administered to 
two dogs, and water containing 5% specially purified dioxane was given to a 
third dog in an experiment reported by Schrenk and Yant [48] in 1936. A 
measured quantity of the 5% dioxane solution was placed in the water pan 
which was securely fastened to the cage. The solutions were placed in the 
cages twice daily only long enough for the dogs to satisfy their thirst.
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The remaining portion was removed and measured. Though there were 
variations, each of these dogs had a greatly reduced water intake. No 
details regarding the use of controls were reported.
The dogs did not show any specific effects for about 4 days, then 
signs of poisoning were noticed in the following order: loss of
aggressiveness, quietness, sluggishness, loss of appetite, vomiting, 
weakness, inability to stand, labored breathing, and unconsciousness. Two 
of the dogs died on the 9th and 10th days after administration. The third 
dog, which was returned to regular drinking water on day 6, was killed for 
autopsy on day 45. The dog had recovered from the signs of intoxication, 
based on its appearance and blood nonprotein nitrogen determinations, the 
values of which were not reported. The blood counts of the two dogs that 
died, which included Hb, RBC, WBC, and differential and platelet counts, 
revealed a tendency towards leukocytosis. The blood nonprotein nitrogen 
was markedly increased shortly before death. The kidney cortices of the 
dogs that died had an abnormal appearance, while those of the dog that was 
killed on day 45 showed fibrosis. The authors [48] stated that fibrosis of 
a varying degree was frequently found in dogs; hence, fibrosis observed in 
the dog that was killed may not have been due to dioxane poisoning. The 
livers were enlarged in the dogs that died. Gastrointestinal tracts were 
congested with many hemorrhagic areas, and the stomachs contained bloody 
fluid. The brains appeared edematous with areas suggestive of hemorrhages. 
The lungs were congested.
The effect of an estimated dioxane intake of 1 ml/kg/day on 10 rats 
given water containing 5% dioxane by volume was reported in 1939 by Kesten 
et al [45]. Eight of ten rats died during days 5 to 12; the other two were
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killed on days 6 and 8. The kidneys of all rats showed extensive hydropic 
degeneration of the convoluted tubular epithelium. High levels of blood 
nonprotein nitrogen were also noted. The livers of six rats showed 
swelling and cellular hydropic degeneration. Two other rats that were 
maintained on 1% dioxane in drinking water for 110 days followed by 3%
dioxane for 41 and 48 days, showed patchy areas of degeneration in the
kidneys, and the liver of one rat showed damage.
Electron microscopic studies of the kidneys of white rats after 
ingestion of dioxane were reported by David [54] in 1964. Forty white rats 
of an unspecified inbred strain, weighing between 150-180 g, were given 
drinking water containing 5% dioxane for 1-10 days. Surviving animals were 
killed for microscopic studies on days 1, 3, 5, 7, 8, and 10 and on days 2, 
4, 7, and 9 after discontinuing dioxane treatment. A total of 15 rats were 
examined. The 35 rats that died were not studied. Studies on control rats 
were not mentioned.
No macroscopic changes were seen in rats killed during the first 7 
days, but, in rats killed later, there were frequent enlargements of the 
kidneys and small to relatively large retracted areas of a grayish-yellow 
coloration giving the renal surface a pock-marked appearance. Microscopic 
examination of the kidneys from the first 3 days showed swelling of the
tubular epithelium in the proximal section of the nephron, causing the
lumen to appear closed. Vesicular degeneration of tubular epithelium was 
first observed at 5 days and became more severe from the 7th day on. An 
accumulation of intracellular hyaline droplets was observed by electron 
microscopy, followed by enlargement of the basal labyrinth. Subsequent 
changes were noted in the tubular epithelium followed by degeneration and
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ultimately resulting in necrosis. The mitochondria showed accumulation of 
fluid, osmiophilic deposits, and needle-shaped crystal formations that 
developed from the cristae. The size of the crystals was not sufficient 
for chemical analysis. By comparison with electron micrographs from other 
studies, David [54] considered that the crystals were formed by the 
addition of calcium salts to the protein component of the cristae and were 
not calcium oxalate.
(3) Inhalation
Inhalation of dioxane caused a variety of signs in guinea 
pigs, rabbits, cats, rats, and mice, including eye and nose irritation and 
narcosis. Tumors, behavioral modification, and microscopic changes in 
kidneys, livers, lungs, and brains were also observed [19,21,24,26,55],
Yant et al [19] exposed an unspecified number of guinea pigs to 
dioxane at concentrations of 1,000, 2,000, 3,000, 10,000, and 30,000 ppm, 
and observed the duration of exposure in minutes up to a maximum of 8 hours 
required to produce signs such as nasal irritation, eye irritation, 
retching movements, changes in respiration, and narcosis. The composition 
of the dioxane vapor-air mixture was calculated from the quantity of liquid 
vaporized and the quantity of air contained in, or flowing through, the 
animal exposure chamber. The calculated composition of the dioxane-air 
mixture was always checked by sorption of the vapor from a measured volume 
of the mixture by air-equilibrated activated charcoal and determination of 
the gain in weight. Guinea pigs that were exposed at 30,000 ppm for 3
hours developed a state of marked narcosis during exposure, and the animals 
died within 2 days. Congestion and edema of the lungs, hyperemia of the 
surface of the brain, and paleness of the liver were seen in guinea pigs
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that were killed immediately after the exposure at 30,000 ppm for 30 
minutes; patches of congestion in the lungs and hyperemia of the surface of 
the brain occurred in those that were killed 4 or 5 days after the test; 
and there were no pathologic changes in the animals killed 9 or 10 days 
after exposure. Congestion of the lungs and a few hemorrhagic areas in the 
mucous membranes of the stomach were seen in the guinea pigs that died 
within 1 day of exposure at 30,000 ppm dioxane and bronchopneumonia and 
severe congestion of the surface vessels of the brain in the animal that 
died 2 days after exposure. Fifteen control animals showed no gross 
pathologic changes resembling those seen in the exposed animals.
The authors [19] concluded that, since exposure at 30,000 ppm for 2-3
hours caused death in the guinea pigs and an 8-hour exposure at 10,000 ppm
did not cause death, workers would not voluntarily tolerate atmospheres
which would cause serious acute poisoning and that no acute trouble would
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be experienced if the symptoms of eye and nasal irritation were regarded as 
a warning to avoid further exposure. However, from Barber's report [20], 
it was noted that workers continued to work throughout the shift despite 
the symptoms during the exposure, although they stayed away from work for a 
couple of days thereafter because of illness.
The effects of inhaling dioxane at 1,000, 2,000, 5,000, and 10,000 
ppm on guinea pigs, rats, mice, and rabbits were described by Fairley and 
his associates [21] in 1934. Animals were placed in a 1-cu m static 
chamber and the calculated amount of the dioxane-water mixture was then 
introduced. The dioxane concentration was obtained by vaporizing the 
calculated quantity of the dioxane-water mixture. The 1,000-ppm vapor was 
obtained by heating the mixture; for the other concentrations, the mixture
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was sprayed into the chamber. The mean temperature of the chamber was 
maintained at 27 C. Each week, the animals were exposed for 1.5 hours 
twice daily for 5 consecutive days, once on the 6th day, and were rested on 
the 7th day.
In general, the guinea pigs were the most affected and the mice the 
least affected at all the concentrations studied. Most of the animals 
exposed at 10,000 ppm died after 2-7 exposures, while, at the lower 
concentrations, the animals were killed after various exposure times. The 
kidneys showed cortical lesions ranging from patchy swelling to complete 
necrosis as the dioxane concentration increased. Hemorrhages and vascular 
congestion were also observed. The livers showed changes ranging from 
vascular congestion to cellular degeneration as the concentrations 
increased. At 10,000 ppm, the lungs showed pulmonary lesions that varied 
from an acute vascular congestion to an advanced infiltration of RBC and 
these pulmonary lesions were the cause of death in these animals. At the 
lower concentrations, the lungs showed only vascular congestion or were 
normal. All other organs appeared to be normal.
Mice were exposed to two grades of dioxane in inhalation experiments 
reported by Wirth and Klimmer [26] in 1936. One grade was a very pure 
product that contained 99.8% dioxane with 0.2% water and was completely 
free of aldehydes and other impurities. The other, a technical grade of
dioxane of 96.4% purity, contained 1.5% aldehyde and acetal, 2.1% water,
and trace amounts of alcohol and acids. Experiments were carried out with 
both grades of dioxane at concentrations ranging from 1,400 ppm for about
8.3 hours to 39,000 ppm for approximately 1 hour on white mice of an
unspecified strain. A static gas mixture in two 32-liter anesthesia flasks 
was employed.
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None of the mice died during the exposure, but deaths occurred as 
early as 12 minutes and as long as 67 hours after removal from exposure. 
Signs of labored breathing followed by disturbance in the sense of 
equilibrium and irritation of the eyes occurred during exposure at all 
concentrations. With one exception, all mice died at dioxane 
concentrations of 8,300 ppm and above. The pathologic changes noted at 
autopsy were signs of inflammation in the respiratory tract and lung nodes 
in a few of the mice. When other mice (numbers not reported) were exposed 
at 1,400 ppm, 8 hours/day, for 17 days, no deaths occurred.
In their experiments with cats, Wirth and Klimmer [26] admitted a 
continuous flowing gas mixture into the exposure chamber at a constant
flow. Again, the same two grades of dioxane were used. Two cats in each
experiment were exposed at concentrations of 12,000 ppm for 7 hours, 18,000 
ppm for 4.3 hours, ,24,000 ppm for 4 hours, and 31,000 ppm for 3 hours.
With both grades of dioxane, a loss of equilibrium, increased salivation,
and lacrimation were manifested during all exposures. Narcotic effects 
appeared earlier in the exposure period as the dioxane concentration 
increased. After removal from exposure, the cats became progressively less 
active and died in 3-10 days. Necropsy findings were fatty livers and 
inflamed respiratory organs.
Three male cats were also exposed at an average of 1,400 ppm for 
about 6.5 hours/day for 14 days. From the 4th day to the end of the 
experiment, the cats seemed sleepy during exposure. Retching and vomiting 
were observed occasionally, with slight polydypsia. None of the animals 
died as a result of exposure. Urinalysis was negative for protein, sugar, 
and blood; bilirubin and urobilinogen were normal. Increased Hb
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concentrations, RBC, and lymphocyte counts without substantial changes in 
total leukocyte counts occurred and had not returned to normal three weeks 
after removal from exposure. In the experiments with mice and cats, only 
slight differences were observed between the two grades of dioxane, the 
paralyzing and narcotic effects occurring a little earlier in the case of 
pure dioxane. No significant changes were observed at autopsy between the 
two grades of dioxane used.
Experimants reported by Gross [24] showed that 21 of 28 animals 
(mice, rats, guinea pigs, and rabbits) died from single 8-hour exposures at 
concentrations of about 4,000-11,000 ppm of dioxane. The animals died 7.5 
hours at the earliest and 5 days at the latest after the completion of the 
experiment. Ten animals (mice, rats, guinea ' pigs, and rabbits) lived 
through exposure at 37,500 ppm for 3 hours; four of them died within 6 
days. The signs of intoxication included signs of irritation of the mucous 
membranes, labored breathing, and narcosis. There was occasional 
albuminuria. Hyperemia and edema of the lungs and liver and kidney 
injuries, stated by Gross [24] to be similar to those observed by De 
Navasquez [38], were found by microscopic examination. Similar toxic and 
pathologic signs were observed at 2,700 ppm and, though less severe, at 
1,350 ppm.
In unpublished work conducted between 1937 and 1955, Smyth [56] noted 
that rabbits were particularly susceptible to eye and nose irritation, and 
that repeated inhalation at 800 ppm killed some guinea pigs from kidney 
injury within 30 days. No details regarding the experimental design, the 
use of controls, or microscopic observations were presented.
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Effects in rats exposed in groups of five to dioxane vapor at
concentrations ranging from about 6,000 ppm to 19,000 ppm for about 4-6 
hours were reported in 1951 by Nelson [50]. The strain, age, and sex of 
the rats used were not mentioned. The survival time decreased with 
increase in dosage as reflected by the product of concentration and 
exposure time, while the anesthetic-narcotic effect increased with dosage.
The LC50 of dioxane for 4-hour exposures of female Carworth Farms- 
Nelson rats, a specific pathogen-free (SPF) strain, was found to be 14,250 
ppm (51.3 mg/liter) by Pozzani et al [57] in 1959. The LD50 by the oral 
route was found to be 6.16 ml/kg.
The effect of inhalation of dioxane vapor on avoidance-escape
behavior and on the growth rate of pretrained 30- to 40-day-old female rats 
was studied by Goldberg et al [55] and published in 1964. The 
concentrations of dioxane were 1,500, 3,000, or 6,000 ppm. Eight to ten 
rats were used in both control and experimental groups in a series of 
experiments with different compounds. The rats were exposed 4 hours/day, 5 
days/week, for 2 weeks. Responses examined were determined each day 
before, during, and 2 hours immediately after removal from exposure. 
Behavioral studies included the effect of dioxane on conditioned pole- 
climbing avoidance response to a buzzer and an unconditioned escape 
response to the buzzer and an electrical shock. The normal response time 
to both stimuli was 2 seconds. It was noted that only one animal was 
affected at 2,500 ppm and its responses were not consistent from day to
day. In the group exposed at 3,000 ppm, the avoidance reaction was delayed
in two to three rats/exposure. About 75% of the rats showed delay of the 
avoidance response after one exposure at 6,000 ppm, but the escape response
was unaffected. After two exposures, the avoidance reaction was blocked in 
all animals and the escape response was blocked in three of eight rats. 
Three or more exposures completely blocked the avoidance response in 37-62% 
of the rats; the escape response was not affected.
It was noted from these experiments that the delay in avoidance
response increased with increase in concentration and, in multiple 
exposures, the escape responses were also blocked in many cases.
(4) Skin Application
Experiments in which liquid dioxane was applied to the skin of 
rabbits, guinea pigs, and mice demonstrated that the chemical was rapidly 
absorbed and produced signs of incoordination, narcosis, and erythema 
[21,50].
To study the effects of dioxane through the skin, Fairley et al [21] 
applied an 80% dioxane-water mixture to the shaved skin of four rabbits and 
four guinea pigs. Each rabbit received 10 drops and each guinea pig 5
drops of the solution for 7-14 weeks. Two applications were given daily
for 5 days, one application on the 6th day, and none on the 7th day of each
week. No skin irritation was observed from these applications. The 
animals remained in apparently normal health. One rabbit and one guinea 
pig were killed on days 49, 66, 77, and 101.
Macroscopically, nothing abnormal was noticed. On microscopic 
examination, the renal and hepatic lesions were progressively worse in the 
first three pairs of animals killed, ranging from no cellular degeneration 
to gross degeneration. The animals killed on day 101 (160 applications)
indicated only an intermediate degree of injury with both kidneys and 
livers showing patchy cloudy swelling, but no definite recovery or repair.
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In other words, injury was greatest after 121 applications (day 77) but,
when checked after 160 applications, it seemed to be moderate. This may 
indicate that either tolerance or regeneration occurred.
The effects of dioxane resulting from its absorption through the skin 
of rabbits were reported by Nelson [50] in 1951. Undiluted dioxane was 
applied to a shaved area of the belly which represented approximately 15% 
of a rabbit's body surface. Dioxane was in contact with the skin of two to 
four rabbits, used in groups, for 1.7, 3.0, 4.1, and 4.8 hours. A control 
rabbit was treated with water for 6 hours and another for 7.7 hours. Three 
rabbits showed evidence of intracutaneous and subcutaneous hemorrhages at 
the end of exposure. When dioxane was administered to two rabbits for 1.7 
hours, unsteadiness and incoordination were noticed in both animals; one 
died within 24 hours and the other was alive 2 weeks after exposure. When 
four rabbits were exposed to undiluted dioxane for 3 hours, all showed 
unsteadiness and incoordination; two died within 3 days, one on the 5th 
day, and the other was alive 2 weeks after exposure. One rabbit exposed
for 4.1 hours and another for 4.8 hours appeared to be in a state of 
narcosis with very weak or absent corneal reflexes and both died at the end 
of exposure. Dioxane caused skin erythema in the two surviving rabbits 
which cleared in a matter of days with a superficial scaling and without 
any evidence of permanent damage.
(5) Other Studies
In 1931, von Oettingen and Jirouch [39] noted hyperemia and 
pus formation and edema of the conjunctiva, and edema of the nictitating 
membrane when a drop of pure dioxane was placed into one eye of a rabbit.
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The effects of dioxane at various concentrations as well as effects 
of some other solvents on the eyes of rabbits were reported by Carpenter 
and Smyth [58] in 1946. Dioxane was applied to the eyes that had earlier 
shown no grossly visible stains from a fluorescein solution. During and 
for 1 minute after the application of dioxane to the center of the cornea,
the lids were held open. On examination 18-24 hours later, it was found
that dioxane caused severe corneal necrosis and that dioxane was more 
injurious than ethanol but less so than either acetone or isobutanol.
The toxicity of dioxane to Eagle's KB strain of human carcinoma cells 
was observed by Smith et al [59] in 1959. In this study, the 
concentrations of dioxane added to the culture were 0.8, 4, 20, 100, and 
500 jug/®l. It was not stated what solvent was used in this experiment. 
The ID50 (dose for 50% inhibition) of dioxane was estimated to be in the 
range of 200-800 yg/ml. By comparison, acetone, methanol, and ethanol had 
ID50 values greater than 5,000 ng/ml.
The effect of dioxane on growth and development of 150 chicken embryo
tibial buds in organotropic cultures was reported by Franceschini [60] in 
1964, Dioxane was added to the culture medium in amounts of 24, 47, 94, 
180, 375, 750, and 1,025 /¿liters. In the same study, thalidomide was added 
to the culture medium of 150 other tibias in amounts of 1,500, 2,000, 
2,500, 3,000, 3,500, 4,000, 5,000, and 7,500 filters. Hypertrophic and 
vacuolized chondroblasts in diaphysis and reappearance of mitosis in the 
metaphysis were the first signs of poisoning in tibias examined after 2 
days1 growth on media containing either dioxane or thalidomide.
A study relative to the teratogenicity of dioxane was reported by 
Schwetz and his colleagues [61] in 1975. Sprague-Dawley rats and Swiss-
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Webster mice were exposed to a commercial preparation of 1,1,1- 
trichloroethane that contained dioxane and other additives and impurities 
for 7 hours/day on days 6-15 of gestation. The exposure concentration of
1,1,1-trichloroethane averaged 875 ppm and that of dioxane about 32 ppm. 
Although a few terata were found in the fetuses of both rats and mice, they 
were not of a consistent type in the two species and did not occur more 
often than in untreated litters of the colonies.
(b) Chronic Studies
Chronic studies were conducted with rats and guinea pigs administered 
dioxane orally and with mice exposed to the chemical by dermal application 
and by inhalation [43,62-70]. Results have demonstrated the induction of 
tumors in the nasal cavity and liver of rats [43,62,64,65], in the gall 
bladder, lungs, and kidneys of guinea pigs [63], and in the skin and lungs 
of mice [66,70], Other reported findings in rats were bronchitis, 
bronchopneumonia, and kidney and liver damage [66,67,70].
A group of investigators at Tulane University [62] noted that some 
chemical carcinogens, such as dimethyldinitrosophthalamide, heptylamine, 
diethylacetamide, and diethylformamide, were also potent protein-denaturing 
agents. Though no tumors from dioxane administration had been found in 
earlier studies by Kesten et al [45], the Tulane group decided to study the 
carcinogenic potential of dioxane because of postulated carcinogenicity, 
based on its protein-denaturing characteristics.
In their first study, in 1965, Argus et al [62] used adult male
Wistar rats, weighing between 150 and 200 g, and housed two to a cage. The
animals were pretreated with 75 mg/liter terramycin for 1 week in their
drinking water, probably to' prevent infection. The animals were then fed
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1% dioxane in their drinking water for 63 weeks at an average estimated 
total dose of 132 g/rat. Nine rats were used as controls. The weights of 
the dioxane-treated rats increased to 500-580 g by the end of the 
experiment; no details regarding weight gain in control rats were given. 
Complete necropsy was performed on all rats.
The changes found in the kidneys resembled glomerulonephritis. The 
tubular epithelium, especially in the convoluted tubules, contained a 
granular precipitate. Many arteries were obliterated and a thickening of 
arterial walls was observed. Epithelial proliferation was quite prominent 
in the glomeruli of some kidneys. One rat showed an early transitional 
cell carcinoma in the renal pelvis 65 weeks after the start of the 
experiment; the surface epithelium showed marked proliferation. This same 
rat also had a 2-cm diameter tumor in the liver but no further details were 
given.
Hepatomas were observed, apparently by microscopic examination, in 6 
of 26 rats, but no details were given except that these hepatomas developed 
64 and 65 weeks after the start of the experiment. In the lungs of many 
rats (number unspecified), both control and treated, there were cases of 
severe bronchitis with epithelial hyperplasia, marked peribronchial 
infiltration, and multiple abcesses. A lymphosarcoma, found in one of the 
control animals, was of a large cell type and localized in the 
retroperitoneal lymph nodes. Leukemia was found in one rat treated with 
dioxane.
In view of the observed hepatomas in 6 of 26 rats, the investigators 
concluded that dioxane is a hepatic carcinogen. However, the following 
points need to be considered regarding the experimental design of Argus et
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al [62]: (1) Animals were pretreated with terramycin for 1 week before the
start of the experiment. Whether a possible action of terramycin on liver 
microsomes affected the subsequent action of dioxane is not clear. (2) 
Four other candidate carcinogens, diethylacetamide, diethylformamide, 
dimethyldinitrosophthalamide, and heptylamine were tested at the same time 
as dioxane. It is not known whether the dioxane-treated rats were housed 
in the same room as the others, and whether cross-contamination could have 
had a significant effect. (3) The dose of dioxane which produced tumors 
was 737 times that producing tumors in diethylacetamide-treated rats, which 
also caused kidney damage. (4) Only nine control rats were used.
In 1970 Hoch-Ligeti and Argus [63] studied various candidate 
carcinogens including dioxane and observed the induction of tumors and 
hyperplasias described as tumor-like in 9 of 22 male guinea pigs given 
dioxane orally. The concentration of dioxane in drinking water ranged from 
0.5 to 2% and was regulated to maintain the normal growth of the guinea 
pigs. The exact amount of dioxane absorbed from the drinking water was not 
known; however, the total amount received by a guinea pig over a 23-month 
period was 588-635 g. The animals were killed within 28 months. Ten 
guinea pigs were used as controls.
Peri- or intrabronchial epithelial hyperplasia and nodular 
mononuclear infiltration were present in the lungs of nine guinea pigs. In 
addition, two guinea pigs had carcinoma of the gall bladder, three animals 
had early hepatomas which were not described, and one had an adenoma of the 
kidney.
The lungs of 4 of 10 control guinea pigs showed peripheral 
mononuclear cell accumulation, one showed hyperplasia of the bronchial
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epithelium, and one showed the formation of a cartilaginous substance in 
the bronchus. Both dioxane-treated and control animals were very small in 
number.
The induction of carcinomas in the nasal cavities of 6 of 120 rats
fed dioxane in drinking water was reported by Hoch-Ligeti et al [64] in
1970. Five groups of 30 male Charles River CD-strain rats, 2-3 months of
age and 110-230 g in weight, were used. These were SPF animals derived 
from a Sprague-Dawley line. Four groups of rats were given drinking water 
containing 0.75, 1.0, 1.4, or 1.8% dioxane for 13 months; the fifth group 
served as a control. The average daily fluid consumption, determined for 
each group over a 3-day period on two occasions, was approximately 36 ml. 
The rats were killed with ether at 16 months or earlier if the nasal cavity 
tumors were clearly observable. Autopsies were performed on all rats. 
Table III-9 presents the total dosage, latent periods, and incidence of 
liver and nasal cavity tumors in six rats.
Table III-9 shows that four of the rats, two that received 1.4%
dioxane and two that received 1.8% dioxane, had liver tumors as well as
tumors of the nasal cavity. One rat at each of the other doses developed
tumors only in the nasal cavity. The nasal cavity tumors, found to be 
heavily necrotic on dissection, were squamous cell carcinomas with marked 
keratinizatlon and formation of keratin pearls. They appeared to arise in 
the anterior part of the nasal cavity as evidenced by dysplasia and in situ
carcinomatous changes of the squamous epithelium. Neurologic signs were
not observed. A small, firm, well circumscribed tumor was found on the 
back of the nose of one control rat, which on microscopic examination 
proved to be a subcutaneous fibroma.
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TABLE III-9
TOTAL DOSES AND LATENT PERIODS OF NASAL AND HEPATIC 
TUMORS FOUND IN SIX DIOXANE-TREATED CHARLES RIVER STRAIN RATS
Concentrat ion 
of Dioxane 
Administered
(%)
Total
Dose*
(g)
Dioxane
mg/kg/day
Latent
Period
(Days)
Nasal
Cavity
Tumor
Present
Hepatic
Tumor
Present
0.75 104 1350 385 Yes No
1.00 142 1750 407 Yes No
1.40 191 2500 382 Yes Yes
1.40 198 2170 456 Yes Yes
1.80 213 3255 329 Yes Yes
1.80 256 2630 256 Yes Yes
*Calculated on the basis of an average daily fluid intake of 36 ml 
Adapted from reference 64
No tumors were found in the livers or nasal cavities of the control 
animals. The investigators [64] ^concluded that dioxane was a hepatic 
carcinogen in the rat and that it possessed the versatility of inducing 
tumors at various locations and hence was of possible carcinogenic hazard 
to humans. In this study, two rats, each given 1.4 and 1.8% dioxane in 
drinking water, showed hepatic tumors which were not described either in 
location or microscopically. The rats given 1% dioxane for 68 weeks did 
not show any hepatic tumors; yet, in the earlier study [62], six 
undescribed hepatomas at the 1% level were observed at 64 and 65 weeks. 
The investigators [64] suggested that a free radical or a carbonium ion may 
be formed during dioxane metabolism which may represent a proximate 
carcinogen.
In another report, apparently of the same experiment, Argus et al 
[43] reported that the hepatocarcinogenicity of dioxane in male rats was a
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function of the total oral dose administered. Five groups of 28-32 Charles 
River CD strain male rats, 2-3 months old, and weighing 110-230 g at the 
beginning of the experiment, were used in each group. The rats were housed 
two to a cage. The experimental animals were given drinking water 
containing 0.75, 1.0, 1.4 or 1.8% dloxane for 13 months with one group used 
as a control. Fresh dioxane solutions were prepared daily. The weights of 
the rats were recorded weekly, and all rats that survived for 16 months 
were killed with ether. Autopsies were performed on all rats. The exact 
number of animals used in each group was not stated and hence the number of 
animals having tumors or the number of tumors/animal could not be 
determined. Four "incipient" tumors were found in the livers in the group 
that received 0.75% dioxane and nine in the group that received 1% dioxane. 
These so-called "incipient" tumors were described as nodules with the 
histologic characteristics of hepatomas. Thirteen "incipient" liver tumors 
and three hepatomas were found in the 1.4% group and 11 "incipient" liver 
tumors and 12 hepatomas were found in the group administered 1.8% dioxane. 
The total dioxane doses administered were about 90, 118, 162, and 205 g in 
the four groups, and the tumor incidence, apparently the percentage of 
animals with either "incipient" or frank hepatomas, was 14, 28, 53, and 82, 
respectively. The hepatomas were manifested grossly as white lesions, 0.5-
1.0 cm in diameter. Microscopically, these lesions consisted of long 
strands of large cells, 2-4 cells thick. A conglomeration of small nodules 
was seen in some tumors. Metastases were not observed. At all doses of 
dioxane, the kidneys showed marked alterations; in many, the changes were 
those of glomerulo- and pyelonephritis with characteristic epithelial 
proliferation of Bowman's capsule, periglomerular fibrosis, and distension 
of tubules [43].
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In their earlier studies, the authors [64] had observed nasal tumors 
at all the four levels, 0.75, 1.0, 1.4 and 1.8% dioxane, one tumor at each 
of the two lower levels and two each at the two higher levels of dioxane. 
In the present study, no nasal tumors were reported and, although lung 
tumors were not found in any of the rats, the lungs of one rat given 1.4% 
dioxane in drinking water showed early peripheral adenomatous change of the 
alveolar epithelium; papillary hyperplasia of the bronchial epithelium was 
found in another rat receiving the same level of dioxane.
For electron microscopic studies, the investigators [43] administered 
1% dioxane in drinking water to 10 male Sprague-Dawley rats. Five of them 
were killed after 8 months and the other five after 13 months of treatment. 
Although microscopic examination revealed no evidence of liver tumors in 
any of the rats killed after 8 months, "incipient" liver tumors, which they 
termed precancerous changes, were seen in two rats consuming dioxane for 13 
months.
The investigators [43] concluded that hepatocarcinogenicity did not 
appear to be strain-specific since both Wistar [62] and Sprague-Dawley 
[43,64] rats seemed to be susceptible. In these studies, 1 of 26 Wistar 
rats showed a transitional cell carcinoma of the kidney pelvis [62], but no 
mention was made of alterations or kidney tumors in their second report 
[64]. The third report [43] showed no kidney tumors, though alterations 
occurred at all four doses. They also stated that, from their third study 
[43], dioxane was considered to be a weak to moderate hepatocarcinogen. 
They also suggested that the combination of repeated exposure to dioxane 
vapor and to an enzyme inducer such as MC could increase the toxicity and 
possibly the carcinogenicity of dioxane. However, as seen earlier in their
studies with MC followed by dioxane, there was no great increase in 
toxicity.
In earlier work with dioxane [43,62,64], the effects of low doses 
were not studied. Since the doses which the rats received were massive, 
some greater than 1,000 mg/kg/day to compensate for the small test animal 
population, it was difficult to estimate the possible hazard in a work 
environment. The need for dose-response data following exposure at lower 
levels of dioxane prompted Kociba et al [65] to conduct a long-term 
toxicity study in male and female Sherman strain rats given dioxane in 
their drinking water, the results of which were published in 1974. Three 
groups of rats, each consisting of 60 males and 60 females, were given 
drinking water containing 1.0, 0.1, or 0.01% dioxane for up to 716 days (2 
years). A fourth group consisting of 60 rats of each sex was used as a 
control. Periodically, samples were collected from individual water 
dispensers and analyzed for dioxane content by gas-liquid chromatography. 
Autopsy was conducted on all rats that died or appeared moribund.
Rats that were fed 1% dioxane in drinking water were found to consume 
dioxane at a daily rate of approximately 1,000 mg/kg (males) and 1,600 
mg/kg (females) over the 2-year period. There were more deaths during the 
first 4 months of the study among experimental animals of both sexes than 
in the control group. After the 5th month, the mortality rate of test 
animals was not statistically significantly different from that of the 
controls. Only one male rat out of 60 fed 1% dioxane was alive during the 
last 60 days of treatment. Rats that received 0.1% dioxane in drinking 
water consumed dioxane daily at rates of about 94 mg/kg (males) or 148 
“g/kg (females) [65].
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Water consumption by rats of both sexes in the 1% group and in 
females of the 0.1% group was significantly lower (P<0.05) than that of the 
controls. The body weights of both male and female rats of the 1% group 
were significantly lower (P<0.05) than those of controls within 2 days 
after the start of the study, and remained depressed throughout the 2-year 
period. The body weights of rats that received 0.1 or 0.01% dioxane in 
drinking water were not significantly different from those of controls.
Gross and microscopic examination of tissues from rats that received
1.0 or 0.1% dioxane revealed variable degrees of renal tubular,
hepatocellular, and epithelial degeneration and necrosis; these effects
were similar to those seen by Fairley et al [21], De Navasquez [38],
Schrenk and Yant [48], and Kesten et al [45], who administered dioxane for
shorter periods. In addition, rats that received 1.0 or 0.1% dioxane
showed evidence of hepatic regeneration as indicated by hepatocellular
*
hyperplastic nodule formation and evidence of renal tubular regeneration as 
indicated by increased tubular epithelial regenerative activity [65]. 
Nasal carcinomas were observed in 3 of 66 rats of the 1% group (P=0.055). 
No evidence of tumor formation or other toxic effects were observed in rats 
maintained on water containing 0,01% dioxane from which they consumed 
dioxane doses of approximately 9.6 mg/kg/day (males) and 19.0 mg/kg/day 
(females).
In the control group of 106 rats, 1 showed a hepatocellular 
carcinoma, another a cholangiocarcinoma, and 2 had hepatic tumors. Since 
earlier work [43,62,64] involved the use of massive doses to demonstrate 
tumor formation and carcinomas, the investigators [65] in this study used 
both high and low doses of dioxane to obtain a dose-response relationship.
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There was a significant increase in hepatocellular carcinomas in rats given 
1% dioxane in drinking water (10/66 vs 1/106) and a suggestive increase in 
the same group in squamous cell carcinoma of the nasal turbinates (3/66 vs 
0/106). There were no significant increases in tumors of other types 
compared to those seen in controls, or in rats given lower doses of 
dioxane.
A report on the effects of orally ingested dioxane on Osborne-Mendel 
rats and B6C3F1 mice was made by Holmes in 1976 [67]. Groups of 35 male 
and 35 female rats and 50 mice of each sex received 1.0 or 0.5% of dioxane 
in drinking water; an additional 35 rats and 50 mice of each sex served as 
controls. Surviving rats were killed after 110 weeks and mice after 90 
weeks. An air-conditioning failure approximately 1 year after the study 
had begun made it necessary to restart the experiment for male rat controls 
and for male rats given 1% dioxane dose. The daily dose of dioxane 
ingested by the experimental animals was measured during the second year of 
the experiment. For rats given 0.5% of dioxane, the average dose was 
calculated as 0.25 and 0.35 g/kg/day for males and females, and 0.60 and 
0.64 g/kg/day for males and females given the 1.0% dose. For mice, the 
calculated average doses were 0.72 and 0.38 g/kg/day for males and females 
given 0.5% dioxane. For male and female mice which drank water containing 
1.0% of dioxane, the average doses were 0.83 and 0.86 g/kg/day.
A high fatality rate was reported for both male and female rats [67], 
with about 80% deaths in the 1.0 and 0.5% dioxane groups and 50% in 
controls, The rats, especially females, were reported to have been highly 
susceptible to murine and other bronchial pneumonias. Many of the deaths 
in the treated groups were attributed to renal and hepatic toxicity. Renal
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toxicity was described as tubular nephrosis with vacuolar degeneration and 
necrosis of the tubular epithelial cells. Liver toxicity was characterized 
as fatty change or frank hepatocellular necrosis beginning as a 
centrilobular lesion and often involving the entire lobule. In females 
only, these hepatic lesions led to formation of hyperplastic nodules, and 
occasionally to hepatocellular carcinomas.
An increase in the number of malignant tumors was seen with 
increasing dioxane doses [67] with 11 tumors in controls, 28 in the 0.5% 
dioxane group, and 41 in the 1.0% group. These tumors were not compared 
statistically. Most of the malignant tumors occurred in the nasal 
epithelium. Tumors were confirmed by microscopic examination but the 
findings were not described. Squamous cell carcinomas of the nasal cavity 
were seen in 0/32 controls, 23/57 of the 0.5% dioxane group, and 23/51 of 
the 1% group. Two animals of the 0.5% group had olfactory neuroblastomas 
and one had a rhabdomyosarcoma. Seven animals of the 1.0% group had 
olfactory neuroblastomas and two had seromucous adenocarcinomas. The two 
seromucous adenocarcinomas metastasized, one to the brain and cervical 
lymph node and the other to the lung. Four of the nine neuroblastomas and 
4 of 46 squamous cell carcinomas also metastasized, mainly to the brain.
Most of the mice, except for 11 of 50 females given 1% of dioxane, 
survived to the end of the experiment. According to the author [67], these 
11 deaths may have been due to chronic rhinitis and murine pneumonia which 
had an increased occurrence among female mice.
The target organ in the mouse was the liver [67], One of 99 examined 
controls had chronic hepatitis compared to 26 of 94 in the 0.5% dioxane 
group and 14 of 87 in the 1.0% group. An increase in malignant liver tumor
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incidence was reported with increasing dose. Three of 99 controls, 11/94 
of the 0.5% dloxane group and 10/87 of the 1% group had hepatic nodular 
hyperplasia. Hepatocellular carcinomas were seen in 4/99, 24/94, and 44/87 
of controls, 0.5%, and 1.0% groups, respectively. The tumors were 
confirmed microscopically. The hyperplasias were described as small, 
circumscribed, single or multiple areas demarcated by surrounding 
compressed liver tissue. Hepatocellular carcinomas were characterized by 
general disruption of normal liver structure with abnormally formed 
trabeculi, sinusoid-like blood spaces, anisocytosis, abnormal staining 
properties, and intranuclear and intracytoplasmic inclusion bodies.
To determine the effects of long-term repetitive inhalation of 
dioxane, Torkelson et al [68] conducted a "lifetime" 2-year study with 
Wistar strain rats. At the time the study was started and until 1971, the 
ACG1H threshold limit value for dioxane was 100 ppm (360 mg/cu m ) ; hence 
this concentration was selected for the 2-year study. In addition, earlier 
studies of animals exposed at 50-100 ppm for shorter periods had shown no 
adverse effects [68],
In the inhalation experiment conducted by Torkelson et al [68], 288 
male and 288 female rats were exposed at 0.4 mg/liter of air (111 + 5 ppm 
of dioxane) for 7 hours/day, 5 days/week, over the 2-year period, with 192 
males and 192 females used as controls. The dioxane vapor concentration 
was monitored by an on-line infrared spectrometer analyzer.
Animals were monitored for evidence of toxicity including changes in 
activity, eye and nasal irritation, skin changes, respiratory distress, 
weight changes, and tumor formation. Hematologic values, including packed 
cell volume, RBC, Hb, WBC and differential WBC, were within normal
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physiologic limits. Blood urea nitrogen (BUN), alkaline phosphatase, total 
protein, and SGPT values were normal. The slightly lower BUN and alkaline 
phosphatase values found in exposed males as compared to control males were 
not considered to be of toxicologic significance. There was no evidence of 
changes in activity, body weights, or in gross or microscopic appearance of 
organs and tissues of the animals because of dioxane exposure [68]. No 
hepatic or nasal tumors occurred in either control or exposed rats. 
Neither any one type of tumor nor the total number of tumors occurred more 
frequently (P<0.05) in the exposed rats than in the controls.
Torkelson et al [68] stated that the absence of a detectable increase 
in the tumors of rats in the inhalation experiment supported their earlier 
hypothesis [65] that liver injury precedes tumor development in the liver.
A comparative calculation of possible daily doses of dioxane was made 
by the investigators between their inhalation study [68] and their earlier 
ingestion study [65] . In the oral study [65], male and female rats that
received 1% dioxane in their drinking water ingested an average of 1,015
and 1,599 mg/kg/day, respectively; those that received 0.1% ingested 94 and 
148 mg/kg/day and rats that received 0.01% Ingested 9.6 and 19 mg/kg/day of 
dioxane. In the inhalation study, about 105 mg/kg/day of dioxane would 
have been inhaled during a 7-hour period, if dioxane was totally absorbed 
from the respiratory tract. This inhalation dose was based on a 
respiratory rate of at least 250 ml/min for male rats weighing 400 g, or
about 105 liters of air/7 hours of exposure. This calculated inhalation
dose of dioxane was very similar to that of male rats ingesting water 
containing 0.1% dioxane, or 94 mg/kg/day. However, only the latter 
exposure caused pathologic changes in the liver.
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As discussed by the investigators [68], a few differences were noted 
between the inhalation and ingestion studies: (1) the administration of
dioxane in the ingestion study was 7 days/week as compared to 5 days/week 
in the inhalation study, (2) although dioxane is very soluble in water, 
less than quantitative absorption may have occurred in the respiratory 
tract, and (3) the gastrointestinal absorption may have exposed the liver 
to a higher concentration of dioxane than absorption from the lungs.
Skin painting experiments were conducted by King et al [66,70] for 
78-110 weeks on mice and rats for a carcinogenesis bioassay study of 
chlorinated dibenzodioxlns and dioxane. Two sets of experiments were 
undertaken, one to determine whether dioxane was a carcinogen, and the 
other to determine whether it promoted the carcinogenicity of 
dimethylbenzanthracene (DMBA). Acetone was used as a vehicle and as a 
control for the chlorinated dibenzodioxins, where 0.2 ml of the sample was 
dissolved in acetone. It is not apparent whether dioxane was also 
dissolved in acetone. Dioxane was applied topically three times weekly to 
the backs of 30 male and 30 female mice. For the study of promotional 
activity, the same number of mice were initially treated with 50 ug DMBA 1 
week prior to the application of dioxane.
Twenty-two of 30 male mice and 25 of 30 female mice survived 60 weeks 
of dioxane treatment. One suspected carcinoma, not confirmed 
microscopically, was seen in the surviving male group, and one subcutaneous 
tumor was seen in the surviving female group. No description of the type 
of tumor was given. One reticulum cell malignant lymphoma was seen among 
eight mice that died, but there was no evidence of skin lesions.
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In the group administered dioxane after pretreatment with DMBA, 4 of 
30 male mice and 5 of 30 female mice survived 59 weeks of test; two 
papillomas and three suspected carcinomas each were found among both male 
and female mice and two subcutaneous tumors were observed among the males. 
Lesions of the liver included megalocytosis, distended bile canaliculi, 
centrilobular necrosis, and cuffed triad vessels. General mononuclear 
periportal infiltration and mild peripherolobular fibrosis were identified 
in a number of the dioxane-treated mice. The skin at the dioxane-treated 
area showed conditions ranging from hyperplasia to dermal fibrosarcoma. 
Squamous cell carcinoma of the nasal septum was observed in one mouse that 
had skin papilloma. Seven of nine mice had malignant lung lesions, three 
of which were considered metastatic from other unspecified sites. No 
studies were performed by the use of DMBA alone; hence, it is difficult to 
ascertain whether lesions and tumors observed were due to dioxane, DMBA, or 
both.
Acetone was used as a vehicle for the study of the dioxins and 
perhaps for dioxane too. No skin tumors were seen in the surviving mice in 
the carcinogenic study, but promotional studies showed the presence of two 
undescribed subcutaneous tumors, and a reticulum cell malignant lymphoma 
was found in one of the female mice.
In a later report of the same experiment, King et al [70] stated that 
mortality was high in the dioxane-promotion group (55/60). The average 
number of papillomas/mouse was about 30% lower than that seen for croton 
oil-treated animals, yet the comparative rate of promotional activity for 
croton oil and dioxane on male mice seemed to be similar.
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Skin painting with dioxane following DMBA initiation led to the 
development of a number of alveolar adenocarcinomas which were not 
metastatic from the skin tumors. On the other hand, in the studies of 
dioxane without DMBA, the incidence of tumors was greatly reduced but 
certain of the systemic responses comparable to those seen in the dioxane 
promotion experiments were found, especially alveolar adenocarcinomas.
The investigators [70] stated that the high incidence of lung
adenocarcinomas in the dioxane-treated groups suggested the possibility 
that inhalation of the compound may have affected the results. Because of 
the caging system, appreciable air concentrations of dioxane were produced, 
a fact which was verified by gas chromatographic analysis. A peak
concentration of 5,278 ppm was found within 3 minutes of the skin 
application, which decreased to 694 ppm at 15 minutes and to 146 ppm at 1 
hour. By 3 hours, the concentration of dioxane had decreased to 55 ppm.
To determine any possible effects of inhalation and to recheck some
of the earlier promotional studies, further work was conducted by King et
al [70] using both acetone and dioxane. In the dioxane promotion 
experiment without the use of filters in the cages, 12 of 30 male mice died 
and one tumor on one of the survivors was noted; 2 of 30 females died and 
no papillomas were observed in the survivors after 54 weeks of treatment. 
With the use of filtered rack, no papillomas were noted and four females 
died during the experiment.
In the acetone promotion experiment, no papillomas were observed in 
mice housed in unfiltered racks. When filtered racks were used, four mice 
showed papillomas and one other developed a papilloma prior to death. The 
repetition of the experiment did not show the high degree of promotional
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activity that was found in the initial study. Microscopic details were not 
completed at the time the report was made.
The total number of tumors, unspecified as to type and site, was 
slightly greater in the 0.5% dioxane group than in controls. The male rats 
given 1% dioxane were not kept for the full term because of laboratory
difficulties and this would account for the lack of an increased incidence
of tumors in males fed 1% dioxane. It was stated that liver tumors were 
seen but the distribution between the various treatment groups was not 
described. The lack of sufficient detail makes this study difficult to
interpret.
Because of the divergent results obtained by various investigators 
and the unknown purity of dioxane used via ingestion, inhalation, and skin 
applications, Perone and coworkers [69] conducted a study to determine the 
toxicity of dioxane and its cutaneous and percutaneous carcinogenic 
potential. For this purpose, mice were given topical applications of
various grades of dioxane, with and without impurities, and with ethyl 
alcohol as a control. The samples were analyzed by gas chromatography. 
Mice of the C3H/HeJ Agouti strain weighing about 20 g each were used.
A preliminary 4-week study was conducted to determine the minimum 
lethal dose defined as the concentration that killed 10% of the animals. 
Different concentrations were used, and 0.05 ml of each concentration was 
applied topically to the shaved interscapular area of each mouse three 
times weekly. The animals were observed daily for toxic effects and for 
weight gain. All mice in each group survived. For the testing of the 
carcinogenic potential of dioxane, 30 male mice were used for each of the 
four grades of dioxane and for ethyl alcohol used as solvent control. Each
mouse was housed individually to prevent male mice from fighting. The 
study was continued for 78 weeks.
There was no gross evidence of tumor formation in any of the five 
groups tested, nor was there any evidence of skin irritation. Weight gains 
were similar for all groups. A large number of mice from all groups died 
because of a malfunction in the heating system; no tumors were grossly 
visible, and necropsy showed respiratory failure as the cause of death. 
Another group of mice died from a respiratory infection caused by 
contamination of some other mice not used in the dioxane study and no 
tumors were observed at necropsy [69].
Of the 40 mice that survived the treatment, five hepatic tumors and 
one pulmonary tumor were observed. In the 17 ethyl alcohol-treated mice 
that were used as solvent controls, two showed hepatic tumors and one 
developed a pulmonary tumor. The investigators [69] concluded that the 
remarkably normal microscopic appearance of the skin of mice of all test 
groups suggested that the treatments of the four dioxane groups and ethyl 
alcohol group were not deleterious. Untreated controls were not used. 
Since the solvent-treated control mice also showed hepatic and pulmonary 
tumors, no conclusion can be drawn about the carcinogenic potential of 
dioxane from this experiment. The high death rate from intercurrent
disease may have helped obscure the presence or absence of real differences 
between control and test animals.
(c) Mechanism of Action
Oxalic acid and diglycolic acid, which are in vitro oxidation 
products of dioxane, were considered by several investigators [21,24,71,72] 
to be likely mammalian metabolites from dioxane exposure. Fairley et al
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[71] provided support for this argument by a comparative study of the 
toxicities of salts of oxalic and diglycolic acids with that of dioxane. 
The sodium salts of oxalic acid and diglycolic acid were administered iv to 
rabbits, and ethyl oxalate was applied to the skin of rabbits and guinea 
pigs. Renal and hepatic changes were similar to those seen with dioxane. 
Wiley et al [72] were unable to demonstrate an increase in the urinary 
content of oxalic acid in dogs and rabbits when 2 ml of 40% dioxane was 
injected daily for 7 days. This suggested that oxalic acid was not a 
metabolite of dioxane.
Some evidence that dioxane metabolism may be involved in its toxicity 
was provided by experiments performed by De Navasquez [38] and Argus et al 
[43]. A tolerance to dioxane at doses that had been determined to be 
lethal was observed by De Navasquez [38] in rabbits first given repeated 
sublethal doses of dioxane. The kidneys and livers were normal in the 
animals given eight dioxane doses of 0.5 ml/kg at weekly intervals followed 
by five "lethal" doses of 1.5 ml/kg. The only observed effect was 
temporary polyuria. In contrast, animals given a single 1.5 ml/kg dose, 
without any pretreatment, died. As reviewed earlier in this section, the 
toxicity of dioxane was reported [43] to have been increased in rats 
pretreated with MC, a microsomal enzyme-inducing agent, but the enhancement 
of toxicity was not marked.
In 1976, Braun and Young [37] demonstrated that beta- 
hydroxyethoxyacetic acid (HEAA), rather than either oxalic acid or 
diglycolic acid, was the major urinary metabolite of dioxane in rats. 
Uniformly labeled C-14 dioxane was administered to two rats by oral 
intubation. Composite 24-hour urine samples were collected and analyzed
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for metabolites using thin layer ion exchange column chromatography and gas 
chromatography, gas chromatography-mass spectrometry, and by nuclear 
magnetic resonance spectroscopy. One major and two minor C-14-containing 
compounds were confirmed by thin layer chromatography. The two minor 
compounds were identical to C-14 dioxane and C-14 diethylene glycol. The 
major compound was identified as HEAA using the other four analytical 
methods. HEAA accounted for approximately 85% of the radioactivity in the 
urine, with dioxane and diethylene glycol accounting for the remaining 15%.
In a study reported by Young and Gehring [30] in 1975, the
pharmacokinetics of dioxane in rats differed depending upon the dose and
regimen of administration. A single dose of 10 mg/kg of C-14 dioxane was 
rapidly metabolized and excreted in the urine as about 95% HEAA and 4% 
dioxane. At a dose of 1,000 mg/kg, dioxane was eliminated slowly, with 
over 25% excreted unchanged into the urine. The renal and pulmonary 
clearance rates of C-14 radioactivity were the same with doses of 10 or
1.000 mg/kg C-14 dioxane, but the plasma clearance rate of dioxane 
decreased from 2.88 to 0.25 ml/minute. Multiple daily doses of dioxane of
1.000 mg/kg were excreted more rapidly than an equivalent single dose.
This was not the case when multiple daily doses of 10 mg/kg dioxane were
administered.
Studies [29,30,37] in 1976 in both rats and humans have shown that 
HEAA is the major metabolite whether dioxane is given in large or small 
doses. Other Investigators [43,64] predicted the formation of a carbonium 
ion but this requires a great amount of energy and is a less likely 
intermediate. A mechanism for the metabolism of dioxane, consistent with 
available data, may be postulated as follows:
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1) An oxonium ion may be first formed, 2) a nucleophilic attack by 
water may take place, thus opening the ring, with the formation of the 
alcohol, 3) reduction of the alcohol to the corresponding aldehyde, which 
is a fast reaction, and 4) oxidation of the aldehyde to the acid, HEAA, 
which is also a fast reaction. The metabolism of dioxane is presented in 
Figure III-l.
The formation of HEAA without the appearance of radioactivity in
either the aldehyde or the alcohol [37] gives evidence that HEAA is the
main product formed. Secondly, the excretion of dioxane per se in the
larger doses used [30] indicates that neither an alternate pathway nor a
blockage of the formation of aldehyde or acid occurs. Thus, at the present
time, no alternate pathway has been noted since the entire radioactivity
was found in dioxane and HEAA combined when both large and small doses of
C-14 dioxane were used. The investigators [30] also stated that
>■
extrapolation of effects from high doses of dioxane to the effects 
anticipated to be associated with exposure to small amounts in the work 
environment could not be correctly done because the pharmacokinetics of 
both doses were different.
91
I 
X 
X 
x
> c/ a "c<tJ
H
o
DIOXANE
H©
■ >
H 2 0:-| 
H > ^ < f < H
H
t o .
H>c C < HH
H>cH I 
H> C
OH
/
O
c
h2o
nucleophilic
attack
OH
H
oxidation
C < u (fast reaction) 
H
HYDROXYETHOXYACETIC ACID 
(HEAA)
OH OH
H .  /  \  . H
H > C  C < HH. I I M
H > C^ / C<H
alcohol
reduction 
(fast reaction)
OH O
“ > f  VH
aldehyde
FIGURE IT -1 . METABOLISM OF DIOXANE
Correlation of Exposure and Effects
(a) Acute and Subacute Effects Related to Occupational Exposure 
Dioxane has been used industrially for about 40 years without 
generating a large number of reports of adverse effects to workers. The 
first such report appeared in England in 1934 as a result of an episode of 
illnesses and deaths in a factory where dioxane was used [20]. In this 
episode, no estimates were made of dioxane concentrations. Historical 
records of the workers who had been exposed during the first 15 months that 
the process was operative indicated some cases of nausea and vomiting with 
lost worktime. Some changes were then made in one of two similar machines
where dioxane was used. The changes probably increased the exposure
concentrations and, at the same time, the workers increased the hours/day 
and days/week that they worked. After 5 weeks of this increased exposure, 
the men working on the altered machine became ill with symptoms of nausea, 
anorexia, vomiting, and "stomach trouble;" five of them died. Signs and 
symptoms of poisoning, such as nausea and vomiting, were followed by 
oliguria for 3-4 days, anuria, coma, and death. Enlarged pale livers, 
swollen hemorrhagic kidneys, and edema of the lungs and brain were found at 
autopsy. Microscopic findings included centrilobular liver necrosis,
necrosis of the renal cortex, and hemorrhages around the glomeruli.
Jaundice was not observed.
The 80 men who worked in the factory and who had any potential for 
exposure to dioxane during the period it was used were examined 7-14 days 
after work was stopped in the dioxane unit. Three or four of these men had 
exposures similar to those who died. When they were examined, there were 
histories of nausea and vomiting, traces of albumin and a few RBC in the
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urine, and a significant leukocytosis. In seven or eight other men, who 
had probably worked directly with dioxane and received less exposure, there 
were also findings of leukocytosis and albumin and RBC in the urine. Among 
these 11 "most exposed" workers, there were also findings of positive 
indirect van den Bergh reactions probably attributable to liver changes, 
and one man had a palpable liver; however, there was no clinically apparent 
jaundice in any of the 80 workers. Thirteen men who had not had any 
exposure to dioxane for at least 2 months showed a tendency toward
eosinophilia. In the other 56 men, who were considered to be valid
controls, a faint trace of albumin was found in the urine of 25, and a 
positive indirect van den Bergh reaction in 7.
Another report of an occupational fatality appeared in 1959 [31]. 
The worker became ill after 1 week of exposure to dioxane and the course of 
his illness was similar to that of the English workers [20]. In this case, 
estimates of exposure concentrations were made after the worker's death. 
Concentrations of 208-650 ppm, with an average of 470 ppm, were found in 
the 75 x 50 x 25 foot workroom. No respirator or exhaust ventilation was
provided. Details of the number of samples, when or where they were taken,
or the method of collection and analysis were not reported. The worker had 
used the dioxane, which he placed in an uncovered bucket between his knees, 
to clean a workbench and to keep his hands free of resin-type glue. By 
this practice, he may have absorbed dioxane through the skin.
A report of dermatitis associated with occupational exposure to 
dioxane was published in 1964 [32]. A 47-year-old woman developed
inflammatory skin abnormalities after several weeks of exposure to dioxane. 
She may have been sensitive to dioxane because, 6-8 months earlier, she had
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suffered first and second degree burns from isoprene. Skin sensitivity 
tests in the patient demonstrated a pronounced hypersensitivity to dioxane 
whereas in two control persons the tests were negative.
The application of 0.05 ml of either pure or technical grade dioxane 
[26] three times daily to the underside of the forearm of a volunteer dried 
the skin but caused no other signs of irritation. A drop of dioxane placed 
on the mucous membrane of the mouth produced a temporary, slight burning 
sensation [26]. When a drop of pure dioxane was placed in an eye of a 
rabbit, it produced hyperemia and pus formation of the conjunctiva, and 
edema of the conjunctiva and nictitating membrane [39]. In another
experiment, undiluted dioxane was found to be more irritating to a rabbit's 
eye than ethanol and less irritating than acetone or isobutanol [58].
That dioxane can be absorbed through the skin has been demonstrated 
in experimental animals [21,50,66,69,70]. An 80% dioxane-water mixture was 
applied twice daily to the skin (rabbits, 10 drops, and guinea pigs, 5 
drops) for up to 101 days. Extensive degenerative changes in the kidneys
and livers were found that were similar to changes caused when dioxane was
given by other routes of administration. In another report [50],
application of undiluted dioxane to rabbits for 3 hours caused unsteadiness 
and incoordination and they died within 5 days. Evidence of liver and 
kidney damage was inconsistent. It is evident from animal studies that 
skin absorption of dioxane does occur and it is concluded from this and 
evidence from human studies [31,32] that skin contact is a potentially 
hazardous route of absorption in man. Skin absorption may be prevented by 
the use of proper protective equipment like gloves, aprons, etc, which are 
described in Chapter V.
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One of the reasons why workers may have been exposed to fatal 
concentrations of dioxane is that it has poor warning properties. Although 
it has a low odor threshold (2.8-5.7 ppm) [26,28], its odor is not
unpleasant and individuals get accustomed to it after the first few minutes 
[19-22,26], Dioxane vapor is also relatively nonirritating to the mucous 
membranes [19,22], Irritation of the eyes, nose, and throat was
experienced by volunteers exposed to dioxane at concentrations of 5,500 ppm 
for 1 minute or at 1,600 ppm for 10 minutes [19], Silverman et al [22] 
observed that a concentration greater than 200 ppm for 15 minutes was
required to cause eye, nose, or throat irritation in the majority of
experimentally exposed subjects. The symptoms of irritation, although 
initially distinct, diminished rapidly both in experimental subjects and in 
occupationally exposed people [26,33].
Concentrations of dioxane in the air that are immediately dangerous 
to the worker's life have not been determined from occupational histories. 
The highest concentration that has been reported in human exposure studies 
was 5,500 ppm. Subjects exposed at this concentration for 1 minute [19] 
experienced a slight vertigo during exposure. In animal experiments, 
guinea pigs that were exposed at 30,000 ppm for 3 hours showed a state of 
narcosis after 87 minutes and died within 2 days [21], The LC50 for rats 
exposed to dioxane for 4 hours was reported to be about 14,000 ppm [57], 
Guinea pigs, rats, and mice exposed at 10,000 ppm for 1.5 hours twice daily 
seemed drowsy after the first exposure and died after 2-7 exposures [21]. 
Such exposures killed all mice and rats after 6-34 exposures and one guinea 
pig after 29 exposures; the remaining guinea pigs survived 63 exposures, 
and all the rabbits survived 33 exposures. All rats, mice, guinea pigs,
and rabbits survived at least 45 exposures at 2,000 ppm [19]. All mice and 
cats exposed at 1,400 ppm, 8 hours/day, 5 days/week, for 2 weeks survived 
[26].
Young et al [29], in 1976, stated that no adverse effects were seen 
in four subjects exposed at 50 ppm dioxane for 6 hours. Laboratory tests 
conducted before and 14 days after the exposure did not show changes. The 
only subjective effect noted was mild eye irritation which persisted 
throughout the exposure as reported by Chenoweth (written communication, 
December 1976). The authors constructed a pharmacokinetic model describing 
the fate of dioxane and HEAA in humans on repeated exposure at 50 ppm. A 
comparison of the assessment of the hazard to humans exposed repeatedly to 
dioxane was made by extrapolation of the toxicologic information from their 
rat data [30]. They concluded that exposure at the current TLV of 50 ppm 
dioxane [73] will not cause adverse effects on repeated exposure. This 
conclusion is probably based on considerations of the effects of dioxane 
alone and may not be valid if the workers in the dioxane manufacturing unit 
are also exposed to various other solvents in their work environment; in 
addition, the effects of alcohol consumed after working hours should be 
taken into consideration. It is not known yet whether the toxicity of 
dioxane in humans is increased with exposure to other solvents and with 
alcohol consumption.
The acute studies indicate that at high levels of dioxane (above
2,000 ppm) symptoms of "stomach trouble" occur, which, on continued 
exposure, are followed by oliguria, anuria, coma, and death. Those exposed 
at lower concentrations show symptoms like nausea and vomiting. The single 
human inhalation study reported in 1976 [29] showed no adverse effects
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other than mild eye irritation on the volunteers at 50 ppm.
(b) Chronic Effects Related to Occupational Exposure 
Epidemiologic studies of workers exposed to dioxane in its 
manufacture have been reported [34,35]. In these studies, it has been 
found that death rates in dioxane-exposed workers have not exceeded those 
of the general population, that there has been no common cause of death 
among them, and that the number of deaths from cancer are not significantly 
different from the number expected from statistics on the normal 
population. Examination of the health status of the workers then employed 
in dioxane manufacture have not resulted in indications of the existence of 
chronic diseases associated with dioxane exposure. Among the workers
examined were some who were exposed for as long as 17-50 years. Estimates
of concentrations of dioxane of the exposed workers were 0.1-23.6 ppm in 
one plant, 0.01-13.28 ppm in another, and 0.2-0.5 ppm in the third.
Chronic inhalation experiments with animals have been limited. One 
experiment was conducted [68] to determine the effects of long-term 
repetitive inhalation of dioxane vapor around 100 ppm, the TLV at the time 
of the experiment. In addition, preliminary studies at exposure 
concentrations of 50 and 100 ppm did not show any adverse effects when 
compared with controls. Hence, rats were exposed to dioxane at a 
concentration intended to be 100 ppm but found to be 111 ppm, 8 hours/day, 
5 days/week, for 2 years. There were no indications of a developing
chronic disease in the rats exposed to 111 ppm dioxane.
To study the long-term absorption of dioxane through the skin, skin 
painting experiments were conducted by King et al [66,70] and Perone et al 
[69]. Both investigators used solvents which themselves might have been
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responsible for changes in the liver, kidney, or lungs. It is not certain 
from the first report of King et al [66] whether acetone was used as the 
solvent vehicle in all their studies. They stated that acetone was 
originally included as a solvent control in the carcinogenesis study but, 
when their promotional studies were started 3 months later, they noted that 
skin tumors and a reticulum cell malignant lymphoma occurred in control 
mice. A repetition of their second study did not confirm their initial 
observations of skin tumors.
Perone et al [69] used ethyl alcohol as the solvent control in a 
study which also showed hepatic tumors and pulmonary adenomas in both test 
and in solvent control animals.
Though these long-term studies of dermal absorption were 
inconclusive, it seems reasonable to interpret that absorption through the 
skin can take place without erythema or other external signs, and that
excessive absorption of dioxane through the skin may cause liver and kidney
damage similar to that seen in the acute human case described by Johnstone
[31] and those observed in animal experiments of Fairley et al [21] and 
Nelson [50].
(c) Effects on the Kidneys
The six men who died after exposure to dioxane had all developed 
anuria [20,31], The deaths occurred about 5-8 days after the initial 
symptoms of illness. In one case, there was a record of kidney dialysis 
and other treatment during hospitalization. In the other cases, there were 
no reports of treatment for the disease. In all six cases, microscopic
findings were necrosis in the renal cortex, RBC in the lumens of tubules, 
and Interstitial hemorrhages. The cells of the renal medulla were intact.
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The concentrations of dioxane at which the five English workers were 
exposed were not known [20]; in the Johnstone report [31], the exposure 
concentrations were estimated at 205-650 ppm, and absorption through the 
skin had apparently occurred [31].
The only indications of kidney injury found in other workers exposed 
to dioxane in the English factory were traces of albumin in the urine of 
seven or eight men and a few RBC in the urine of two or three [20]. The 
concentrations of dioxane and other exposure characteristics of these men 
were not known.
Animal experiments demonstrated probable species differences in 
susceptibility of the kidney to dioxane [21,24], particularly at lower 
exposures. Cortical damage was apparent with vascular congestion and 
hemorrhages also being present. No cell degeneration was noted in the 
renal medulla and hemorrhages, though present, were less marked than in the 
cortex. Similar microscopic findings were found in the kidneys of the four 
species exposed at 10,000 and 5,000 ppm. At 2,000 ppm, microscopic 
findings in the rabbits and guinea pigs were still severe, whereas the 
changes in rats did not include cellular degeneration and, in mice, only 
vascular congestion was found. The findings at 1,000 ppm were not 
described In detail; it was only stated that well-marked cortical lesions 
were seen in all animals. In another report, rabbits repeatedly exposed to 
dioxane at 800 ppm died with kidney injury within 30 days [56], Neither 
sufficient details of the experimental design nor the nature of the kidney 
injury were given in this report. In another inhalation experiment [24], 
no significant microscopic changes in the kidneys were found at 1,000 ppm. 
Torkelson et al [68] observed no changes in kidneys when rats were exposed
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at 111 ppm, 7 hours/day, 5 days/week, for 2 years.
When given drinking water containing 5% dioxane, two of three dogs 
died after 8 days, most rats died within 30 days, and mice survived up to 
67 days [21,45,48], Grossly, the kidneys were swollen and hemorrhagic but 
microscopic examination of the dogs were not conducted in all studies. All 
rats and some mice showed severe cortical degeneration, and some of the 
mice showed no cell changes except vascular congestion in the kidneys even 
after 67 days. Hemorrhages were present throughout the kidneys. A 
tolerance was noted when two rats were fed 1% dioxane in drinking water for 
110 days followed by 3% dioxane for 41 and 48 days; only patchy areas of 
degeneration were observed in the kidneys.
One of 22 guinea pigs which ingested 0.5-2% dioxane in drinking water 
for 23 months [63] developed an adenoma in the kidney. No other
microscopic studies of the kidneys were reported in this study.
Many rats that ingested 1% dioxane in drinking water for 63 weeks
[62] showed extensive changes in the blood vessels of the kidneys and the
tubular epithelium, particularly in the proximal convoluted tubes, and had 
a granular precipitate. An early transitional cell carcinoma was found in 
the renal pelvis of one rat.
Rats that ingested 0.75-1.8% dioxane in drinking water for 13 months 
[43] showed marked alterations; in many, the changes were those of
glomerulo- and pyelonephritis with characteristic epithelial proliferation 
of Bowman's capsules.
Rats that ingested 0.1 and 1% dioxane in drinking water [65] showed 
varying degrees of renal tubular epithelial degeneration and necrosis and 
evidence of regeneration. No microscopic changes were seen at the 0.01%
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dioxane level. A renal carcinoma was found in one of two rats but this 
carcinoma appears not to have been related to dioxane ingestion.
Kidney changes due to repeated exposures were also found in rabbits
and guinea pigs when dioxane was applied to the skin [21], After 49 days 
of application, the changes consisted of cloudy swelling, congestion, and 
hemorrhages. After 66 days, there was extensive cortical cell degeneration 
and necrosis with hemorrhages. After 77 days, the cortical necrosis was
more extensive and the hemorrhages extended to the medulla. After 101
days, the changes seemed less severe, but vascular congestion was extreme.
Among the workers exposed to dioxane who have been the subject of 
recent reports, there is little evidence of kidney involvement (only one 
case of kidney insufficiency) in two studies [34,35] involving exposure 
concentrations of dioxane less than 25 ppm. However, in view of evidence 
at higher concentrations, perhaps including skin penetration [20,31], and 
from evidence from animal experiments [21,24,43,62,64,65], it is concluded 
that both tubular and glomerular changes may occur in workers sufficiently 
exposed to dioxane.
(d) Effects on the Liver
The only evidence of liver injury among the 80 English workers 
examined by Barber [20] was a palpable liver in 1 of the 11 "highly 
exposed" workers. Livers were not palpable in two employees who had worked 
long shifts on the altered machine and who were away from work due to 
"stomach trouble." Six of the 24 German workers then employed in dioxane 
production had elevated SGPT levels, and the SGOT levels of 2 of these 6 
workers were slightly elevated. All six workers were known to have 
consumed about 80 g of alcohol daily in the form of beer or wine. When
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five of these workers reduced their beer consumption, their transaminase 
levels returned to normal. Serum creatinine was slightly elevated in five 
workers.
Animal experiments have shown probable species differences in the 
susceptibility of the liver to dioxane [21,26,43,45,48,56,62,64-68],
Injury to the liver was noted to vary from a normal condition at
1.000 ppm to vascular congestion and cell degeneration as the 
concentrations were increased to 10,000 ppm with repeated inhalation 
exposure of 1,5 hours twice daily for 5 days, once on the 6th day and no 
exposure on the 7th in a repeated pattern [21], The narcotic-anesthetic 
effects also seemed to increase with the total dosage as represented by the 
product of concentration and exposure time [50] . The signs of narcosis 
seemed to appear earlier in experiments where pure dioxane was used but no
differences between the pure and commercial grades were noted on
microscopic observation of the liver [26]. No evidence of damage to liver
was found after chronic inhalation exposures of rats at 111 ppm for 7
hours/day, 5 days/week, for 2 years.
These studies indicate that chronic inhalation at concentrations of
2.000 ppm and above cause liver damage and increase the narcotic-anesthetic 
effect in animals.
Acute and subacute administration of dioxane by ingestion 
[21,45,48,54] caused liver injury that varied with the species as well as 
the amount of dioxane used. Mice seemed to be the least affected and 
showed only vascular congestion compared to rats, rabbits, or guinea pigs 
which showed cellular degeneration as well as extreme vascular congestion. 
Cellular degeneration was more marked when 5% dioxane was given to the 
animals in drinking water.
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In chronic experiments, concentrations of 1.4 and 1.8% dioxane in 
drinking water for 13 months [64] produced hepatic "incipient" tumors as 
well as hepatomas, while ingestion of 0.75 and 1.0% dioxane did not cause 
any changes. In another report [43], some rats given 1% dioxane for 13 
months also showed "incipient" tumors which the investigators considered 
precancerous changes, but rats given the same amount for 8 months did not 
show any changes. In an earlier report [62], 6 of 26 rats were stated to 
have produced hepatic tumors but no further description of the tumors was 
provided.
In a more recent report, a dose-response relationship was seen when 
rats were fed 0.01, 0.1, and 1.0% dioxane in drinking water [65]. Hepatic 
tumors and carcinomas were seen at the 1.0% dose; in addition, there was 
evidence of hepatic regeneration as indicated by hepatocellular 
hyperplastic nodule formation at both 0.1 and 1.0% levels. No changes were 
observed among rats which ingested 0.01% dioxane. However, 1 of 120 
control rats showed a hepatocellular carcinoma, another showed 
cholangiocarcinoma, and two others showed hepatic tumors.
Varying degrees of liver damage were also seen when dioxane was 
applied to the skin of rabbits and guinea pigs, the total number of 
applications varying from 75-160 [21], Two applications were given each 
day for 5 days, one on the 6th, and none on the 7th, in a repeating 
pattern. After 75 applications, the liver was still normal on microscopic 
examination but vascular congestion, later followed by cellular 
degeneration, was noted after 105 and 121 applications. However, in both 
rabbits and guinea pigs, when tested after 160 applications, only vascular 
congestion was noted. This may again mean that either a tolerance had been
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developed or that cellular regeneration may have taken place.
In the long-term skin painting experiments, King et al [66] stated
that liver lesions of a mild nature were seen which included megalocytosls, 
occasional distended bile canaliculi, occasional centrilobular necrosis, 
cuffed triad vessels, and mild peripherolobular fibrosis. No details were
given as to how many mice showed these changes.
In the skin-painting experiments of Perone et al [69], hepatic tumors 
and pulmonary adenomas were noted in alcohol-treated control mice and in 
dioxane-treated mice.
Despite the fact that these skin application studies did not show
definite hepatic changes compared to controls, dioxane can penetrate 
through the skin and is a hazard if proper protection against skin 
absorption is not taken.
In conclusion, liver changes such as vascular congestion and cellular 
degeneration have been noted at concentrations higher than 2,000 ppm by 
inhalation and above 1.0% in drinking water. The skin absorption 
experiments were inconclusive, but it is evident that dioxane can penetrate 
the skin and cause damage if absorbed in large quantities, similar to the 
damage observed as a result of ingestion or inhalation.
(e) Effects on Other Organs and Tissues
Edema of the brain was seen at autopsy in the three workers exposed 
to dioxane who had been hospitalized prior to their deaths [20,31]. Two of 
the three also had edema of the lungs [20], These brain and lung changes 
were probably terminal, possibly agonal, rather than specific toxic effects 
of dioxane. No changes in tissues and organs other than to the kidneys and 
liver were found among workers exposed to nonlethal concentrations of
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dioxane [20,31] nor were any noted among workers in the two epidemiologic 
studies [34,35], However, in animals exposed to dioxane, changes in 
tissues and organs, other than kidneys and liver, have been reported
[19,21,24,26,63,66,70].
In inhalation experiments where animals were exposed at 30,000 ppm 
for 3 hours, hyperemia of the brain and congestion of the lungs were seen 
when animals were killed immediately after exposure [19], Animals that 
died within 1 day of exposure at a concentration of 30,000 ppm for 30 
minutes showed congestion of the lungs and hemorrhagic areas in the mucous 
membranes of the stomach. An animal that died 2 days after the exposure at
30.000 ppm showed a beginning bronchopneumonia and severe congestion of the 
surface vessels of the brain. When animals were killed 9-10 days after the 
experiment had been completed, no brain or lung changes were seen. In the 
studies by Fairley et al [21], animals survived only 2-7 exposures at
10.000 ppm, pulmonary edema being the main cause of death. At 5,000 ppm 
and up to 94 exposures, signs of bronchopneumonia were seen only In one 
rabbit, while the remainder of the animals showed liver and kidney damage. 
No changes were seen in the lungs or organs other than the liver and 
kidneys of rabbits, guinea pigs, rats, and mice exposed to dioxane at 2,000 
or 1,000 ppm for up to 102 and 202 exposures [21]. Hyperemia and edema of 
the lungs were seen when mice, rats, rabbits, and guinea pigs were exposed 
at 37,500 ppm for 3 hours or 4,000-14,000 ppm for 8 hours [24],
In view of the evidence of irritation of the respiratory tract at 
only very high levels, injury to lungs is judged not likely to be an effect 
at concentrations in an occupational environment.
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When 5% dioxane was given in drinking water [21], gastroenteritis was 
seen in two rats that died after 31 and 34 days of exposure. Four other
rats similarly exposed for 17-67 days showed no such damage. Gross
examination of six mice given 5% dioxane in drinking water for up to 67 
days showed enlarged spleens [21]. When three dogs were given 5% dioxane 
in drinking water, two died after 8 days and the other was killed on day 
45. Gastrointestinal tracts of the two dogs that died after 8 days were 
congested with many hemorrhagic areas and their stomachs contained bloody 
fluid. Brains were edematous with areas suggestive of hemorrhages and the 
lungs were congested. Six of twenty-two guinea pigs given 0.5-2.0% dioxane 
in drinking water for 23 months showed peri- or intrabronchial epithelial 
hyperplasia, nine showed nodular mononuclear infiltration in the lungs, and 
gall bladder carcinomas were seen in two of the animals [63]. However, 6
of 10 control animals showed changes including mononuclear cell
accumulation (4/10), hyperplasia of bronchial epithelium (1/10), and 
cartilaginous formation in the lung (1/10). When rats were given 0.75, 
1.0, 1.4, or 1.8% dioxane in drinking water for 13 months, one, one, two,
and two, respectively, developed tumors of the nasal cavity [43]. Chronic 
bronchopneumonia, including murine pneumonia, was seen in rats that died 
after exposure to 0.5-1.0% dioxane in drinking water for up to 42 weeks 
[66 ].
Pulmonary edema and edema of the brain were seen at concentrations of
10,000 ppm by inhalation and 5% dioxane when ingested. At lower levels, no 
changes in any organs other than the liver or kidney were seen.
(f) Synergistic Effects of Dioxane
Studies have been reported which suggest that the toxicity of dioxane
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may be enhanced when workers are exposed to other chemicals
[35.43.52.53.66.70]. Smyth et al [52,53] reported that acute toxicity was 
greater than additive when dioxane was given intragastrically to rats in 
pair-combinations with acetonitrile or tetrachloroethylene, whereas the 
toxicity was less than additive when dioxane was given with propylene 
glycol. These differences occurred when the two chemicals were given in 
equal volumes as well as in volumes proportional to their respective 
LD50's.
The acute toxicity of dioxane was also reported to have been 
increased when the chemical was given in conjunction with microsomal 
enzyme-inducing agents [43], where the LD50 of dioxane was reduced from 5.6 
to 5.2 ml/kg and kidney changes were more severe when rats were treated 
with MC 23 hours previously. This change in LD50 from 5.6 to 5.2 ml/kg, 
though statistically significant, is not large where toxicity is concerned. 
Animals pretreated with DMBA showed a higher incidence of skin, lung, and 
lymphatic tissue lesions when mice were treated topically with dioxane
[66.70], but no details with DMBA alone were provided. It is not known 
whether the incidence of lesions seen in the skin, lung, and lymphatic 
tissue were due to DMBA, dioxane, or both.
It is not known whether alcohol promoted the toxicity of dioxane in 
the workers who died, became ill, or showed subclinical evidence of dioxane 
toxicity [31,34]. In the case of the worker who died after 1 week’s 
exposure to dioxane and who was known to be a heavy beer drinker, it is 
evident that dioxane penetrated the skin, apparently causing liver and 
kidney damage, since he dipped his hands in a bucket containing dioxane 
during his work. Secondly, six workers who consumed more than 80 g of
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alcohol/day showed elevated transaminase levels, but these levels became 
normal in five of them when they reduced their alcohol consumption. If, 
indeed, a synergistic effect had occurred, the transaminase levels would 
not likely have returned to normal, and toxic effects on tissues or organs 
would have been expected.
Studies indicate that dioxane may markedly increase the effects of 
known carcinogens or microsomal enzyme stimulators like DMBA, MC, etc. 
Evidence of significant enhancement of toxicity by other materials is not 
strong but is at least suggestive. However, this evidence is from acute 
toxicity, and potentiation of chronic toxicity is not interpreted from 
available information. As a result, a standard based in part on 
potentiation of dioxane toxicity by other substances is not proposed. 
However, it does seem appropriate that dioxane workers exposed to other 
chemical substances, especially other solvents, and workers who drink 
significant amounts of alcohol should be studied for evidence of 
potentiating toxicity. Experimental research to elaborate interaction is 
also important.
Carcinogenicity, Mutagenicity, Teratogenicity, and Effects on Reproduction
(a) Carcinogenicity
The carcinogenic potential of dioxane was first reported by Argus et 
al [62] in 1965 when they gave the chemical to rats in drinking water. 
Since then several other studies [43,63-67,70] have shown the induction of 
tumors in guinea pigs, rats, and mice when dioxane was administered in 
drinking water or applied to the skin. However, a description of the types 
of tumors observed was not given in some of the reports [43,62,64,66,70],
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A summary of cancers and other tumors observed by various investigators is 
presented in Table 111-10. The second report of King et al [70] has not 
been included in the table since the authors stated that later studies in 
both skin painting and oral administration did not show the same high 
degree of promotional activity of dioxane as was seen in the initial study. 
Also, it is not known whether acetone was used as the solvent vehicle. The 
authors [70] stated that tumors were induced in mice when acetone alone was 
administered. These studies have been reviewed in more detail in the 
previous section and are summarized here.
Neoplastic lesions most often described in rats given dioxane in 
drinking water were tumors of the liver and of the nasal cavity
[43,62^64,65,67], In the liver, they were described as "incipient" liver
tumors, hepatomas, and hepatocellular carcinomas. In the nasal cavity,
epithelial carcinomas, olfactory neuroblastomas, seromucous 
adenocarcinomas, and rhabdomyosarcomas were observed. Another important 
finding was the dose-response relationship reported by two groups of 
researchers in rats given dioxane in drinking water [43,65]. In the study 
of Kociba and coworkers [65], no tumors were observed at the 0.01% dioxane 
concentration. At 0.1%, one hepatocellular carcinoma (statistically not
significant) was seen. At 1.0% dioxane doses, a significant increase 
(P<0.05) was reported in hepatic tumors of all types, in hepatocellular 
carcinomas, and in nasal carcinomas as compared to those seen in control 
animals (12/66 vs 2/106, 10/66 vs 1/106, and 3/66 vs 0/106, respectively). 
In the second study [43], the incidence of liver tumors was 14, 28, 53, and 
82% when rats were given 0.75, 1.0, 1.4, and 1.8% of dioxane, respectively.
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SUMMARY OF CANCER AND OTHER TUMORS REPORTED IN ANIMALS ADMINISTERED DIOXANE*
TABLE III-10
Ref Species Route Dose Duration Neoplastic or Preneoplastic Changes
No. (wk)
62
44
63
Rat
Mouse
G pig
Drinking
water
iP
Drinking
water
1% after 
75 mg
terramycin
0.16-0.31 
ml/kg
0.5-2.0%
63
3 inj/wk 
for 4 wk
100
6 hepatomas, 1 renal adenoma, 1 leukemia, 
lung hyperplasia
24 gross pulmonary tumors
3 hepatomas (undescribed), 1 renal 
adenoma, 9 lung hyperplasia, 2 gall 
bladder carcinomas
64
43
67
Rat 0.75-1.8%
0.5-1.0%
56 1 epithelial carcinoma, 1 squamous cell
carcinoma, 2 adenocarcinomas of nasal 
cavity, 2 hepatic carcinomas
56 Increase in "incipient" hepatic tumors
with increasing dose, marked alterations 
in kidney
110 Nasal cavity carcinomas,
rhabdomyosarcomas and seromucous 
adenocarcinomas
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TABLE III-10 (CONTINUED)
SUMMARY OF CANCER AND OTHER TUMORS REPORTED IN ANIMALS ADMINISTERED DIOXANE*
Ref
No.
Species Route Dose Duration
(wk)
Neoplastic or Preneoplastic Changes
67 Mouse Drinking
water
0.5-1.0% 90 Chronic hepatitis, hepatocellular 
carcinomas, hyperplasia
65 Rat I t 0.01-1.0% 102 Carcinomas of the nasal cavity, hepatic, 
renal, and bronchial carcinoma, and 
lymphosarcomas
69 Mouse sk Various grades 78 
with and without 
impurities
Hepatic cell adenomas
68 Rat inh 111 ppm, 7 
hr/d, 5 d/wk
104 Fibromas of kidney and lung, 1 lung 
carcinoma, subcutaneous fibrosarcomas and 
lymphosarcomas
ip = intraperitoneal, sk - skin application, inh = inhalation
In another report of what appears to be the same experiment, these authors
[64] reported 1, 1, 2, and 2 squamous cell carcinomas in rats given water
containing 0.75, 1.0, 1.4, and 1.8% of dioxane, respectively.
In the Holmes report [67], a dose-response relationship was also 
apparent in rats. A total of eleven malignant tumors were seen in the 
control group, 28 in the 0.5% dioxane group, and 41 in the 1.0% group. One 
of 32 examined controls, 23/57 of the rats given 0.5% dioxane in drinking 
water, and 23/51 of the 1% dioxane group had squamous cell carcinomas of
the nasal cavity. Two of the 0.5% dioxane group had olfactory
neuroblastomas, and one had a rhabdomyosarcoma. Seven of the 1% group had 
olfactory neuroblastomas, and two had seromucous adenocarcinomas. The two 
seromucous adenocarcinomas, 4/9 neuroblastomas, and 4/46 squamous cell 
carcinomas had metastasized to other sites.
In mice given dioxane in drinking water [67], a dose-response 
relationship was seen with 4/99 of the examined controls, 24/94 of the 0.5% 
dioxane group, and 44/87 of the 1.0% group having developed hepatocellular 
carcinomas.
In 22 guinea pigs given 0.5-2.0% dioxane in drinking water, two had 
gall bladder carcinomas, three had early hepatomas, nine had lung 
hyperplasia, and one had an adenoma of the kidney [63]. Four of ten 
controls showed mononuclear cell accumulation and one epithelial 
hyperplasia in the lung.
Evidence of cancer induction and promotion were reported when dioxane 
was applied to the skin of mice [66]. In mice that survived 60 weeks of 
dioxane treatment, one suspected carcinoma, not confirmed microscopically, 
was reported in 1 of 22 males and one unspecified subcutaneous tumor was
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seen in 1 of 25 females. One reticulum cell malignant lymphoma was seen in 
the eight mice that died. In animals pretreated with DMBA 1 week prior to 
dioxane application, 2 papillomas and three suspected skin carcinomas were 
reported among 9 of 60 surviving mice. A squamous cell carcinoma of the 
nasal septum was observed in one mouse that had a skin papilloma. Seven of 
the nine surviving mice had malignant lung lesions, three of which were 
considered metastatic from other unspecified sites. These findings of 
cancer induction and promotion are judged to be inconclusive, as results of 
this study [66] were not duplicated when the study was repeated [70]. It 
is unclear whether acetone was used as a solvent vehicle in these two 
studies. In the second study [70], acetone alone appeared to induce
tumors. In the skin painting study by Perone et al [69], results were also
inconclusive; hepatic tumors and pulmonary adenomas were observed in both 
control and dioxane-treated animals.
There was no statistically significant evidence (P<0.05) of increased 
tumor Incidence in 423 rats exposed at 111 ppm dioxane for 2 years [68]. 
However, an experimental animal population of several hundred will usually 
be too small to detect a difference of tumor incidence of 10/100,000, which 
is a realistic cancer incidence to be concerned with in man [74]. If rats 
are much more sensitive to dioxane-induced cancer than man, an experimental 
population of several hundred rats might suffice, but information on 
relative sensitivities of the two species is lacking. In fact, a
speculation that rats are much less sensitive than man cannot be disproved 
by available data. Therefore, the results from the exposure of rats at 111 
ppm [68] do not provide enough assurance that similar exposure of humans
will not result in an increased incidence of tumors.
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In the epidemiologic studies of Dernehl (written communication, April
1976), of Thiess and coworkers [34], and of Buffler et al [35], no 
significant differences were seen by the authors between the observed and 
expected number of cancer deaths in the worker population. In the 
epidemiologic study conducted on 74 workers, Thiess et al [34] noted no
statistically significant difference between the 12 deaths observed in the
plant and the 14.5 deaths expected. Two men, aged 66 and 71 years, 
respectively, apparently died from cancer, the former from a lamellar 
epithelial carcinoma of the left lumbar region and the latter from a 
myelofibrotic leukemia. In the study conducted by Buffler and associates 
[35], 2 of 7 deaths among the 100 workers in the production area were due
to cancer, a carcinoma of the stomach and an alveolar cell carcinoma.
These two men had been exposed to dioxane for less than 4 years; one had
also been exposed to hydrogen chloride, carbon tetrachloride, 
perchloroethylene, and trichloroethylene, and the other to vinyl chloride 
for about 11 years and to methylene chloride for 1.5 years. The two cancer 
deaths were not significantly different at a P value of 0.05 or less from 
expected deaths due to cancer. One of five deaths among 65 workers in the 
processing area was also due to cancer, a malignant mediastinal tumor. 
This death was not significantly different from expected cancer deaths from 
processing area workers. In the unpublished data provided by the other 
manufacturing concern (written communication, CU Dernehl, April 1976), four 
cancer deaths in the dioxane unit occurred; one man died with cancer of the 
colon, one with lymphosarcoma, one with lung carcinoma, and one with 
glioblastoma.
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Although no statistically significant increase was seen between the 
total number of observed and expected cancer deaths in the reports from 
Dernehl (written communication, April 1976), Thiess et al [34], and Buffler 
and coworkers [35], these results are not conclusive evidence that the 
reported concentrations of dioxane in air represented safe worker exposure 
levels. The populations at risk were very small, 74, 165, and 80 workers. 
Statistical tests may be too insensitive to detect very small increases in 
cancer death rates in such populations. Furthermore, these studies gave 
total cancer mortality rates, rather than rates from tumors of specific 
kinds and sites. While understandable in these cases in consideration of 
the small populations studied, appropriate mortality studies should 
classify tumors, and compare by classification with rates in the normal 
population.
From the animal studies, development of tumors from large doses of 
dioxane seems apparent in rats and guinea pigs. Findings in rats have been 
confirmed by independent investigators [43,62,64,65], although shortcomings 
exist in some of the studies. Results at lower doses are inconclusive in 
that the test populations of animals may have been of insufficient size to 
detect those lower incidences of cancer induction that are typical of 
humans exposed to environmental chemical carcinogens. One inference from 
the human and animal metabolism studies [29,30,36] is that dioxane is 
carcinogenic only at high doses that overwhelm the ability of the organism 
to detoxify and excrete dioxane adequately. This inference, drawn by the 
authors [29] of the studies as a conclusion, is impressive, but not 
completely persuasive. Their data can also be interpreted to suggest that, 
even at lower concentrations, metabolism of dioxane was not complete. If
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so, metabolic defenses against the possible cancer-inducing properties of 
dioxane at low doses may not be complete, assuming that metabolic defenses 
against induction of cancer by dioxane exist. Thus, although the evidence 
from animal studies suggests that dioxane is a carcinogen in man, no 
quantitative data have been found which delineate safe and unsafe
concentrations of dioxane for humans.
(b) Mutagenicity and Teratogenicity
Franceschini [60] studied the effect of dioxane on the growth of 
chick embryo tibial buds. The tibia were removed from 7- to 8-day-old 
embryos and studied in pairs as described in an earlier section. In the
same study, thalidomide was also used. Hypertropic and vacuolized
chondroblasts in diaphysis and reappearance of mitosis in the metaphysis of 
the tibia were seen in media containing dioxane or thalidomide. The
relevance of this study to any conclusion on human teratogenesis is not now 
clear. Direct injection of chemicals into the avian embryo precludes 
maternal modification, such as metabolism, detoxication or activation, 
excretion, or placental transfer. Thus, confirmation in mammals is needed 
before extrapolating these data to a standard for occupational exposure to 
dioxane.
The other study related to teratogenesis conducted by Schwetz et al 
[61] showed a few terata in fetuses of both rats and mice, both control and 
treated, but the terata were not of a consistent type. Dioxane (about 
3.5%) was added to 1,1,1-trichloroethane as an additive and the exposure 
concentration of dioxane was 32 ppm. These results are inconclusive, at 
least so far as they pertain to dioxane exposure.
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No studies of mutagenicity in animals or humans exposed to dioxane 
have been reported.
Summary Tables of Exposure and Effects
Case summaries of humans occupationally exposed to dioxane as well 
as inhalation experiments on humans are presented in Tables 111-11 and H I -  
12 . The summaries of animal experiments with regard to parenteral 
injection, ingestion, percutaneous administration, and inhalation are 
presented in Tables 111-13 and 111-14.
TABLE III-11
CASE SUMMARIES OF OCCUPATIONAL EXPOSURE TO DIOXANE IN HUMANS
Ref.
No.
Exposure
Concentration
(ppm)
Time
Effects
31 208-650 1 wk Liver and kidney damage, death
20 Unknown 5 d Liver and kidney damage, 
edema, death
lung
It ti 4-6 wk Anuria, death
ft it 1» Liver and kidney damage, death
It h tl Liver and kidney damage, 
death
coma,
tl h 7-8 wk Liver and kidney damage, 
congestion
lung
32 - - Skin erythema, no death
118
TABLE III-12
EXPERIMENTAL INHALATION EXPOSURES IN HUMANS
Ref.
No.
Exposure 
Concentration Time 
(ppm) (min)
Effects
19 5,500 1 Irritation of eye, nose, throat 
vertigo
21 2,000 3 Strong odor, tolerance
19 1,600 10 Mucous membranes, burning
21 1,000 5 Odor
22 300 15 Irritation of eye, nose, throat
M 200 480 Safe concentration for sensory tests
27 170, 270 - 170 ppm - odor threshold 
270 ppm - pronounced odor
26 2.8, 5.6 — 2.8 ppm - detection threshold 
5.6 ppm - recognition threshold
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TABLE III-13
INJECTION, PERORAL AND PERCUTANEOUS EXPERIMENTS IN ANIMALS*
Ref. Species Route Dose; Duration 
No.
Effects
38 Rabbit iv 0.2 ml/kg;
single dose
0.2 ml/kg; 
weekly intervals
1.0 ml/kg; 
single dose
1.5 ml/kg; 
single dose
" " 0.5 ml/kg, 8 doses
+ 1.5 ml/kg,
5 doses
No visible effect
Temporary narcosis
Minimum lethal dose
Tolerance, transient 
polyuria
45
39
24
40
42
Rabbit " 1.5 ml/kg;
single dose
Mouse sc 10 ml/kg;
single dose
Rabbit " 1-2 ml/kg;
single dose
G pig " 2-6 ml/kg;
single dose
Cat " 2 ml/kg;
single dose
G pig " (a) 1 ml/g pig;
10 d
(b) 0.2-0.75 ml/ 
g pig; 35 d
Mouse ip 1.65 ml/kg;
single dose
0.76 ml/kg; 
single dose
Liver and kidney 
damage
Minimal fatal dose
Albuminuria
Liver and kidney 
damage
Internal organ damage, 
blood changes
100% mortality
LD50
120
TABLE III-13 (CONTINUED)
INJECTION, PERORAL AND PERCUTANEOUS EXPERIMENTS IN ANIMALS*
Ref.
No.
43
I I
44
If
41
21
50
50
38
38
49
49
50
Species Route Dose; Duration Effects
Rat
Mouse
Rat
Rabbit
ip 5.6 ml/kg;
single dose
10 mg MC +
4.9-5.3 ml/kg; 
single doses
1.25-5 ml/kg;
3 inj/wk/4 wk
" 0.16-0.63 ml/kg;
3 inj/wk/4 wk
" 1.8-4.4 ml/kg;
single doses
pc 10 drops/rabbit;
5 drops/g pig; 
2/d/5d;l/6th, 
0/7th, repeated
Pure, 1.75-4.8 
hr/2 wk
ig 0.8-8.8 ml/kg;
Single doses
" 1 ml/kg; single
dose
LD50
After MC, LD50 
5.18 ml/kg
Fatal to mice
0-66% deaths
0-100% mortality
Renal and hepatic 
lesions in some
Temporary erythema; 
high doses, death
0-100% mortality
Temporary narcosis
Mouse
G pig
Rat
ig
2 ml/kg;single 
dose
4.5-7.5 ml/kg; 
single doses
3.90 ml/kg; 
single dose
6.0 ml/kg; 
single dose
Minimal lethal dose
Mortality increased with 
dose
LD50
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TABLE III-13 (CONTINUED)
INJECTION, PERORAL AND PERCUTANEOUS EXPERIMENTS IN ANIMALS*
Ref. 
No.
Species Route Dose; Duration Effects
50 Rabbit ig 2.0 ml/kg; 
single dose
LD50
52 Rat t t 6.47 ml/kg; 
single dose
I I
21 Mouse po 5% daily; 11-67 d Liver and kidney damage
45 I I I t 1 ml/kg, 1-12 d t l
45 I t II 1%/110 d, + 
3%/41, 48 d
Liver and kidney damage, 
slight, tolerance
48 Dog t t 5%/lOd, 
twice daily
Lung, liver, kidney 
damage, slight
54 Rat II (a) 1-10 d
(b) 9 d + ad lib 
water/2, 4, 7, 9 d
Kidney damage
iv - intravenous, sc ■ subcutaneous, ip ■ intraperitoneal, 
pc ■ percutaneous, ig = intragastric, po ■ drinking water
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TABLE III-14
ANIMAL INHALATION EXPERIMENTS
Ref.
No.
Species
Exposure 
Concentration, ppm; 
Duration
Effects
24 G pig,
rabbit, rat, 
mouse
37,500; 3 hr 50% death; lung, liver, 
and kidney damage
26 Mouse 1,400-39,000; 
single doses
Death above 8,300 ppm
II Cat 12,000-31,000; 
until irritation 
noted in min
Narcosis
24 G pig, rat,
rabbit,
mouse
4,000-11,000; 
8 hr
Liver and kidney damage
19 G pig 1,000-30,000; 
maximum 480 min
Mucous membrane irritation; 
congestion, edema of lungs
55 Rat 1,500-6,000; 
Avoidance to 
buzzer, shock, 
in min
Behavioral changes above 
3,000 ppm
21 G pig, rat, 
mouse
1,000-10,000; 
twice/5 d, once/ 
6th and 0/7th d
Liver and kidney damage 
increased with doses; 
death at 10,000 ppm after 
2 exposures
24 Cat, mouse, 
rabbit,
8 Pig
1,350-2,700; 
8 hr/34-45d
Liver and kidney damage
26 Cat 1,400; 6.5 hr/ 
14 d
Increased blood counts
68 Rat 111; 7 hr/d,
5 d/wk, for 2 yr
Various tumors in both 
control and dioxane- 
treated
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IV. ENVIRONMENTAL DATA
Environmental Concentrations
Dioxane concentrations ranging from 208 to more than 650 ppm, with an 
average of 470 ppm, were reported by Johnstone [31], in which a fatality 
occurred with a highly significant skin contact with the liquid. No 
exhaust ventilation was used.
Samples taken during a recently compiled survey of exposure 
conditions in both the production and drumfilling facilities in a US 
manufacturing concern in 1974 and 1975 revealed average breathing zone 
concentrations of about 12 ppm for 30 samples, and 4.28 ppm for 44 samples, 
in the general workroom atmosphere. The concentration of dioxane at point 
sources (leaks, vents, etc) averaged 46 ppm for 15 samples. Area 
monitoring was accomplished using carbon tubes and by grab sampling in 50 
ml glass syringes (written communication, RE Peele, January 1977).
Average concentrations at the workplace of three manufacturing 
concerns were 1,07 ppm (range, 0.03-7.20 ppm) [34], 0.9 ppm (range, 0.6-2,0 
ppm) [35], and 6.5 ppm (range, 0,1-23.6 ppm) (written communication, CU 
Dernehl, April 1976). The concentrations around the storage tanks 
containing dioxane taken in 1968 were 100 and 800 ppm [35], with no other 
details given. The concentrations around the storage tanks were not 
reported when area monitoring was conducted again in 1974 and 1975.
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Environmental Sampling and Analytical Methods
(a) Introduction
Review of the literature has indicated that reporting of sampling and 
analytical methods for dioxane in air has not been extensive. Reid and 
Hofmann [9], in 1929, mentioned the reaction of dioxane with tetra- 
nitromethane to produce a yellow color that had been reported by Macbeth 
[75] in 1915, and erroneously said that the author had suggested its use 
for identification of dioxane. Subsequent to the report by Reid and 
Hofmann, this reaction was mentioned by others [1,2,76] in discussions of 
analytical methods for dioxane, but it apparently never was used.
In experimental exposures of humans and animals to dioxane vapor, 
Yant et al [19] reported in 1930 that dioxane was collected on activated 
charcoal and was determined gravimetrically. The dioxane concentrations 
monitored in this way were 1,000-30,000 ppm. Actual concentrations were 
probably lower, inasmuch as the charcoal probably adsorbed other materials.
In their 1936 report of animal exposures, Wirth and Klimmer [26] 
considered that no adequately accurate quantitative method for dioxane was 
available to monitor the nominal concentrations used that ranged up to
4,000 ppm.
Rowe [2], in 1963, and Browning [1], in 1965, mentioned that the 
interferometer and combustible gas methods could be used, but they did not 
report any actual use of these nonspecific methods for determinations of 
occupational exposure to dioxane. Goldberg et al [55] reported in 1964 
that an interferometer had been used to monitor exposure chamber 
concentrations of dioxane for maintenance to within 10% of nominal 
concentrations of 1,500, 3,000, and 6,000 ppm.
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The first report of a method that specifically mentions monitoring 
exposure of workers to dioxane was that of Chemodanova [77] in 1948.
Dioxane is drawn through a solution of potassium dichromate at 10-15
liters/hour until a color change occurs, and is determined titrimetrically. 
The method is not specific for dioxane, but, in the absence of interfering 
substances, could be used effectively for dioxane. The reaction has been 
used for application to certain mixtures containing dioxane [78] and for 
analysis of dioxane in biologic samples [79].
The estimation of dioxane concentrations reported by Johnstone [31], 
in 1959, was the first found in the US literature for an occupational 
exposure. Johnstone did not describe his sampling and analytical methods.
A report indicating that gas chromatography could be used for dioxane 
analysis appeared in 1949 [80], and first reports about its use appeared in 
1966 [81,82].
Infrared (IR) spectrophotometry was used to monitor continuously 
exposure chamber atmospheres operated at dioxane concentrations of about 
100 ppm during a 2-year study reported by Torkelson et al [68] in 1974.
(b) Collection Methods
In general, air samples for evaluation of occupational exposure can
be collected in glass syringes or plastic bags, drawn directly into 
measuring instruments, or components of the air mixture can be collected by 
bubbling air through a suitable solvent, or reactant, or over a suitable 
adsorbent or reactant, or by combinations of these.
Collection of air samples in 50-ml glass syringes followed by direct 
injection into a gas chromatographic column has been used for determination 
of dioxane concentrations around point sources [written communication, RE
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Peele, January 1977], Impermeable plastic bags have been used for 
collecting air samples for monitoring work areas and point sources for 
dioxane concentrations [35]. Absorption of dioxane in solutions of 
potassium dichromate has been used for monitoring of dioxane concentrations 
in workplaces where other substances were not present [77]. Drawing air 
directly into measuring instruments for analysis of dioxane concentrations 
in the workplace may have been used [2] and is applicable for IR analysis 
[68]. Collection of dioxane by charcoal has been used for monitoring point 
sources of dioxane as reported by Peele (written communication, January
1977) and for personal monitoring of dioxane exposure [35].
Special charcoal tubes have been developed for use with personal 
monitoring pumps [83]. The tubes contain a 100-mg section of charcoal 
through which air is sampled separated from a reserve section of 50 mg of 
charcoal. The purpose of the reserve section is primarily to indicate 
overload of the first section and secondarily to collect vapor that has 
penetrated the first section. If the amount of dioxane found on the 
reserve section of charcoal exceeds 10% of that found on the larger 
section, sample loss is indicated. These tubes, which are commercially 
available, were used in a collaborative testing program that involved 15 
laboratories [84]. Air was sampled at 1 liter/minute for 10 minutes from 
chambers containing about 6, 60, 100, 150, and 200 ppm of dioxane. Four 
samples were collected by each laboratory at each concentration. Under the 
conditions of the test, there were no samples where the amount of dioxane 
on the reserve section of charcoal exceeded 10% of that on the main 
section. The data indicate that, under the conditions of the test, the 
upper limit of adsorption by the 100-mg section of charocal was about 7 mg
127
of dioxane. This study was conducted in the absence of other air 
contaminants. In another study [85], air containing dioxane and 13 other 
chemicals was similarly sampled on 180 mg of charcoal. Dioxane was present 
at about 50, 100, 200 ppm, and the other chemicals at 0.5, 1, and 2 times 
their respective threshold limit values (TLV). There was some indication 
of reduced recovery of dioxane at 50 ppm [85]. This may have been due to 
decreased adsorption, decreased desorption, or reaction on the adsorbent. 
Studies of other factors which might influence the adsorption, such as 
water vapor and air flowrates, have not been reported for dioxane. Further
details of this investigation are given in the next section.
(c) Analytical Methods
The analytical methods can be divided into two broad categories: (1) 
those based on dioxane chemical reactions, and (2) those based on its 
physicochemical characteristics.
The chemical method that has been used is oxidation of dioxane to C02 
and water by potassium dichromate [77-79,86]. In one application of the 
method, a measured volume of air containing dioxane is drawn through a 
solution of potassium dichromate contained in two absorbing flasks
connected in series until a color change occurs. The extent of reaction 
and thus the amount of dioxane is determined by titration with sodium
thiosulfate [86]. The method is not specific for dioxane.
A chemical method is also used in dioxane detector tubes. These are 
glass tubes packed with chemicals that change color as a measured flow of 
air containing dioxane passes through the chemical. The length of color 
change is proportional to the dioxane concentration. Federal regulations 
on detector tubes provide that measurements with colorimetric indicator
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tubes shall be correct to within 25% of the value read (42 CFR 84.50). 
Some currently available detector tubes can measure dioxane at 10 ppm, but 
they are not specific and are not certified by NIOSH [87-89].
Methods based on the physicochemical properties of dioxane include 
interferometry, IR spectrophotometry, and gas chromotography.
An IR spectrophotometer in conjunction with a suitable recorder can 
be used to record instantaneous concentrations or to record continuously. 
With this method, concentrations are measured directly and it is not 
necessary to collect individual samples or to transport them to a
laboratory for analysis [90]. Dioxane absorbs sufficient IR radiation for 
analytical purposes at several wave numbers in the range of 800 to 
1,300/cm. Torkelson et al [68] used an IR spectrophotometer with a 4.5- 
meter gas cell and measured light absorption at a wavelength of 11.4 m  for 
analysis of dioxane at concentrations around 100 ppm. The method is not 
adaptable to personal monitoring, but can be used for area and worksite 
monitoring in conjunction with sample collection in plastic bags [68], or 
with a sampling system similar to that used for vinyl chloride by Baretta 
et al [90], or by use of portable instruments [91]. Some IR instruments 
are sensitive to less than 0.10 ppm of dioxane [91,92]. IR analysis is 
subject to interferences from other air contaminants and these
interferences are not easily detected or resolved without substantial
knowledge of IR spectrophotometry.
Gas chromatography provides a quantitative analytical method which 
can be specific for dioxane [85]. Every compound has a specific retention 
time in a given gas chromatographic column, but several compounds in a 
mixture may have similar retention times [93]. This problem can be
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overcome by altering the stationary phase of the gas chromatographic 
column, by changing the column temperature, or by other analytical 
parameters. Altering conditions usually will change the retention times 
and separate the components. Data on chromatographic characteristics of 
dioxane under a variety of conditions are available [82,94-97],
A mass spectrometer can be used subsequent to gas chromatography to 
identify the substance present in a gas chromatographic peak more 
positively. Linked gas chromatograph-mass spectrometer instruments yield 
data allowing this identification. A charcoal capillary tube traps and 
transfers the material associated with a gas chromatographic peak to a mass 
spectrometer for qualitative identification when only unlinked units are 
available [98]. Mass spectra of dioxane have been reported [99].
Samples collected in syringes or plastic bags can be injected 
directly into the gas chromatographic column. Dioxane collected on 
charcoal must be removed by desorption before analysis.
As was discussed in the previous section on Collection Methods, the 
use of carbon disulfide for desorption of dioxane has been studied [84,85]. 
In one study [85], liquid dioxane was applied directly to 180 mg of 
charcoal in amounts equivalent to those that would be present in 10 liters 
of air at 60 and 100 ppm. The respective amounts desorbed in repeated 
trials were 90-95% and 85-98% of the amounts injected. The effect of six 
other solvents coadsorbed with dioxane was also studied. Amounts of 
dioxane desorbed were 81-91% and 83-99% at the two concentrations of 
dioxane, respectively. These data indicate that, with the six compounds 
used, there may have been some interference with dioxane desorption at the 
lower concentration equivalent. Atmospheres of large chambers containing
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50, 100, and 200 ppm of dioxane and six other, unnamed, substances at 0.5, 
1, and 2 times their respective TLV’s were sampled through 180 mg of 
charcoal and recoveries of 78-87, 84-98, and 91-96% of the expected amount 
of dioxane were found at the three concentrations, respectively. Although 
the authors did not consider these values to be less than those found when 
the dioxane was added directly to the charcoal, the data seem to indicate 
some loss of dioxane either in sampling or by incomplete desorption at 50 
ppm.
In the interlaboratory study conducted by NIOSH [84], atmospheres 
containing about 6, 60, 100, 150, and 200 ppm of dioxane were sampled at 10 
liters/minute for 10 minutes by 15 laboratories. The laboratories 
determined desorption factors by injecting an amount of dioxane onto 
charcoal equivalent to the amount that would be collected by sampling at 
100 ppm. The average desorption efficiency was 91.6%, but the desorption 
efficiency values determined by individual laboratories varied from 81.5 to 
97.4%. These data indicate that careful determination of the desorption 
efficiency and attention to detail in desorbing dioxane from the samples 
are necessary. Altering the solvent may change the desorption efficiency 
[100],
The data from the interlaboratory study [84] were analyzed for 
sources of variation. The average amounts of dioxane recovered ranged from 
88 to 92% of the nominal amount of dioxane collected and were not dependent 
on the concentration sampled.
At the lowest concentration of dioxane studied, the method 
underestimated the nominal concentration, with 95% confidence, by 0-20%, 
the sampling and analytical errors combined had a coefficient of variation
131
of 9%, and the total error of the method for determination of a single 
sample, including sampling, analytical, day-to-day, and laboratory 
variations, had a coefficient of variation of 36%.
(d) Recommendations
Although factors such as water vapor and air flow rates that may 
effect adsorption of dioxane by charcoal have not been reported, and the 
desorption by carbon disulfide is variable and incomplete, collection and 
desorption of dioxane by these methods are recommended in conjunction with 
gas chromatography for monitoring exposure of workers. The adsorption 
capacity of the charcoal is sufficient, and desorption constant enough for 
use as recommended in Appendices I and II. While the method is indirect, 
involving collection, desorption, and analysis, it can be specific for 
dioxane, while simultaneously analyzing for other substances, and the 
combined sampling and analytical methodology, as specified in Appendices I 
and II, have been found adequately accurate and precise.
Samples that are representative of the breathing zones of individual 
workers may be collected by the use of commercially available personal 
sampling pumps attached to the workers for drawing air through the charcoal 
tubes. Other methods of collection such as plastic bags, glass syringes, 
and direct sampling into analytical apparatus, such as IR analyzers, may be 
used for monitoring worker exposure, provided the samples adequately 
represent workers' breathing zones. Other sampling and analytical methods 
should be at least as good as those recommended in Appendices I and II.
132
V . WORK PRACTICES
The principal method of manufacturing dioxane is by dehydrogenation 
of ethylene glycol [3]. It can also be produced by catalytic dimerlzation 
of ethylene oxide or by reaction of bis(2-chloroethyl) ether or 2- 
chloroethyl-2-hydroxyethyl ether with strong aqueous sodium hydroxide 
[7,8].
Dioxane is miscible with water and is a solvent for both organic and 
inorganic compounds. It forms an azeotrope with water, which boils at 87.8 
C at atmospheric pressure, and contains 81.6% dioxane by weight; at 260 mm, 
this azeotrope boils at 60 C and contains 84.6% dioxane by weight [7], 
Dioxane shows the characteristic properties of aliphatic ethers, as it is 
stable in the presence of acids, alkalis, metallic sodium, ammonia or mild 
oxidizing agents [3]. It is hygroscopic and forms peroxides, acetaldehyde, 
ethylene acetal and acidic materials on standing. Peroxides which may form 
during storage, especially in the presence of light, are explosive and must 
be destroyed chemically before distillation or evaporation to avoid 
possible explosion [3]. Dioxane may contain bis(2-chloroethyl) ether, a 
potentially dangerous precursor, as an impurity. If there is any 
possibility of this or similar alkylating ethers being present, strict 
precautions must be taken to prevent any exposure to them.
Dioxane has flammable and toxic properties [10]. At room 
temperature, liquid dioxane can give rise to vapor-air mixtures within the 
explosive range. Jones and coworkers [l'Ol] described limits of 
flammability and pressures for dioxane. The lower flammable limit in air 
(dried on calcium chloride) was 1.97% by volume at standard temperature and
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pressure. The pressure that developed reached 80 psi when 3.54% of dioxane 
was present. Higher concentrations of dioxane in air could not be reached, 
since some of the dioxane condensed out in the copper tubing at higher 
concentrations. The upper limit of flammability for dioxane in air (dried
on calcium chloride) at 100 C and at standard pressure was found to be
22.25% by volume. The ignition temperature for 2.15% dioxane was found to 
be 476 C and, as the concentration of dioxane was increased until 4.03% 
dioxane was present, the ignition temperature was lowered to 438 C [101],
(a) Personal Protective Equipment and Protective Clothing
(1) Protective Clothing
Protective clothing should be used when working with dioxane
in amounts or procedures that may cause skin contact. The clothing should
be both impervious to penetration and resistant to degradation by dioxane. 
Materials coated with neoprene seem to be suitable for work with dioxane, 
since no penetration, leakage, breakage, or shrinkage were seen at the end 
of 7 hours (written communication, RW McKee, November 1976). Neoprene- 
coated gloves, boots, overshoes, and bib-type aprons that cover boot tops 
will sometimes be necessary. Impervious supplied-air hoods or suits should 
be worn when entering confined spaces, such as pits or tanks, unless they 
are known to be safe.
If skin comes into contact with dioxane, promptly wash or shower to 
remove dioxane from the skin, thereby preventing penetration of dioxane 
through the skin. Clothing that is wet with dioxane can be easily ignited; 
hence, wet clothing must be removed immediately. This clothing must not be 
reworn until the dioxane is removed from the clothing. The employer should 
ensure that all personal protective clothing is inspected regularly for
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defects and is maintained in a clean and satisfactory condition by the 
employee.
(2) Respiratory Protection
Information on the selection and use of respirators has been 
provided in Table I— 1; further details can be obtained from the Respiratory 
Protection Devices Manual [102] published by the American Industrial 
Hygiene Association and the American Conference of Governmental Industrial 
Hygienists in 1963. The American National Standard Practices for 
Respiratory Protection, ANSI Z88.2-1969 [103], also classifies, describes, 
and gives the limitations of respirators. This has also been incorporated 
in 29 CFR 1910.134 (b),(d),(e), and (f).
For respiratory protection from a volatile carcinogen like dioxane, 
it is proposed to recommend use of positive-pressure respirators, so that 
facepiece leakage, a problem with negative-pressure respirators, will not 
occur.
NIOSH periodically issues a list of approved or certified respiratory 
protective devices. All devices approved by the Mining Enforcement and 
Safety Administration are listed in Information Circular 8559 and 
supplements. All types of devices certified by the Testing and 
Certification Laboratory of NIOSH are listed in a separate publication. 
These are available from the Testing and Certification Laboratory, NIOSH, 
Morgantown, West Virginia, 26505.
(3) Skin and Eye Protection
Only one report of dermatitis linearis was described in the 
literature [32] when dioxane came into contact with the skin. In this 
case, the eczema developed on an area of the arm and hand where the skin
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had been damaged previously. Penetration of skin to cause systemic effects 
is probably more Important than local skin effects in the case of dioxane. 
As was discussed in Chapter III, dioxane can cause skin irritation and can 
penetrate skin readily. Hence, protective clothing that will prevent skin 
contact should be used whenever liquid dioxane is handled.
Irritation of the eyes and nose has been noticed by human volunteers 
[19,22] at various levels of exposure to dioxane. Also, liquid dioxane 
instilled in rabbits' eyes was very irritating [39,58]. Hence, eye 
protection must be provided for and used by employees working with dioxane. 
Chemical-type goggles, safety glasses with splash shields, or plastic face 
shields (8-inch minimum), made completely of dioxane-resistant material, 
should be used. Where splashes of dioxane occur, eyecup goggles that meet 
the specifications of Section 6.1.1 of the American National Standard 
Practice for Occupational and Educational Eye and Face Protection should be 
worn. This is incorporated in 29 CFR 1910.133 (a)(2)(vi).
(b) Bulk Handling, Storage, and Use
Piping and valves at the unloading station should be of dioxane 
resistant material and should be carefully inspected prior to connection to 
transport vehicles. The containers should be unloaded with care and stored 
and supported properly. Embankments and other safeguards should be 
provided to prevent the spread of liquid escaping accidentally from storage 
and process containers. Personal protection must be provided during both 
inspection and connection. Periodic inspection during unloading is also 
recommended to avoid the possibility of leaks. Eyewash fountains and 
safety showers must be immediately available. The employer should ensure 
that the equipment is in proper working order through regularly scheduled
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inspections performed by qualified maintenance personnel.
All personnel involved in unloading must be made aware of the toxic, 
flammable, and explosive properties of dioxane and the necessity for 
wearing proper personal protection. Additional precautions suitable for 
transfer of dangerous materials including flagging of the materials must be 
taken. All spilled dioxane should be properly flushed away with water and 
care should be taken to prevent undecontaminated dioxane-containing 
material from entering drains or sewers.
All systems where dioxane is handled should be inspected daily for 
signs of leaks by personnel attired in specified protective equipment 
including protective clothing. If there is a leak, it should be corrected 
immediately using nonsparking tools. Work in the dioxane area should 
normally resume only after necessary repair or replacement has been made, 
the room ventilated, and the concentration of dioxane determined by 
monitoring to be at or below the environmental limit.
Dioxane must be stored in tightly closed containers in a cool, dry, 
well-ventilated area away from heat, sparks, open flames, moisture, and 
strong oxidizers. Storage facilities should be designed to contain spills 
completely within a surrounding dike and to prevent contamination of 
workroom air. Dioxane when stored must be checked for peroxide content in 
accordance with the manufacturer's recommendations. All piping and 
equipment should be marked as containing dioxane. Piping should be located 
so that the possibility of mechanical damage to it is minimized. 
Nonsparking tools must be used when opening or closing metal containers of 
dioxane. Containers must be bonded and grounded when pouring or 
transferring liquid dioxane. At least two separate means of exit should be
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provided from each room or building in which dioxane is stored or handled 
in quantities that could create a hazard. Storage containers should be 
periodically inspected for leakage.
Ventilation switches and emergency respiratory equipment should be 
located outside storage areas in readily accessible locations known to be
free from dioxane exposure. Recommended electrical equipment and equipment
storage have been described in the National Electrical Code, Articles 500 
and 501, respectively.
Liquid dioxane is classified as a class 1(b) flammable liquid. Spray 
finishing operations must be performed in accordance with 29 CFR 1910.107 
and 29 CFR 1910.94(c). Dip tank operations must be performed in accordance 
with sections 1910.108 and 1910.94(d). Whenever dioxane is being handled, 
exclusion of open lights and other sources of ignition such as smoking 
should be strictly adhered to. As is mentioned in the discussion of 
ventilation, below, local exhaust ventilation should be used to control 
vapor from open or partially open systems. A scrubber such as a water 
tower or activated charcoal filter should be installed in the venting 
system to prevent dioxane vapor from escaping to the outside atmosphere. 
All outside exhaust vents must be located away from working area. 
Recording of accidents is important for future reference should the 
incident result in adverse health effects.
(c) Sanitation Practices
Plant sanitation should meet the requirements of 29 CFR 1910.141.
Appropriate locker rooms should be made available for changing into 
required protective clothing in accordance with 29 CFR 1910.141(e). 
Clothing that is contaminated with liquid dioxane should be immediately
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removed and placed in a closed container in a cool, dry, well-ventilated
area for later disposal or decontamination. All personnel who work with
dioxane should shower thoroughly before leaving the workplace at the end of 
a workday.
No smoking or eating should be permitted in areas where liquid 
dioxane is handled, processed, or stored. When handling liquid dioxane, 
hands not protected by gloves should be washed throughly with soap or mild 
detergent and water before eating, smoking, or using toilet facilities. 
Eyewash fountains and drench-type safety showers must be immediately 
available wherever liquid splashes may occur. Eyes splashed with dioxane 
must be promptly flushed with copious amounts of water. If skin is 
contacted with liquid dioxane, skin should be promptly washed or a shower 
taken to remove any dioxane from the skin.
(d) Equipment Maintenance
Cleaning of dioxane tanks and equipment should be performed under
appropriate supervision. The tanks should be first emptied, flushed 
thoroughly with water, purged with fresh air, and tested for dioxane vapor 
and oxygen deficiency before entry is made. No tank or vessel should be 
entered unless it has a manhole opening large enough to admit a person 
wearing proper protective clothing and safety equipment such as safety 
harness, life line and emergency respiratory equipment. Constant 
observation should be maintained on the personnel inside the tank, and 
rescue personnel must be readily available. Emergency entry may be made 
only if a self-contained breathing unit is provided and protective clothing 
is worn, such as a protective suit with neoprene coating or a combination 
supplied-air suit with auxiliary self-contained air supply. Ventilation
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should be continued during an emergency by blowing or drawing fresh air 
through the system. Safety precautions for emergency rescue require that 
all maintenance personnel be informed of the toxic and hazardous properties 
of dioxane and be instructed on the necessity of wearing personal 
protective equipment.
(e) Ventilation
Since dioxane is used principally as a solvent, most operations 
should lend themselves to control of dioxane vapor through the use of 
closed systems. Where complete enclosure is not feasible, local exhaust 
ventilation should be utilized to keep the vapor out of the workroom 
atmosphere [10]. This local exhaust ventilation system should be so
designed as to prevent the accumulation or recirculation of dioxane in the 
workroom, to maintain dioxane concentrations at or below the limit of the 
recommended standard, and to remove dioxane from the breathing zones of the 
employees. Natural ventilation, if used, should be supplemented with 
forced-draft, explosion-proof fans. Exhaust systems discharging into 
outside air must conform with applicable local, state, and federal air 
pollution regulations. Discharged air can be treated to remove dioxane by 
passing such air through filters of activated charcoal. Water scrubbers 
can also be effective and may be more efficient.
Continued inspection and maintenance of ventilation systems is 
essential to prevent or promptly eliminate any leakage of dioxane. This 
also ensures effectiveness of the ventilation system which should be 
verified by periodic airflow measurements at least every 3 months. These 
measurements should be made by trained personnel using proper protective
equipment and protective clothing. Measurements of ventilation system
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efficiency should also be made by trained, appropriately attired personnel 
immediately when a change in production, process, or control is made, that 
may result in increased concentrations of airborne dioxane.
Where reliance is placed on general ventilation, there is, as with 
all solvents, the danger of excessive concentrations building up during 
cold weather when doors and windows are kept closed. The design of exhaust 
ventilation systems should incorporate the principles contained in 
Fundamentals Governing the Design and Operation of Local Exhaust Systems, 
Z33.1-1974 (ANSI) [104], and Industrial Ventilation— Manual of Recommended 
Practice [105]. Recirculation of exhausted air within the workplace should 
not be allowed. Cooling coils to condense dioxane vapor may be useful in 
some operations, either instead of or in addition to local ventilation.
Situations in which relatively small quantities of dioxane are used, 
possibly on an intermittent basis, may not lend themselves to the use of 
enclosed systems. However, even in such cases, the importance of 
preventing exposure to airborne vapor, even for brief periods, should not 
be underestimated. Operations resulting in the release of dioxane vapor 
should be controlled, where feasible, through use of local exhaust 
ventilation with additional protection, if indicated, through use of 
respiratory equipment.
(f) Emergency Procedures
Spills must be anticipated. Storage tanks must be diked to contain 
the contents of the tank. Drum storage areas also must be diked to contain 
the volume of dioxane present in the drums, so as to prevent release to 
other areas. Areas where major spills are likely to occur should be 
constructed so that they can be closed until properly protected personnel
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can ventilate, enter, and clear the area. Warning signs should be posted 
so that no unauthorized personnel will enter the area. Normal work should 
be discontinued until the concentration of dioxane has been reduced to the 
recommended workplace environmental level. Combustion operations, if any, 
should be stopped until the spill is cleared. Disposal of dioxane should 
be performed in compliance with any applicable local, state, and federal 
waste disposal regulations that may be available. Consideration should be 
given to pumping the diked spill to another tank for later processing or 
decontamination and dumping. In addition, it is advisable to have 
facilities for transfer of the contents of a leaking tank to another 
suitable tank.
In general, if dioxane is spilled or leaked, the following steps 
should be taken: (1) Remove all ignition sources, (2) ventilate the area
of spill or leak, (3) for small quantities, absorb on paper towels using 
appropriate protective gear such as gloves; evaporate in safe place (such 
as fume hood); allow sufficient time for vapor to completely clear hood, 
duct work, then burn the paper. Large quantities can be collected and 
burned in a suitable combustion chamber. Dioxane must not be allowed to 
enter a confined space, such as a sewer, because of the possibility of an 
explosion. Small portable spark-proof exhaust fans may be used in confined 
areas where local exhaust ventilation is not feasible. Workers should not 
return to any work area if the odor of dioxane is still perceptible or if 
there is other evidence of the presence of dioxane vapor. However, it 
should not be assumed that if dioxane cannot be detected by odor that a 
safe situation exists.
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Maintenance personnel involved in emergency rescue or cleanup should 
be informed of the toxic and hazardous properties of dioxane and instructed 
as to the use of protective clothing and equipment. Nonessential employees 
should be restricted from areas of spills or leaks until cleanup has been 
completed. The employees in adjacent areas should be trained in evacuation 
procedures in the event that these work areas become involved.
Only personnel trained in emergency procedures and attired in 
protective clothing should shut off sources of dioxane, clean up spills, 
control and repair leaks, and fight fires in dioxane areas. The leaks 
should be corrected using non-sparking tools. For fire fighting 
procedures, alcohol foam, carbon dioxide, or dry chemical should be used. 
Proper protective respirators and protective clothing should be worn by all 
personnel in the hazard area until airborne dioxane has been removed.
Showers, eyewash fountains, and washroom facilities should be so 
located as to be readily accessible to employees in case of emergency. If 
liquid dioxane is splashed on the skin, contaminated clothing should be 
promptly removed and the skin washed with soap and water. If liquid 
dioxane contacts the eyes, they should be irrigated immediately with 
copious quantities of running water. Exposures should be promptly reported 
to the immediate supervisor by the affected worker or a fellow employee and 
a decision on the need for prompt medical attention reached.
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VI. DEVELOPMENT OF STANDARD
Basis for Previous Standards
In 1945, Cook [106] compiled a list of maximum allowable 
concentrations of atmospheric industrial contaminants which included 
dioxane. He cited the Utah state standard for dioxane of 1,000 ppm. In 
addition to this value he suggested 500 ppm as an accepted and tentative 
value based on animal studies conducted by Fairley et al [21].
The American Conference of Governmental Industrial Hygienists (ACGIH) 
adopted a list of "Maximum Allowable Concentrations of Air Contaminants for 
1946" [107] that included 500 ppm for dioxane as recommended by Cook [106]. 
The Maximum Allowable Concentration (MAC) for dioxane was reduced to 100 
ppm in 1947 [108] but no explanation of the changes was given. At the 10th 
Annual Meeting of the American Conference of Governmental Industrial 
Hygienists [109], the term "Maximum Allowable Concentration" was changed to 
Threshold Limit Value (TLV). In 1959, Elkins [110] recommended 50 ppm as 
the MAC for dioxane as "tentative," based on reports from Yant et al [19], 
Barber [20], and De Navasquez [38] but Elkins [110] did not elaborate. At 
the 27th Annual Meeting of the ACGIH [111] in 1965, the term "skin" was 
added to the TLV to denote that dioxane can be absorbed through the skin of
man, and that reliance upon the observation of a TLV of 100 ppm alone might
not be sufficient to prevent toxicity.
Tables of "Permissible Levels of Toxic Substances in the Working
Environment" for many countries were published by the International Labour
Office (ILO) in 1970 [112]. The reported dioxane standards are presented 
in Table VI-1.
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TABLE VI-1
LIST OF HYGIENIC STANDARDS 
OF DIOXANE FROM VARIOUS COUNTRIES (1970)
PPm mg/cu m
Bulgaria 3 10
Finland 100 360
Germany 100 360
Poland 3 10
Rumania 15 50 (skin)
United States 100 360 (skin)
USSR 3 10
Yugoslavia 100 360
Adapted from reference 112
Table VI-1 shows that the MAC for dioxane used by Bulgaria, Poland, 
Rumania and the USSR is much lower than that of other countries including 
the US but the basis for these lower limits was not described in the ILO 
report.
The 1971 Documentation of Threshold Limit Values for Substances in 
Workroom Air which was updated by the ACGIH in 1974 [113] supported the
dioxane TLV of 100 ppm as a time-weighted average based on reports of Yant 
et al [19], Schrenk et al [48], Fairley et al [21], De Navasquez [38], 
Smyth [56], Barber [20], and Johnstone [31], The TLV of 100 ppm as 
established by the ACGIH was believed to be low enough to prevent systemic 
poisoning [113],
A tentative TLV of 50 ppm with a "skin" notation for dioxane was 
published by the ACGIH in a list of intended changes for 1972 [114], and
1973 [115], The TLV of 50 ppm (180 mg/cu m) (skin) was adopted in 1974
[116].
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The Swedish National Board of Occupational Safety and Health [117] 
gave a limit of 25 ppm (90 mg/cu m) in 1974, noting that dioxane can be 
absorbed through the skin and that it also has carcinogenic properties.
In the Transactions of the 36th Annual Meeting of the ACGIH [118] in 
1974, the committee classified dioxane as an experimental animal 
carcinogen. However, the following year [119], the experimental carcinogen 
listing of dioxane was removed, with a note that the issue would be kept 
under continuing review by the TLV Committee.
The TLV for dioxane remained at 50 ppm (180 mg/cu m) (skin) in 1975 
and 1976 [73,120]. In 1976, the term Short-Term Exposure Limit (STEL) was 
instituted. It represented the maximal concentration to which workers can 
be exposed for a period up to 15 minutes continuously without suffering 
from (1) intolerable irritation, (2) chronic or irreversible tissue change, 
or (3) narcosis of sufficient degree to reduce work efficiency. Not more 
than four excursions per day were permitted, with at least 60 minutes 
between exposure periods and the daily TLV-TWA also not being exceeded. 
The STEL value for dioxane was tentatively set the same as the TLV, ie, 50 
ppm [73]. In the guidelines set by the ACGIH for experimental animal 
carcinogens, dioxane was excluded as a carcinogen since it exceeded the 
dosage limitations put forth by their committee [73]. They stated that no 
substance was considered by the Committee as an occupational carcinogen if 
given to rats at doses greater than 2,000 mg/cu m by the respiratory route, 
above 3,000 mg/kg by the dermal route, and above 500 mg/kg/day by the oral 
route for a lifetime, which is equivalent to 100 g total dose for the rat. 
The hepatocellular and nasal tumors observed when 1% dioxane was given to 
rats by Argus et al [62] and by Kociba et al [65] was equivalent to 132
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g/rat or 1,015 mg/kg/day. Evidence or arguments supporting these criteria 
of classification of carcinogens were not presented by the ACGIH Committee.
The current federal standard for dioxane (29 CFR 1910,1000) is 100 
ppm, as a TWA, which was adopted from the 1968 ACGIH recommendation [121].
Basis for the Recommended Environmental Standard
(a) Permissible Exposure Limit
Dioxane has been shown to induce tumor formation in experimental 
animals [43,62-67,70], There is confirmed evidence of cancer induction in 
rats given large oral doses of approximately 1% dioxane in drinking water 
[43,62,64,65,67], Neoplastic lesions most often described were tumors of 
the liver and nasal cavity. In the liver, they were described as 
"incipient" liver tumors, hepatomas, and hepatocellular carcinomas. In the 
nasal cavity, epithelial carcinomas, olfactory neuroblastomas, and 
seromucous adenocarcinomas (as well as rhabdomyosarcomas) were described. 
In two of these studies [43,65], a relationship was reported between the 
amount of dioxane ingested in drinking water and the Incidence of tumors. 
In one study [65], a statistically significant increase (P<0.05) in hepatic 
tumors of all types, in hepatocellular carcinomas, and in nasal carcinomas 
was seen in rats given drinking water containing 1% dioxane as compared to 
the controls (12/66 vs 2/106, 10/66 vs 1/106, and 3/66 vs 0/106,
respectively). One hepatocellular carcinoma (statistically not 
significant) was seen in a rat given drinking water containing 0,1% of 
dioxane. In the other study [43], the incidence of liver tumors was 14, 
28, 53, and 82% in rats given drinking water containing 0.75, 1.0, 1.4, and 
1.8% of dioxane, respectively. These tumor percentages apparently included
both "incipient" tumors and hepatomas. In another report of what appears 
to be the same experiment, these authors [85] reported 1, 1, 2, and 2 
squamous cell carcinomas in rats given water containing 0.75, 1.0, 1.4, and
1.8% of dioxane, respectively.
In the Holmes report [67], a dose-response relationship was also 
apparent with 1/32 of controls, 23/57 of the 0.5% dioxane group, and 23/51 
of the 1.0% dioxane group having developed squamous cell carcinomas of the 
nasal cavity. Two of the 0.5% dioxane group had olfactory neuroblastomas 
and one had a rhabdomyosarcoma. Seven of the 1% group had olfactory 
neuroblastomas and two had seromucous adenocarcinomas. The two seromucous 
adenocarcinomas, 4/4 of the neuroblastomas and 4/46 of the squamous cell 
carcinomas had metastasized to other sites.
A dose-response relationship also occurred among mice given dioxane 
in their drinking water [67]. Four of 99 examined controls, 24/94 of the 
0.5% dioxane group, and 44/87 of the 1.0% dioxane group had hepatocellular 
carcinomas.
Two gall bladder carcinomas, three early hepatomas, nine cases of 
epithelial lung hyperplasia, and one adenoma of the kidney were seen in 22 
guinea pigs given 0.5-2.0% dioxane in drinking water [63], One case of 
epithelial hyperplasia, four of mononuclear cell accumulation in the lung, 
and one cartilaginous growth were seen among 10 controls.
There was inconclusive evidence of cancer induction when mice were 
topically treated with dioxane and of cancer promotion when the topical 
application was preceded by 1 week with application of DMBA [44,69,70].
As commented in Chapter III, the lack of a significant excess in 
numbers of tumors in several hundred rats does not give reassurance of lack
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of tumor excess in 100,000 humans similarly exposed, because of 
discrepancies in population sizes and because of lack of evidence on 
relative sensitivities to tumor induction in the two species.
In the epidemiologic studies reported by Dernehl (written 
communication, April 1976), Thiess and coworkers [34], and Buffler and 
associates [35], no significant differences were seen between the observed 
and expected numbers of cancer deaths in the worker populations at risk.
In one study [34], two cancer deaths, a lamellar epithelial carcinoma 
of the left lumbar region and a myelofibrotic leukemia were reported among 
12 deaths in a group of 74 workers who had been exposed to dioxane in the 
workroom air. Concentrations of airborne dioxane were reported to range 
from 0.01 to 13.28 ppm. In the second study [35], two of seven deaths that 
occurred among 100 exposed workers were attributed to cancer (carcinoma of 
the stomach and an alveolar cell carcinoma). Workroom concentrations of 
dioxane measured in 1968, 1973, and 1974 ranged from less than 0.01 to 16.0 
ppm. The person who died from carcinoma of the stomach had also been 
exposed to hydrogen chloride, carbon tetrachloride, perchloroethylene, and 
trichloroethylene. The other worker had been exposed to vinyl chloride for 
about 11 years and to methylene chloride for 1.5 years. In the third study 
(written communication, CU Dernehl, April 1976), four cancer deaths were 
reported. They were attributed to cancer of the colon, lymphosarcoma, lung 
carcinoma, and glioblastoma. In all, 80 workers had been exposed to 
dioxane during the 42-year period the company had been producing dioxane. 
Analysis of workroom air in 1974 and again in 1975 showed dioxane to range 
in concentrations from 0.05 to 51 ppm.
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Although no statistically significant increase was seen between the 
total number of observed and expected cancer deaths in the reports of 
Dernehl (written communication, April 1976), Thiess et al [34], or Buffler 
and coworkers [35], these results cannot be accepted as conclusive evidence 
that the reported air concentrations of dioxane represented safe worker 
exposure levels. The populations at risk were very small, 74, 165, and 80 
workers, respectively. Therefore, the statistical tests would not have 
been able to detect other than major increases in cancer death rates. In 
addition, only general mortality rates were compared although specific 
types of cancer can have mortality rates of magnitude less than the total 
cancer mortality rate. Expected cancer deaths based on the total expected 
cancer mortality rate are, therefore, misleading and cannot be considered 
conclusive evidence that humans occupationally exposed to dioxane do not 
have a greater risk of cancer induction than humans not exposed to the 
chemical.
The pharmacokinetic study conducted by Young and Gehring [30] showed 
that the fate of dioxane in rats was markedly dose-dependent due to an 
apparent limited capacity to metabolize dioxane to HEAA. A more rapid 
excretion of HEAA was noted when multiple daily doses of 1,000 mg/kg 
dioxane were given but not with equivalent single doses or with multiple 
daily doses of 10 mg/kg. This indicates that, at high daily doses, dioxane 
induced its own metabolism. The differences in metabolism at high doses as 
compared with those in lower doses may have been quantitative rather than 
qualitative; some unchanged dioxane was excreted even at the lower doses, 
if dioxane at less than 1% of the total urinary metabolites is significant. 
In any case, it remains to be demonstrated whether tumors from dioxane are
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from the unchanged chemical or from the metabolite of the chemical. It
seems probable that the nasal tumors arose from local contact with 
unmetabolized dioxane. It may be that the liver tumors arose from 
unmetabolized dioxane or, conceivably, from a metabolic product, either 
intermediate or end product. While this is speculative, it is also
speculative to interpret that complete metabolism of dioxane will prevent
the development of tumors.
An additional argument to consider in the interpretation of the 
studies of experimental carcinogenicity also concerns the question of the 
occurrence of tumors in experimental animals only at high doses and not at 
lower doses. Tumor incidence is proportional to dose and a dose-response 
relationship was seen in the ingestion studies [65], Even if dioxane is a 
veak carcinogen, an incidence of 1-10 cases of cancer in a population of
100,000 would not be unexpected. Such an incidence in experimental animals 
would probably not be detected in a population of 1,000 animals; yet, in 
none of the experiments reviewed here has that large a population been used 
in any one treatment group. If these animals were much more sensitive than 
man to cancer induction by dioxane, the smaller number of experimental
animals might give adequate negative evidence of carcinogenicity. At
present there are too few data to be sure of the relative sensitivity of 
the several species including man in induction of cancer by dioxane. This 
last statement presumes that dioxane can induce cancer in man; the
statement is, of course, unproved, but seems reasonable inasmuch as it can
induce cancer in some other mammalian species tested.
Dioxane has been shown to penetrate the skin of animals [21,50] and 
man [31] causing liver and kidney damage. Therefore, prevention of skin
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contact by use of appropriate work practices is very important.
Cancer in workers is the primary health concern in the development of 
this recommended standard for exposure to dioxane. In addition, liver and 
kidney damage are potential effects. The permissible limit recommended for 
occupational exposures to dioxane is based on the belief that dioxane can 
cause tumors in exposed workers and on the belief that information allowing 
the derivation of a safe exposure limit is not now available. Thus, a 
limit that is the lowest concentration reliably measureable over a short 
sampling period is recommended. This limit is 1 ppm, based on 30-minute 
sampling at a sampling rate of 1 liter/minute. The reasons for concluding 
that this is the lowest measureable limit are described in Section (c), 
Sampling and Analysis.
(b) Medical Surveillance and Recordkeeping
Several human [20,31] and animal studies [21,38-40,43,44,46-51,63- 
66,69,70] demonstrated that exposure to dioxane produced systemic damage in 
the kidney and liver. A medical surveillance program should include 
preplacement and periodic medical examinations that give attention to the 
kidneys and liver. Appropriate examination to detect possible tumors
should be performed; liver function tests are probably significant in this 
examination, as is examination of the upper respiratory tract, especially 
the nose. Because dioxane is believed capable of inducing cancer, NIOSH 
recommends that all medical and environmental records involving dioxane 
exposure be kept for 30 years after termination of employment. This is 
also consistent with the requirements of the Toxic Substances Control Act.
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(c) Sampling and Analysis
Dioxane in air samples should be collected with activated coconut 
charcoal, desorbed with carbon disulfide, and analyzed by gas 
chromatography. The basis for this is discussed in Chapter IV, and
detailed directions are provided in Appendices I and II. These methods 
have chosen because of their availability and specificity.
The Lower limit of the sampling and analytical methods has not been 
determined. The combined sampling and analytical method has been tested 
and found by NIOSH to be sufficiently accurate and precise for the
determination of the amount of dioxane collected by sampling 10 liters of 
air containing 6,25 ppm. The amount of dioxane collected on the charcoal 
under these conditions averaged 0.20 mg when the nominal amount sampled was 
0.23 mg. The desorption efficiency was determined with approximately 4 mg 
added to the charcoal. If the desorption efficieny had been determined at
0.20 mg/100 g of charcoal, the accuracy might have improved. It is 
recommended that desorption efficiency be determined with various amounts 
of added dioxane that are representative of the concentrations likely to 
exist and sampling times required by these concentrations. The method is 
described in Appendix II.
Although the method has not been tested by sampling atmospheres 
containing less than 6.25 ppm, or by collecting less than a nominal amount 
of 0.23 mg of dioxane, it is reasonable to expect that the method will be 
sufficiently accurate and precise at lower concentrations in the air with 
smaller amounts collected on the charcoal. For example, sampling an 
atmosphere containing dioxane at 1 ppm for 4 hours at 200 ml/minute would
result in collection of 0.17 mg of dioxane, an amount that would likely be
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measured with acceptable accuracy and precision for monitoring exposures of 
this magnitude. As another example, sampling an atmosphere containing 1 
ppm of dioxane at 1 liter/minute for 30 minutes would result in collection 
of about 0.11 mg of dioxane which the data indicate could be satisfactorily 
measured.
As is evident from this discussion, the definitive data to allow 
derivation of the lowest amount of dioxane reliably detectable are not 
complete. The conclusions reached reflect concern about the amount of 
dioxane that can be retained by the charcoal in the presence of competing 
substances, such as water or 1,1,1-trichloroethane. For this reason, the 
total amount of sample obtained at a sampling rate of 1 liter/minute is 
proposed to be limited to 30 liters. (While it is felt that 60 liters may 
tax the retention ability of the charcoal in the tube, data to prove this 
are not available). The resultant amount of dioxane adsorbed from air 
containing 1 ppm is below the amount detectable with a precision of 5-10% 
relative standard deviation. What the precision will be is not known, but 
it is believed to be about 15-20%. Better precision would obviously be 
preferred, but alternatives (risk of incomplete adsorption, other sampling 
means for which equipment has not been proved, higher permissible limit) 
seem less acceptable.
On this basis, a permissible exposure limit of 1 ppm based on a 30- 
minute sampling period at 1 liter/minute is recommended for occupational 
exposures to dioxane.
(d) Personal Protective Equipment and Protective Clothing 
Dioxane has been shown to penetrate the skin of man [31] and animal 
readily [21,50,66,69,70]. Therefore, care must be exercised to ensure
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adequate protection against contact with dioxane. Proper protective
devices such as full face-shields, neoprene-coated gloves, boots, and bib- 
type aprons that cover boot tops should be used while working with dioxane 
to prevent contact and consequent absorption of dioxane through the skin.
(e) Informing Employees of Hazards from Dioxane Exposure
A continuing education program is an important part of a preventive 
hygiene program for employees occupationally exposed to hazardous materials 
such as dioxane. Properly trained persons should periodically apprise
employees of possible sources of dioxane exposure, the adverse health 
effects associated with such exposure to dioxane, the engineering and work
practice controls in use and being planned to limit exposure, and the
environmental and medical monitoring procedures used to check on the 
exposure and health status of employees. Personnel occupationally exposed 
to dioxane must be warned and advised of the adverse effects of accidental 
exposure and must be informed of the signs and symptoms of dioxane
exposure.
(f) Work Practices
Absorption of dioxane can be minimized by adherence to the work 
practices recommended in Chapter I and discussed in Chapter V. The basis 
for these practices is the avoidance of contact with dioxane by confinement 
of the material and by personal protection of the worker. Engineering
controls must be used whenever needed to control concentrations of airborne 
dioxane within the recommended environmental limit. Wherever dioxane is 
present, a closed system of control should be used. During the time
required to install adequate controls and equipment, to make process
changes, to perform routine maintenance operations, or to make emergency
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repairs, exposure to dioxane can be minimized by the use of respirators, 
protective equipment, and protective clothing. However, respirators should 
not be used as a substitute for proper engineering controls during normal 
operations.
Since dioxane can penetrate skin readily to cause systemic toxicity 
and can also cause local skin effects or eye damage, drench-type safety 
showers and eye wash fountains must be nearby wherever liquid splashes may 
occur.
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VII. RESEARCH NEEDS
The only teratogenic study conducted was on chick embryos [60], and 
this poses problems in extrapolation to mammalian systems, as discussed 
earlier in Chapter III. Studies of the possible teratogenic and other 
reproductive effects of dioxane should be conducted in animals in order to 
evaluate the need for protecting female workers of childbearing age and 
their offspring.
There is no information available on possible mutagenic effects of 
dioxane. This is another area where research is needed.
The pathways of metabolic transformation, distribution, and 
elimination of dioxane as a function of the dose, rate, and route of 
administration, have not been adequately investigated in animals and in 
man. One important factor is to determine whether it is unchanged dioxane 
or any of its metabolites that induces cancer.
Those studies most indicative of dioxane as a carcinogen have 
involved administration of dioxane to experimental animals in drinking 
water. The drinking water may have been chlorinated community water, in 
which case chemical reactions between components of the water and dioxane 
are conceivable. If such reactions occur, it seems that chlorinated 
derivatives of dioxane would be the most likely products. One derivative, 
dichlorodioxane, has been suggested to be a tumorigen, albeit on the basis 
of development of sarcomas at the sites of injection [122]. While 
chlorination of dioxane or its breakdown products is not expected to be a 
significant factor, in part because of the low concentrations of chlorine 
in water supplies, the possibilities should not be overlooked. Research to
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investigate such reactions and, if significant, their toxicologic 
consequences should be conducted.
Workers in one dioxane-manufacturing concern [35] are exposed to 
various other chemicals such as trichloroethylene, perchloroethylene, 
carbon tetrachloride, methylene chloride, and vinyl chloride. Both 
experimental and epidemiologic studies, involving exposure to other 
chemicals in conjunction with dioxane, should be conducted to determine the 
possible additive, synergistic, or inhibitory effects of exposure to other 
substances and to dioxane on workers. It is noted that there is suggestive 
evidence of interactive toxicity in one epidemiologic study [34].
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IX. APPENDIX I
SAMPLING PROCEDURE FOR 
COLLECTION OF DIOXANE
General Requirements
(a) Collect air samples representative of the breathing zones of 
workers to characterize the exposure from each job or specific operation in 
each work area.
(b) Collect samples to represent exposure of individual workers.
(c) Suggested records:
(1) The date and time of sample collection;
(2) Sampling rate and duration;
(3) Total sample volume;
(4) Location of sampling;
(5) Temperature, pressure, and relative humidity at time
of sampling;
(6) Other pertinent information.
Sampling
(a) Collect samples as near as practicable to the face of workers 
without interfering with freedom of movement.
(b) Collect samples to permit determination of exposures for
every job involving dioxane in sufficient numbers to express the 
variability of the exposures for the work situation.
(c) Apparatus for Charcoal Tube Sampling
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(1) Pumps, battery-operated, complete with clips for
attachment to the worker, capable of calibration to within 5% at 
operational flowrates.
(2) Charcoal Tubes
(A) The analytical method (Appendix II) is written 
for samples collected by use of glass tubes 7 cm long with outside diameter
of 6 mo, and a inside diamter of 4 mm, that contain two sections of 20/40
mesh activated coconut-shell charcoal that was fired at 600 C. The first 
is the adsorbing section and contains 100 mg of charcoal. The second, or 
reserve section, contains 50 mg of charcoal. The sections are separated by
2 mm of urethane foam. 3 mm of urethane foam are placed between the end of
the tube and the reserve section, and a plug of silated glass wool is 
placed between the other end of the tube and the adsorbing section.
(B) The pressure drop across the tube must be less 
than 1 inch of mercury at a flowrate of 1 liter/minute.
(C) Tubes meeting the specification in (A) and (B) 
are commercially available.
(d) Calibration of Sampling Instruments
(1) Calibrate air sampling Instruments at operational 
flowrates with a representative charcoal tube in line. Positive- 
displacement diaphragm pumps require accurate determination of the stroke 
factor. Recalibrate pumps after making any repairs or modifications to the 
sampling system.
(2) Spot-check the volumetric flowrate through the sampling
system and make adjustments before, and during, each study to ensure 
accurate airflow data.
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(e) Collection and Handling of Samples
(1) Immediately before sampling, score and break both ends 
of the charcoal tube to provide openings at least one-half the internal 
diameter of the tube (2 mm).
(2) Position the smaller or reserve section of charcoal 
toward the sampling pump,
(3) Place the charcoal tube in a vertical position during 
sampling to prevent channeling, and to avoid consequent sample loss.
(4) Draw the air sample directly through the adsorbing
section of charcoal without first passing it through any tubing; tubing may
be used to connect the back of the tube to the pump.
(5) With pumps that operate at 200 ml/minute, it is
recommended that 48 liters of air be sampled. With pumps that operate at 
about I liter/minute, it is recommended that 30 liters of air be sampled.
(6) Cap the charcoal tubes with inert plastic immediately 
after sampling. Under no circumstances should rubber caps be used.
(7) Prepare a charcoal tube to serve as an analytical 
blank. No air is sampled through this tube, but it is broken, sealed, and, 
if appropriate, transported in the same way as the sample charcoal tubes.
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X. APPENDIX II
ANALYTICAL PROCEDURE FOR DETERMINATION OF 
DIOXANE
Principle of the Method
(a) Draw a known volume of air through a charcoal tube to adsorb 
the dioxane vapor.
(b) Desorb dioxane from the charcoal with carbon disulfide.
(c) Inject an aliquot of the desorbed sample into a gas 
chromatograph.
(d) Determine the area of the resulting peak and compare it with 
areas obtained from the injection of standards.
Range. Sensitivity, Precision, and Accuracy
(a) The lower limit of the range of the method has not been 
determined for dioxane. The method has been evaluated for dioxane at 220 
jug/sample by sampling 10 liters of air containing dioxane at 6.25 ppm or 22 
mg/cu m at 1 liter/minute. This is equivalent to sampling 60 liters of air 
containing approximately 1 ppm of dioxane. Under the conditions of the 
test, the method underestimated the nominal amount of dioxane by 0-20% at a 
95% confidence level. The coefficient of variation for a single 
determination due to sampling and analytical errors was 9%, and the total 
error, including day-to-day variation within laboratories, was 17%.
(b) The upper limit of the range of the method is dependent on 
the adsorptive capacity of the charcoal tube. This capacity varies with 
the concentrations of dioxane and other substances in the air. It is
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estimated that 6 mg is the maximum amount of dioxane that can be collected 
on the front section of charcoal before dioxane will penetrate in 
significant amounts to the reserve section. This is equivalent to sampling 
60 liters of air containing 100 mg/cu m (30 ppm).
Interferences
(a) Dioxane may not be trapped efficiently when the amount of
water in the air is so great that condensation occurs in the charcoal
sampling tube.
(b) Any compound which has the same retention time as dioxane with
the chromatographic conditions described in this method will interfere with 
the analysis. Such interferences may be eliminated by altering the 
operating conditions of the gas chromatograph.
Advantages of the Method
(a) It provides one basic method for determining many different
organic compounds.
(b)„ The sampling device is small, portable, and involves no
liquids.
(c) The analysis of the tubes can be accomplished rapidly.
Disadvantages of the Method
(a) The amount of sample which can be taken is limited by the
weight of dioxane which the tube will hold before overloading.
(b) When the sample value obtained for the reserve section of
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charcoal exceeds 10% of that found on the front section, the possibility of 
sample loss exists.
(c) High concentrations of other organic compounds may displace
dioxane from the charcoal.
Apparatus
(a) Gas chromatograph equipped with a flame ionization detector.
(b) Stainless steel column (20 ft x 1/8 in) with 10% free fatty 
acid polymer stationary phase on 80/100 mesh Chromosorb W (or equivalent), 
acid washed and treated with dimethyldichlorosilane.
(c) Recorder, and some method for determining peak area.
(d) Glass stoppered microtubes, 2 ml, or 2-ml vials that can be 
sealed with inert caps.
(e) Microsyringe, 10 jil, and convenient sizes for making 
standards.
(f) Pipets, 0.5 ml, or 1.0 ml graduated in 0.1-ml increments.
(g) Volumetric flasks, 10 ml, or convenient sizes for making 
standard solutions.
Reagents
(a) Carbon disulfide, chromatographic quality.
(b) Dioxane, analytical reagent grade.
(c) Helium, purified.
(d) Hydrogen, prepurified.
(e) Air, filtered, compressed.
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(f) Decane, or other suitable internal standard (optional).
Analysis of Samples
(a) Wash equipment used in the analysis in detergent followed by 
tap and distilled water rinses.
(b) Score the charcoal tube with a file in front of the first 
section of charcoal and break it open. Remove the glass wool and discard. 
Transfer the charcoal in the first (larger) section to a 2-ml stoppered 
test tube or container. Remove and discard the separating foam and 
transfer the charcoal in the second section to another similar test tube or 
container. Analyze the two sections of charcoal separately. Prior to 
analysis, pipette (not by mouth) 1.00 ml of carbon disulfide into each test 
tube to desorb dioxane from the charcoal. A desorption time of at least 30 
minutes, with occasional agitation, is recommended.
EXTREME CAUTION MUST BE EXERCISED AT ALL TIMES WHEN 
USING CARBON DISULFIDE BECAUSE OF ITS HIGH TOXICITY 
AND FIRE AND EXPLOSION HAZARDS. IT CAN BE IGNITED BY 
HOT STEAM PIPES. ALL WORK WITH CARBON DISULFIDE MUST 
BE PERFORMED UNDER AN EXHAUST HOOD.
(c) Typical chromatographic operating conditons:
(1) 30 ml/minute (60 psig) helium carrier gas flow;
(2) 35 ml/minute (25 psig) hydrogen gas flow to detector;
(3) 400 ml/minute (60 psig) air flow to detector;
(4) 225 C injector temperature;
(5) 250 C manifold temperature (detector);
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(6) 75 C isothermal oven or column temperature.
(d) Injection
To eliminate difficulties arising from blowback or distillation 
within the syringe needle, the solvent flush injection technique can be 
used for injecting the sample into the gas chromatograph. With this 
technique, first flush the 10-jil syringe with carbon disulfide several 
times to wet the barrel and plunger and then draw 3 jul of carbon disulfide 
into the syringe. Remove the needle from the carbon disulfide solvent and 
pull the plunger back about 0.2 yl to separate the solvent flush from the 
sample with a pocket of air to be used as a marker. Then immerse the 
needle in the sample and withdraw a 5-jul aliquot. Take into consideration 
the volume of the needle, since the sample in the needle will be completely 
injected. After the needle is removed from the sample, and prior to 
injection, pull the plunger back a short distance to minimize evaporation 
of the sample from the tip of the needle. Make duplicate injections of 
each sample and standard. Using this technique, the maximum difference 
expected between results of duplicate injections is 3%.
Other injection techniques, such as use of automatic sample 
injectors, are acceptable if their reproducibility is at least as good as 
the solvent flush technique.
(e) Measurement of area
Measure the area of the sample peak and read the preliminary results 
from a standard curve prepared as discussed below.
Determination of Desorption Efficiency
It is necessary to determine percentages of dioxane on the charcoal
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that are removed in the desorption process. These desorption efficiencies 
may vary with the amount of dioxane adsorbed on the charcoal and with the 
adsorption characteristics of the batch of charcoal. These variables 
necessitate determination of a desorption efficiency curve for each batch 
of charcoal, as described below. Charcoal from the batch used in preparing 
the sample tubes can be obtained from unused ones of the same batch. 
Measure 100 mg quantities of it into glass tubes 2.5 inches long, 4 mm 
inside diameter, and flame-sealed at one end. Inject known amounts of 
dioxane directly into the charcoal with a microliter syringe, and cap the 
tubes with inert plastic.
At least five tubes with different amounts of added dioxane are 
prepared in this manner and allowed to stand at least overnight to ensure 
complete adsorption of dioxane onto the charcoal. Preparation of replicate 
tubes with each amount of added dioxane is recommended. These tubes will 
be referred to as the desorption samples. Prepare a parallel blank tube in 
the same manner, except for addition of dioxane. Desorb and analyze the 
desorption samples and blanks in exactly the same manner as previously 
described.
Prepare desorption standards by injecting the same volumes of 
dioxane into 1.00 ml of carbon disulfide with the same syringe used in the 
preparation of the desorption samples. Replicate standards are recommended 
with each amount of added dioxane. These are analyzed with the desorption 
samples.
The desorption efficiency at each added amount of dioxane equals the 
difference between the average area of the gas chromatographic peaks due to 
dioxane recovered from the charcoal and the corresponding area due to the
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charcoal blank divided by the average area due to dioxane added directly to 
the carbon disulfide or,
desorption efficiency = area of sample-area of blank
area of standard
The desorption efficiency versus weight of dioxane found is plotted, 
and the curve is used for correction of losses due to adsorption.
Calibration and Standards
It is convenient to prepare standards in terms of milligrams (mg) of 
dioxane/1.00 ml of carbon disulfide because samples are desorbed In this 
amount of carbon disulfide. To minimize error due to variability of carbon 
disulfide, 10 times the weight of dioxane can be injected into 10 ml of 
carbon disulfide. For example, to prepare 0.2 mg/1.00 ml of standard, 
inject 2.0 mg of dioxane into exactly 10 ml of carbon disulfide in a glass- 
stoppered flask. Use the density of dioxane (1.0356 at 20 C) to convert mg 
into Ml for easy measurement with a microliter syringe. Prepare a series 
of standards, varying the amount of added dioxane over the range of 
interest, and analyze them under the same gas chromatographic conditions 
and during the same time period as the unknown samples. Establish curves 
by plotting average peak area versus milligrams of dioxane/1.00 ml of 
carbon disulfide.
Alternately, carbon disulfide containing a predetermined amount of 
an internal standard can be used, and the dioxane concentration in mg/ml 
can be plotted versus the area ratio of dioxane to the Internal standard. 
However, it needs to be established whether the concentration in solution 
is changed by adsorption on the charcoal.
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Calculations
(a) Read from the standard curve the weight in mg corresponding 
to the peak area. No volume corrections are needed, because the standard 
curve is based on mg dioxane/1.00 ml carbon disulfide, and the volume of 
sample injected is identical to the volume of the standards injected.
(b) Separately determine the weights of dioxane on the front and 
reserve sections of the charcoal tube.
(c) Make corrections to the dioxane weights determined on both 
the front and reserve sections for the weights of the respective sections 
of the blank charcoal tube:
(1) Subtract the weight of dioxane found on the front
section of the blank charcoal tube from the weight of dioxane found on the
front section of the sample charcoal tube to give a corrected front section
weight.
(2) Subtract the weight of dioxane found on the reserve
section of the blank charcoal tube from the weight of dioxane found on the
reserve section of the sample charcoal tube to give a corrected reserve 
section weight.
(3) Add the corrected amounts of dioxane present on the 
front and reserve sections of the sample tube to determine the total 
measured dioxane in the sample, and divide this total weight by the 
appropriate desorption efficiency to obtain M, the total mg per sample.
(d) Convert the liters of air sampled (V) to volume (V') at 
standard conditions of 25 C and 760 mm Hg, as follows:
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v' = 298VP 
760(T+273)
0.392VP
(T+273)
Where:
V' = volume of sampled air in liters at 25 C and 760 mm Hg 
V = measured volume of sampled air in liters 
P = barometric pressure in mm Hg, measured at time of
sampling
T = temperature of air in degree Celsius, measured at time of
sampling
(e) The concentration of dioxane in the sampled air can be
expressed in various ways using M, the weight of dioxane obtained in
(c)(4), and V', the standardized sample volume, obtained in (d), as 
follow8:
(1) mg/liter = M/V’
(2) mg/cu m ■ ¿ig/liter = 1,000 M/V’
(3) ppm - 278 M/V'
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XI. APPENDIX III - MATERIAL SAFETY DATA SHEET
General instructions for preparing a Material Safety Data Sheet 
(MSDS) are presented In this chapter. The examples used in the text are 
for illustrative purposes and are not intended to apply to any specific 
compound or product. Applicable information about a specific product or 
material shall be supplied in the appropriate block of the MSDS.
The product designation is inserted in the block in the upper left
corner of the first page to facilitate filing and retrieval. Print in
upper case letters as large as possible. It should be printed to read
upright with the sheet turned sideways. The product designation is that 
name or code designation which appears on the label, or by which the 
product is sold or known by employees. The relative numerical hazard 
ratings and key statements are those determined by the guidelines in 
Chapter V, Part B, of the NIOSH publication, An Identification System for 
Occupationally Hazardous Materials. The company identification may be 
printed in the upper right corner if desired.
(a) Section I. Product Identification
The manufacturer's name, address, and regular and emergency
telephone numbers (including area code) are inserted in the appropriate 
blocks of Section I. The company listed should be a source of detailed 
backup information on the hazards of the material(s) covered by the MSDS, 
The listing of suppliers or wholesale distributors is discouraged. The 
trade name should be the product designation or common name associated with 
the material. The synonyms are those commonly used for the product, 
especially formal chemical nomenclature. Every known chemical designation
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or competitor's trade name need not be listed.
(b) Section II. Hazardous Ingredients
The "materials" listed in Section II shall be those substances which 
are part of the hazardous product covered by the MSDS and individually meet 
any of the criteria defining a hazardous material. Thus, one component of 
a multicomponent product might be listed because of its toxicity, another 
component because of its flammability, while a third component could be 
included both for its toxicity and its reactivity. Note that a MSDS for a 
single component product must have the name of the material repeated in 
this section to avoid giving the impression that there are no hazardous 
ingredients.
Chemical substances should be listed according to their complete 
name derived from a recognized system of nomenclature. Where possible, 
avoid using common names and general class names such as "aromatic amine," 
"safety solvent," or "aliphatic hydrocarbon" when the specific name is 
known.
The "%" may be the approximate percentage by weight or volume 
(indicate basis) which each hazardous ingredient of the mixture bears to 
the whole mixture. This may be indicated as a range or maximum amount, ie, 
"10-40% vol" or "10% max wt" to avoid disclosure of trade secrets.
Toxic hazard data shall be stated in terms of concentration, mode of 
exposure or test, and animal used, ie, "100 ppm LC50 rat," "25 mg/kg LD50- 
skin-rabbit," "75 ppm LC man," or "permissible exposure from 29 CFR 
1910.1000," or, if not available, from other sources of publications such 
as the American Conference of Governmental Industrial Hygienists or the 
American National Standards Institute Inc. Flammabllity or reactivity data
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could be flashpoint, shock sensitivity, or other brief data indicating 
nature of the hazard.
(c) Section III. Physical Data
The data in Section III should be for the total mixture and should 
include the boiling point and melting point in degrees Fahrenheit (Celsius 
in parenthesis); vapor pressure, in conventional millimeters of mercury (mm 
Hg); vapor density of gas or vapor (air = 1); solubility in water, in
parts/hundred parts of water by weight; specific gravity (water ■ 1); 
percent volatiles (indicated if by weight or volume) at 70 degrees
Fahrenheit (21.1 degrees Celsius); evaporation rate for liquids or 
sublimable solids, relative to butyl acetate; and appearance and odor. 
These data are useful for the control of toxic substances. Boiling point, 
vapor density, percent volatiles, vapor pressure, and evaporation are 
useful for designing proper ventilation equipment. This information is 
also useful for design and deployment of adequate fire and spill
containment equipment. The appearance and odor may facilitate 
identification of substances stored in improperly marked containers, or 
when spilled.
(d) Section IV. Fire and Explosion Data
Section IV should contain complete fire and explosion data for the
product, including flashpoint and autoignition temperature in degrees
Fahrenheit (Celsius in parentheses); flammable limits, in percent by volume 
in air; suitable extinguishing media or materials; special firefighting 
procedures; and unusual fire and explosion hazard information. If the 
product presents no fire hazard, insert "NO FIRE HAZARD" on the line 
labeled "Extinguishing Media."
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(e) Section V. Health Hazard Information
The "Health Hazard Data" should be a combined estimate of the hazard 
of the total product. This can be expressed as a time-weighted average 
(TWA) concentration, as a permissible exposure, or by some other indication 
of an acceptable limit. Other data are acceptable, such as lowest LD50 if 
multiple components are involved.
Under "Routes of Exposure," comments in each category should reflect 
the potential hazard from absorption by the route in question. Comments 
should indicate the severity of the effect and the basis for the statement 
if possible. The basis might be animal studies, analogy with similar 
products, or human experiences. Comments such as "yes" or "possible" are 
not helpful. Typical comments might be:
Skin Contact— single short contact, no adverse effects likely;
prolonged or repeated contact, irritation, and cracking.
Readily absorbed through the skin with severe systemic effects.
Eye Contact— some pain and mild transient irritation; no
corneal scarring.
"Emergency and First Aid Procedures" should be written in lay
language and should primarily represent first-aid treatment that could be 
provided by paramedical personnel or individuals trained in first aid.
Information in the "Notes to Physician" section should include any
special medical information which would be of assistance to an attending 
physician including required or recommended preplacement and periodic
medical examinations, diagnostic procedures, and medical management of 
overexposed workers.
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(f) Section VI, Reactivity Data
The comments in Section VI relate to safe storage and handling of 
hazardous, unstable substances. It is particularly important to highlight 
instability or incompatibility to common substances or circumstances such 
as water, direct sunlight, steel or copper piping, acids, alkalies, etc. 
"Hazardous Decomposition Products" shall include those products released 
under fire conditions. It must also include dangerous products produced by 
aging, such as peroxides in the case of some ethers. Where applicable, 
shelf life should also be indicated.
(g) Section VII. Spill or Leak Procedures
Detailed procedures for cleanup and disposal should be listed with 
emphasis on precautions to be taken to protect workers assigned to cleanup 
detail. Specific neutralizing chemicals or procedures should be described 
in detail. Disposal methods should be explicit including proper labeling 
of containers holding residues and ultimate disposal methods such as 
"sanitary landfill," or "incineration." Warnings such as "comply with 
local, state, and federal anti-pollution ordinances" are proper but not 
sufficient. Specific procedures should be identified.
(h) Section VIII. Special Protection Information
Section VIII requires specific information. Statements such as 
"Yes," "No," or "If Necessary" are not informative. Ventilation 
requirements should be specific as to type and preferred methods. Specify 
respirators as to type and NIOSH or MESA approval class, ie, "Supplied- 
air," "Organic vapor canister," "Suitable for dusts not more toxic than 
lead," etc. Protective equipment must be specified as to type and 
materials of construction.
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(i) Section IX. Special Precautions
"Precautionary Statements" shall consist of the label statements 
selected for use on the container or placard. Additional information on
any aspect of safety or health not covered in other sections should be
inserted in Section IX. The lower block can contain references to 
published guides or in-house procedures for handling and storage. 
Department of Transportation markings and classifications and other 
freight, handling, or storage requirements and environmental controls can 
be noted.
(j) Section X. Signature and Filing
Finally, the name and address of the responsible person who completed 
the MSDS and the date of completion are entered. This will facilitate 
correction of errors and identify a source of additional information.
The MSDS shall be filed in a location readily accessible to workers 
potentially exposed to the hazardous material. The MSDS can be used as a 
training aid and basis for discussion during safety meetings and training 
of new employees. It should assist management by directing attention to 
the need for specific control engineering, work practices, and protective 
measures to ensure safe handling and use of the material. It will aid the 
safety and health staff in planning a safe and healthful work environment 
and suggesting appropriate emergency procedures and sources of help in the 
event of harmful exposure of employees.
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XII. TABLES
TABLE XII-1
SELECTED PHYSICAL AND CHEMICAL PROPERTIES OF DIOXANE
Chemical Abstract serial number 
Common synonyms
Molecular formula
Formula weight 
Boiling point 
Melting point 
Vapor density 
Specific gravity
Solubility
Density of saturated vapor 
Concentration of saturated vapor 
Flammable (explosive) limits
00012391
I,4-Dioxane 
p-Dioxane
Diethylene dioxide 
Diethylene 1,4-dioxide 
Diethylene ether 
Glycol ethylene ether
C4H8 02
88.10
101.32 C (214.4 F) at
II.8 C (53.2 F)
Approximately 3 (air = 1 )  
1.0356 (20 C), (water *=
1.000 at 4 C)
Miscible with water, 
alcohol, ether, acetone, 
benzene, acetic acid and other 
organic solvents; forms a 
constant boiling mixture 
with water that contains 
81.6% dioxane and boils 
at 87.8 C, 760 mm Hg.
Approximately 1.1 (air ** 1) 
5.26% by volume at 25 C 
Explosive mixtures with air at 
100 C:
upper limit = 22.25 volumes % 
lower limit = 1.97 volumes %
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TABLE XII-1 (CONTINUED)
SELECTED PHYSICAL AND CHEMICAL PROPERTIES OF DIOXANE
Flashpoint 11 C (52 F) (closed cup)
Odor Threshold:
Detection threshold 2.8 ppm
Identification threshold 5.7 ppm
Vapor pressure Temp F Temp C mm Hg
-1.2 29.8 10
12 53.6 20
25.2 77.4 40
33.8 92.8 60
45.1 113.2 100
62.3 144.1 200
81.8 179.2 400
Conversion factors, 
(25 C, 760 mm Hg)
1 mg/liter 
1 mg/cu m !
1 ppm 3.6 mg/cu m 
1 ppm - 3.6 /Lig/liter
278 ppm 
0.278 ppm
Adapted from references 1-3,9,26,28
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TABLE XII-2
OCCUPATIONS WITH POTENTIAL EXPOSURE TO DIOXANE
Adhesive workers
Cellulose acetate workers
Cellulose ester workers
Cement workers
Cosmetic makers
Degreasers
Deodorant makers
Detergent workers
Dioxane workers
Dye makers
Emulsion makers
Fat processors
Fumigant workers
Glue makers
Histology technicians
Lacquerers
Lacquer makers
Metal cleaners
Adapted from reference 18
Oil processors 
Painters 
Paint makers 
Paint remover workers 
Plastic makers 
Polish makers 
Printers 
Resin makers 
Shoe cream makers 
Solvent workers 
Stainers 
Stain makers 
Textile makers 
Varnish makers 
Varnish remover makers 
Varnish removers
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